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S u m m a r y
The first system atic documentation of dynamic cerebral vascular changes 
associated with focal seizures was made by Penfield in the thirties. In recent years in 
vivo imaging techniques, principally single photon emission computed tomography 
(SPECT), have been used to study regional cerebral blood flow (rCBF) in patients 
with focal epilepsy. The main finding has been of focal hypoperfusion, the location in 
the brain differing according to the site of the focus. The incidence and clinical 
associations of this finding have varied, and few large studies have been carried out. 
Until the development of the blood flow tracer HMPAO (hexamethylpropyleneamine 
oxime) there was no practical way to study regional cerebral blood flow during or soon 
after seizures. When the present work was started no studies existed, although several 
have appeared during its course. Only complex partial seizures of temporal lobe origin 
have been systematically studied.
This work aims to define the incidence and clinical associations of interictal 
abnorm alities of regional cerebral blood flow in patients with complex partial 
seizures, and to define the ictal and postictal patterns of regional rCBF seen  in 
association with such seizures. The work is divided into three parts:
1. A study of interictal rCBF in patients with complex partial seizures;
HMPAO SPECT was used to determine rCBF in 92 patients suffering from 
complex partial seizures. rCBF w as abnormal in 53% of the 81 patients with 
tem poral lobe seizures, the abnormality most commonly taking the form of 
hypoperfusion of the temporal lobe. The principal clinical association of abnormal 
regional cerebral blood flow was early age at onset of epilepsy. The 11 patients with 
complex partial seizures originating outside the tem poral lobe all had normal 
interictal regional cerebral blood flow.
2. A study of ictal and postictal regional cerebral blood flow in 42 of the above 
patients;
HMPAO SPECT was used to determine rCBF in 33 patients with complex partial 
seizures of temporal lobe origin. During the seizure, hyperperfusion of the whole 
temporal lobe was seen . Early in the postictal period, hyperperfusion of the 
hippocampus with lateral temporal hypoperfusion was seen , and in the late postictal 
period hypoperfusion of the whole temporal lobe was seen. Different patterns of rCBF 
were seen  in the 9 patients with complex partial seizures originating elsewhere in the 
brain .
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3. A study of regional cerebral blood flow, as  determ ined both by the 14C 
iodoantipyrine (IAP) and HMPAO methods, during focal motor seizures in the rat;
rCBF was determined during penicillin-induced focal motor seizures in 5 
rats, and in 5 control animals, using a double label method which permitted the 
autoradiographic determination of IAP and HMPAO uptake at adjacent time points in the 
sam e animal. The two m ethods produced similar patterns of optic density on 
autoradiographs, with good correlation between optic densities obtained, at high as 
well as low flows. The data support the use of HMPAO as a blood flow tracer during 
seizures. The changes in regional cerebral blood flow seen  were similar to changes 
seen  in studies of local cerebral metabolic rate in the sam e model of epilepsy, and had 
obvious broad parallels with changes seen in humans.
It is concluded that in focal epilepsy a proportion of patients have focal 
hypoperfusion in the interictal period, the main association of which appears to be 
early onset of seizures. Peri-ictal changes have as their main features hyperperfusion 
at or around the focus, with more distant hypoperfusion, which becom es more 
prominent in the postictal period. These changes are in accord with early observations 
in humans, and with changes found in animal models of focal epilepsy.
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Chapter 1
General introduction 
E p ilep sy
Epilepsy is a common disease, with a prevalence of approximately 1:200 of the 
general population (Hauser & Kurland, 1975)). It com prises a group of disorders 
which have as their common pathophysiological them e an increase in cerebral 
neuronal excitability which leads to a tendency to recurrent paroxysmal discharges. 
These discharges are responsible for the common clinical theme of the epilepsies, the 
seizure.
Focal vs. generalised epilepsy
The epilepsies may be divided into generalised and focal disorders. Generalised 
epilepsies have as their basis a tendency to excitability throughout the grey matter of 
the brain. Most generalised epilepsies, such as juvenile myoclonic epilepsy, are 
thought to have a genetic basis (Delgado-Escueta & Greenberg, 1984; Noebels, 1984). 
Focal epilepsies have as their basis a tendency to excitability which is localised to one 
point or, more correctly, a specific volume of grey matter in the brain. This usually 
occurs in the grey matter a t the margin of an area of tumor, or of scarring which 
results from a local injury of some kind, or in an area of cortical dysgenesis. The 
injury may be mechanical (head trauma), metabolic (local effects of hypoxia of 
ischaemia) or infective (meningitis, encephalitis)(M argerison & Corsellis, 1966; 
Corsellis & Meldrum, 1976; Robitaille et al., 1992).
Complex partial seizures
Focal seizures take a  variety of forms, depending on the site of the focus and its 
anatomic connexions. The most common form of focal seizure in the adult human is the 
complex partial seizure, which is the main reason for it being chosen for study in this 
work. The clinical hallmark of the complex partial seizure is the absence (Baldy- 
Moulinier, 1990). This is characterised by an immobile stare, which typically lasts 
up to 1 minute. Temporal lobe absences may be accompanied by tonic posturing and
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automatic movements, and may be preceded by an aura referrable to the area of origin 
of the seizure (e.g. deja vu feeling, hallucination of smell or taste). They are often 
followed by a period of confusion or somnolence, and sometimes headache. Frontal lobe 
absences are often brief, lasting a few seconds only, and may lack prodrome and 
postictal features. Onset and 'offset' are often abrupt. Automatisms tend to be more 
frenetic and bizarre than in temporal lobe seizures (Williamson et al., 1987). In both 
temporal and frontal epilepsies, secondary generalised seizures may also occur.
The majority of patients with complex partial seizures have foci in the 
temporal lobe, with a sizeable minority (10-15%) having foci in the frontal lobe 
(rarely complex partial seizures may originate in other areas) (Williamson et al.,
1 9 8 7 ).
The electrical and metabolic basis of focal seizures
The seizure is characterised by an electrical discharge. Recording from the 
surface, a typical series of electrical events may be seen  (Baldy Moulinier, 1990; 
Binnie, 1990). They are illustrated in Figure 1.1. The initial event is usually a 
flattening of the trace, which may be preceded by a series of interictal-type spike- 
wave discharges. The flattening may last up to a few seconds, and is progressively 
replaced by a  high frequency, low amplitude sinusoidal discharge (it may be that the 
flattening of the trace is simply due to the fact that the frequency of the discharge is at 
that point too high for the frequency sensitivity characteristics of current EEG 
technology). The discharge progressively augments in amplitude and, as it does so, 
diminishes in frequency. Clinically, this phase corresponds to the tonic (stiff) phase 
of the seizure (or to the stare phase of a complex partial seizure). This phase lasts 
from a few seconds to 1 minute or so. As frequency continues to diminish, the wave 
form becom es sharper, and spike or spike-w ave activity su pervenes. This 
corresponds to the clonic (jerking) phase of the seizure, and is variable in duration, 
lasting up to 1 minute typically. In the postictal period following this, there is a 
either slow wave activity or flattening of the trace, which gradually recovers to 
resting activity. This phase may be brief or absent, or may last many minutes. 
Clinically, the postictal period is characterised by drowsiness and/or variable levels 
of confusion.
Similar electrical changes may be seen during direct intracranial recordings 
(Figure 1.2). Direct intracranial recording removes problem s of muscle artefact, 
better defines the topography of the discharge, and allows the detection of low- 
arrplitude high frequency discharges which cannot be distinguished in surface 
recordings. The presently accepted relationship between macroscopic (surface or
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depth) and cellular recordings was described using data from the penicillin model of 
epilepsy in the cat by Ayala et al. (1970), and is illustrated in Figure 1.3. The ictal 
discharge is manifested by a period of reduced m embrane potential (paroxysmal 
depolarisation shift), during which there is a burst of action potentials (the 
macroscopic manifestation is the spike). W hereas the interictal spike discharge is 
followed by a period of hyperpolarisation (the macroscopic manifestation is the slow 
wave), the transition to an ictal discharge is attended by after-hypopolarisation of the 
membrane, resulting in repetitive and continuing action potentials (corresponding to 
the high-frequency discharge). As the seizure p rogresses, after-hyperpolarisation 
becom es progressively re-established, resulting in the action potentials becoming less 
continuous, again appearing in bursts. Macroscopically, this produces a reduction in 
the frequency of the discharge, and a change in morphology to spike-wave. Ayala et al. 
regarded the change from after-hyperpolarisation to after-hypopolarisation as 
important in the triggering of a seizure, and presented data to show that excitatory and 
inhibitory influences from other neurones were involved. This and other data 
(Sloviter, 1991) suggests that abnormal function of populations or networks of 
neurones, rather than single neurones is required for the triggering of seizures. Hence 
the concept of the 'epileptogenic zone', as opposed to the epileptic focus.
Intracranial EEG recording shows that ictal discharges may remain localised or 
may spread  into other parts of the brain through normal neuronal pathways, 
disrupting normal function, and giving rise to abnormal function. As Jackson (1890) 
was the first to realise, the nature of the clinical manifestations of the seizure are 
therefore related to the site of origin of the discharge, and its anatomic connexions. All 
the electrical activity involved in the seizure requires energy, much of which goes to 
power the ion pumps which restore ionic gradients after depolarisation. This requires 
delivery of glucose and oxygen, as well as the removal of carbon dioxide and hydrogen 
ions, requiring in turn an increase in perfusion.
Clinical, electrical, metabolic and circulatory effects are all, therefore, 
intrinsic and essential components of the seizure.
The pathogenesis of focal epilepsy
In a simplistic way, one can understand the pathogenesis of focal epilepsy as a 
series of events and effects as depicted in Figure 1.4. A tissue abnormality gives rise 
to a change in neurotransm itter function. This cau ses  the change in neuronal 
excitability, characterised  by the 'paroxysmal depolarisation shift' (Ayala et al., 
1970; Johnson & Brown, 1984 - see  above), which in turn gives rise to the tendency 
for paroxysmal neuronal discharges, which causes the clinical manifestation known as
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the seizure. The volume of tissue which gives rise to the seizure discharge is termed 
the 'epileptogenic zone'.
Seizures themselves may cause neuronal damage, probably by the 'excitotoxic' 
effects of excitatory neurotransmitters such as glutamate. This may apply either to the 
tissue around the primary focus, or to distant tissues. Where these tissues (e.g. the 
cerebellum (Duncan et al., 1990b)) are not potentially epileptogenic, then the effect 
is of loss of tissue and of function, which may manifest itself as cognitive impairment. 
W here dam aged tissues are potentially epileptogenic (e.g. the hippocampus), the 
phenomenon of 'secondary epileptogenesis' may occur (McNamara, 1984).
The relevance of interictal and ictal regional cerebral blood flow (rCBF) to focal 
epilepsy
In the normal brain, rCBF is closely coupled to regional metabolic rate (see 
below). An alteration in rCBF therefore represents a change in the level of function of 
neurones in a given volume of brain, or a change in the number of neurones. The 
imaging of rCBF in the interictal state therefore provides a m eans by which localised 
functional alterations resulting from cell loss or other processes may be detected. The 
imaging of rCBF during seizures provides a means of showing the location and extent of 
ictal ch anges in the level of neuronal activity, w hether reflecting primary 
involvement in the seizure discharge, secondary activation or inhibition.
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The control of the cerebral circulation
Cerebral autoregulation
The term autoregulation refers to the intrinsic ability of an organ or a 
vascular bed to maintain a constant perfusion in the face of blood pressure changes. In 
the brain, autoregulation is effective over a wide range of arterial blood pressures. 
Under normal conditions cerebral perfusion is maintained constant between mean 
arterial p ressures of 60 and 150mmHg (McHenry et al., 1974). Below the lower 
limit, vasodilatation continues although com pensating increasingly inadequately for 
falling arterial pressure (MacKenzie et al., 1979a). Below the limit of autoregulation 
cerebral function is preserved to some extent by an increase in oxygen extraction 
from the blood. Above the upper limit of autoregulation, segmental forced dilatation of 
arterioles and blood-brain barrier dam age occurs (Mackenzie et al., 1976; Skinhoj & 
S trandgaard, 1973).
Various m echanism s have been suggested to explain autoregulation. The 
myogenic hypothesis (Folkow, 1964) proposes that blood vessels constrict or dilate in 
response to changes in the transmural pressure gradient. Cerebral vascular smooth 
muscle and intact cerebral vessels do contract in response to increasing transmural 
pressure, but the mechanism of the effect is uncertain. It has been proposed that 
changes in intracellular mem brane potential are involved (Harder & Lombard, 
1985). There is also evidence that the vascular endothelium is involved; the 
constriction response of cerebral vessels to an increase in transluminal pressure has 
been observed to be abolished by disruption of the endothelium (Harder, 1984), while 
responses to direct stimulation by agonists such as 5HT are maintained. It has been 
suggested  that there are endothelium-derived substances which relax and contract 
vascular smooth muscle (Furchgott et al., 1984; Rubanyi et al., 1986), and the 
endothelium serves as a transducer in the autoregulatory response to pressure.
The metabolic hypothesis proposes that metabolic changes in the cellular 
m icroenvironm ent resulting from neuronal energy m etabolism  give rise to 
autoregulatory vascular responses (Kuchinsky & Wahl, 1978). Many mediator 
molecules for a metabolic mechanism of autoregulation have been suggested, including 
CO 2 , H+, K+, Ca2+ and adenosine (Kuchinsky, 1987). There is evidence against the 
involvement of some of these molecules, and it may be that an oxygen sensitive 
m echanism  is also involved (Wei & Kontos, 1984). The coupling of cerebral 
metabolism and blood flow is further discussed below.
There is evidence that perivascular nerves play a role in autoregulation. Nerve 
fibres originating from the superior cervical ganglia and cranial ganglia such as the
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sphenopalatine and otic ganglia provide sympathetic, parasympathetic and sensory 
innervations of the cerebral circulation (Edvinsson, 1975; Uddman & Edvinsson, 
1989; W alters et al., 1986).
The sympathetic system has a small effect on resting blood flow, but has a 
marked effect on cerebral blood volume (via cerebral capacitance vessels (Edvinsson 
et al., 1971)), and stimulation shifts the limit of autoregulation upward (MacKenzie 
et al., 1979b). This is partly because its effect is predominantly on larger vessels 
(Harper et al., 1972), so constriction reduces the flow available to smaller vessels, 
which then have to use their vasodilatory capacity to com pensate. Neuropeptide Y is 
colocalised with norepinephrine in sympathetic nerve endings in the CNS. It has a 
direct constrictor effect and potentiates the effect of exogenous norepinephrine and 
electrical stimulation (Edvinsson et al., 1987; Bevan, 1987).
Parasympathetic stimulation gives rise to an increase in cortical blood flow 
(Seylaz et al., 1988). Acetylcholine induced vasodilatation appears to result from 
activation of muscarinic receptors located on the endothelium of cerebral arteries, and 
the subsequent release of an endothelium-derived relaxing factor (Rosenblum, 1986). 
In som e species, acetylcholine produces cerebral vasoconstriction, which appears to 
be mediated by prostanoids (Armstead et al., 1989a). Vasoactive intestinal polypeptide 
is associated with cholinergic systems (Hara et al., 1985) and produces vasodilatation 
via a prostanoid-dependent mechanism (Wei et al., 1980).
Sensory fibres from the trigeminal ganglion may also be involved in cerebral 
vascular reflexes (Goadsby & Duckworth, 1987), and there is evidence that dilation of 
cerebral blood vessels can result from activation of CNS neural pathways (Ishitsuka et 
al., 1984, se e  below): e.g. electrical stimulation of the fastigial nucleus of the 
cerebellum in the rat produces increases in cerebral blood flow unaccompanied by a 
rise in metabolic rate (Nakai et al., 1983)). These neurogenic system s act via 
vasoactive neurotransmitter substances such as  vasoactive intestinal peptide (VIP), 
substance P, calcitonin gene-related peptide (CGRP) and others (Edvinsson et al, 
1987; Edvinsson et al., 1980; Duckies & Said, 1982; Uddman & Edvinsson, 1989).
The endothelium contributes to the control of cerebral vessels by the realease 
of endothelium derived relaxant (EDRF) and contractile (EDCF) factors. EDRF is 
thought to be nitric oxide, or a nitric oxide-containing substance (Marshall & Kontos, 
1990). Possible EDCF substances include prostanoids and a polypeptide substance 
called endothelin (Faraci, 1989). Endothelin causes vasoconstriction in the cerebral 
circulation, and d ec rease s  cerebral blood flow, an effect which is blocked by 
indomethacin suggesting that prostanoids mediate it (Sanchez-Ferrer & Marin, 1990; 
Armstead et al., 1989b).
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The coupling of cerebral blood flow and cerebral metabolic rate
Barbiturate anaesthesia that produces EEG silence reduces oxidative catabolism 
of glucose in the brain to 40% of normal levels, and a further reduction to 20% 
reduction occurs with inhibition of Na+K+-ATPase. This suggests that up to 80% of 
the 20 Watts generated by the energy metabolism of the brain goes toward maintenance 
of ionic gradients (Edvinsson et al., 1993a), and that this is the proportion that will 
vary according to the level of neuronal activity. The brain derives its energy almost 
entirely from oxidative catabolism of glucose, so oxygen and glucose delivery by the 
cerebral circulation must be responsive to cerebral metabolic rate on a moment-to- 
moment basis.
Increased neuronal activity such as is seen during seizures is followed almost 
immediately by an increase in perfusion (see below). Roy & Sherrington (1890) 
originally postulated that some product of cerebral metabolism mediated vasodilatation 
in response to neuronal activity. It was originally thought that the effect was mediated 
directly by the CO2  produced by oxidative metabolism of glucose (Sokoloff & Kety, 
1960), but it now appears more likely that the effect is m ediated through the 
resulting increase in hydrogen ion concentration and extracellular pH. (Edvinsson et 
al., 1993b). The effect may also be partly mediated through endothelium-derived 
factors such as nitric oxide (Wang et al., 1992).
Hypoxemia also causes cerebral vasodilatation and increases cerebral blood 
flow, but this m echanism  only o p e ra te s  at low oxygen tensions (below 
60mmHg)(Edvinsson et al., 1993b). There appears to be no influence on the response 
of the cerebral circulation to CO2  of CNS or extrinsic neural influences (Skinhoj & 
Paulsson, 1969).
The extrinsic neural system s mentioned above under the heading of 
autoregulation may be involved in flow-metabolism coupling. Scopolam ine, a 
cholinergic blocker with no direct vascular effect, can block rises in rCBF without 
affecting associated rises in metabolism (Pearce et al., 1981) and acetylcholine- 
induced vasodilatation occurs independently of rises in metabolic rate (Seylaz et al.,
1988). There is also evidence for the involvement of adrenergic, serotonergic, 
dopaminergic and other system s (Lou et al., 1987).
Intrinsic neural m echanism s may also be involved. In animal studies, 
electrical stimulation of som e brain areas, notably the dorsal medullary reticular 
formation and the cerebellar fastigial nucleus, can produce increases in rCBF which 
are independent of metabolism (McKee et al., 1976; ladecola et al., 1983; Nakai et al., 
1983), producing local or global uncoupling. Such data have been taken to indicate that 
an intrinsic neural system exists that is capable of influencing flow independently of 
metabolism in some situations. The neural pathways through which such a mechanism
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might operate are unknown (Lou et al., 1987).
During somatosensory stimulation in humans it has been noted that rCBF may 
rise out of proportion to the local rise in metabolic rate (Fox et al., 1986). Whether 
this represents uncoupling or a change in coupling param eters remains unknown. The 
slope of the relationship between blood flow and metabolism may change under certain 
experim ental circum stances which have pathophysiological counterparts (e.g. 
m etabolic acidosis, K+ deficiency (Kuchinsky, 1987)), and ch an g es in the 
relationship, rather than true uncoupling may be occurring. There appears to be little 
experimental evidence for true uncoupling (Kuchinsky, 1987; Lou et al., 1987).
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Studies of cerebral blood flow, cerebral perfusion and 
cerebral metabolic rate in epilepsy
Changes in cerebral blood flow (CBF) and metabolic rate (CMR) in epilepsy 
have been of interest from the point of view of their part in the pathophysiology of 
epilepsy, and in particular their possible involvement in the development of seizure- 
related neurological dam age. In recent years tomographic imaging methods (single 
photon emission computed tomography (SPECT) and positron emission tomography 
(PET)) have allowed the development of the clinical use of focal abnormalities of 
regional cerebral blood flow (rCBF) and local cerebral metabolic rate (ICMR) to 
localise epileptic foci prior to surgical resection. Many of the studies described below 
result from this.
The present work is concerned with blood flow rather than metabolism. 
Nonetheless, the two param eters are closely related and in most situations show 
parallel changes. This introductory review of the literature therefore includes studies 
of cerebral metabolic rate and studies of the relationship between metabolic rate and 
blood flow.
Early observations and studies of cerebral blood flow and metabolism in epilepsy
Cooper showed in 1836 that convulsions could be produced by carotid ligation, 
and suggested an ischaemic mechanism for epilepsy, but Penfield (1933; 1937) was 
the first to make systematic study of the dynamic vascular changes associated with 
seizures themselves. He pioneered the use of resective surgery for focal epilepsy and 
used intraoperative stimulation of the cerebral cortex in the area of the focus to 
induce seizures. He was therefore able to make direct observations of changes in the 
pial blood vessels. Because intraoperative induction of seizures is no longer carried 
out, no such observations have been made for many years. Penfield's were detailed and 
well documented, to the extent that an account of ictal changes in cerebral blood flow 
which is inconsistent with them should probably be regarded with circumspection.
He described a total of 49 examples of seizures in conscious patients whose 
cerebral cortex was open to direct observation on the operating table. He noted 
vascular changes in most of these cases, and categorised his findings as follows:
1 1
1. Cessation of arterial pulsation during a fit.
The alm ost invariable observation was arrest of visible pulsation of pial 
arteries. This was widespread in general seizures and focal where seizures were focal. 
It started and ended with the seizure, but pulsation might recur during the seizure if 
the latter were prolonged.
2. Postconvulsive hyperemia.
This was seen in a minority of patients, but was striking when it occurred. 
After the attack the cerebral arteries becam e bright red and highly pulsatile. The 
veins took on an arterial hue, and Penfield cited a remarkable observation of this. The 
patient had been stimulated, producing a unilateral focal motor seizure:
“One minute later my assistant, Dr. Thomas Hoen, called my attention to a 
curious stripe in some of the larger veins. An amazing change had taken place. The 
central portion of the parietal lobe was redder than the rest of the brain. This zone was 
bounded by large veins.
Into the tributaries of these large veins was flowing arterial blood from this 
reddened zone, while into tributaries from the outlying brain was flowing dark venous 
blood. The result was that the outer half of each vein was dark blue and the inner half 
dark red, the two stream s maintaining their separation as  when a muddy tributary
joins aclear river and fails to mix for a long distance  In such cases  it must be
concluded that the blood is passing rapidly through a widely opened capillary bed or 
that the tissues are for the time being incapable of taking up oxygen"
3. Focal blanching of the pia.
This might appear during the seizure, but more usually afterward.
4. Post convulsive arterial spasm.
This occurred from 15-30 min following the seizure, and w as sufficiently 
marked to occlude the artery. The spasm was markedly segmental, and tended to appear 
at the sam e time as pial blanching. He noted that this observation was less common in 
later operations, attributing this to the fact that smaller currents were used to induce 
seizures, inducing localised more often than generalised seizures.
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6. Cyanosis of the brain.
This was usually observed during major seizures, and accompanied systemic 
cyanosis.
7. Increase in local cerebral blood flow near the site of the focus.
Changes in blood flow were detected by means of a thermocouple heated above 
body tem perature and inserted into brain tissue. The degree of cooling of the 
thermocouple was related to the flow of blood through the surrounding tissue. Rises in 
local blood flow were seen  soon after the onset of the seizure, the time apparently 
depending of the distance between the site of origin of the seizure and the thermocouple 
In one case the thermocouple was 6cm from the focus, and the rise in blood flow was 
seen 1min after seizure onset. The increase lasted 4min after return of consciousness, 
and even then settled to a higher than basal level.
Penfield originally thought that these vasomotor changes produced ischemia 
which in turn caused the seizures, but Gibbs et al (1934) showed that there was no 
fall in cerebral blood flow preceding seizures, showing in fact that it increased, ruling 
out ischemia as  a cause, and Penfield (1937) accepted this. His conclusions were:
1. That during a seizure there was increased blood flow through the involved cerebral 
cortex. The area involved remained local even when the seizure becam e generalised.
2. That vasodilatation might continue after seizure activity had ceased. Post convulsive 
hyperemia was characterised by the appearance of oxygenated blood in the cortical 
veins.
3. Cyanosis and bulging of the brain were due to respiratory em barrassm ent, and had 
nothing to do with the epileptogenic mechanism.
Penfield et al. (1939) later studied local cerebral blood flow in Monkeys and 
humans in which seizures were induced by local cerebral stimulation. They used the 
heated thermocouple method used by Gibbs et al., inserting the thermocouple into 
brain tissue. They found increases in blood flow in the cortex contralateral to focal 
seizures, but not ipsilateral. Where generalised seizures were produced, the rise in 
blood flow occurred on both sides. They also found rises in blood flow in the basal 
ganglia, of greater magnitude than those in the cortex. Changes in subcortical white 
matter were small and sluggish. The cortical rises in blood flow, were detected 4-1 Os 
after the first convulsive movement, continuing for som e time after the convulsions
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had ceased. Thermocouples placed distant from the focus showed either no increase in 
blood flow or a preliminary decrease.
They concluded that their observations showed that changes in blood flow were 
due to local, not systemic, factors and were secondary to the sudden increase in 
neuronal discharge during a seizure. They observed in one attack that cessation of 
pulsation was coincident with the increase in blood flow, concluding from this that 
cessation of pulsation, whatever the cause, was not due to a decrease in flow.
These observations established the basic principles that seizures were 
associated with changes in cerebral blood flow, local in the case  of focal seizures, and 
(probably) generalised in generalised seizures, that these changes were secondary to 
the seizures rather than causal, and that they were to a great extent independent of 
systemic circulatory changes (though Mosier et al. (1957), White et al (1961), and 
Plum et al (1968) later showed that a rise in systemic blood pressure was necessary 
for the large rises in cerebral blood flow seen in generalised seizures). It was thought 
that blood flow followed the metabolic demand of brain tissue. This was consistent with 
the observations of Jasper & Erikson (1941), who noted decreases in cortical pH of 
cats during seizures, with those of Schmidt et al (1945) who used the nitrous oxide 
method to show increases in blood flow and metabolism in monkeys during seizures, 
and with those of Plum et al (1968) and Posner et al (1969) who showed that 
cerebral oxygen consumption rose substantially during induced generalised seizures in 
monkeys, and that oxygen supply kept pace with demand. Early studies of interictal 
cerebral blood flow in patients with seizures showed conflicting results. Gibbs et al 
(1946) and Grant et al. (1947) failed to find any difference in total CBF between 
normal patients and patients with epilepsy. Kennedy et al (1958) did find lower 
cerebral blood flow in a  group of 12 children with epilepsy. However, this was a 
heterogenous group which included children with mental retardation and other forms 
of cerebral injury who may have had extensive cerebral dam age. One might therefore 
expect low blood flow in such patients, whether epileptic or not.
Recent studies of cerebral blood flow (CBF and rCBF) and metabolic rate (CMR and 
LCMR) in epilepsy
In the last two decades there has been considerable study of cerebral 
metabolism and blood flow in seizure disorders, both in man and in animals. In man, 
PET and SPECT have allowed imaging and determination of regional cerebral blood flow 
and local cerebral metabolic rate for glucose (ICMRGIc) or cerebral oxygen 
consumption (ICMR02). Autoradiographic techniques using 14C iodoantipyrine and
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14C deoxyglucose have allowed similar studies in animals. Two major factors have 
shaped the course of these  studies. Firstly, there has until very recently been no 
practicable way to image changes in metabolism and blood flow during or soon after 
seizures in man, so that most studies to date are of humans in the interictal state. 
Secondly, the lack of a suitable animal model of chronic epilepsy has meant that animal 
work has been largely confined to the study of blood flow and metabolism during 
seizures.
Generalised epilepsy - interictal studies of CBF, rCBF, CMR and ICMR
Theodore et al. (1984; 1985) found normal local and overall cerebral 
regional glucose metabolism (ICMRGIc) in a total of 17 patients with primary 
generalised epilepsy, and Sakai et al. (1978) found normal rCBF in 9 patients. 
Touchon et al (1986), using the 133 Xenon technique, found normal rCBF in 14 
patients with primary generalised epilepsy. Engel et al (1983;1985) found normal 
interictal ICMRGIc in 4 patients with true petit mal epilepsy.
In summary, rCBF and ICMRGIc are normal in the interictal state in primary 
generalised epilepsy.
Generalised epilepsy - ictal and postictal studies of CBF, rCBF, CMR and ICMR
The early studies mentioned above suggested that there was a generalised 
increase in CBF during generalised seizures, and it was assum ed that the sam e held for 
brain metabolism. Further studies in man and in animals using the nitrous oxide 
method (Schmidt et al., 1945; Grant et al., 1947; Kety et al., 1948; Meyer et al., 
1965; Plum et al., 1968; Posner et al., 1969;) confirmed this, and showed postictal 
depression of CBF. The degree of the ictal rise in CBF varied between 140-500%, but 
the study of Meldrum and Nilsson (1976) found a rise early in generalised seizures in 
rats of 900%, by measuring venous outflow, and using the 133Xe desaturation method. 
They found also that the rise became less as seizure activity continued, to less than 
300% after 2 hours of seizure activity.
The limited number of PET studies available in humans have tended to confirm 
that these changes also occur in cerebral metabolism (Engel et al., 1982b; 1983; 
Engel, 1983; 1984). The long time frame of fluorodeoxyglucose (FDG) PET 
m easurem ent (approximately 10minutes) m eans that these  studies encom pass a 
relatively short period of ictal activity followed by several minutes of postictal
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depression . This probably explains som e stud ies which have shown 'ictal' 
hypometabolism. Interestingly, studies of generalised absence seizures have shown a 
greater rise in ICMRGIc (200-350%) than for tonic clonic seizures, probably 
because there is no depression of metabolism postictally. One study (Brodersen et al., 
1973) of patients undergoing electroconvulsive therapy, using the Xe133 carotid 
method showed increases in rCBF averaging 111% during seizures, but failed to show 
depression of flow postictally.
Autoradiographic studies in animals have shown increases in blood flow which 
are greatest in the hippocampus, thalamus and neocortex (Horton et al., 1980). Rises 
in metabolic rate have been greatest in the hippocampus and amygdala (Evans & 
Meldrum, 1984).
Blood flow rises within seconds of the onset of seizure activity (Meldrum & 
Nillsen, 1976), and the rise is g reatest in the first 4 minutes of seizure activity 
(< 900% ).
In summary, blood flow and metabolism rise several fold in the early part of a 
seizure, the rise becoming less if the seizure is prolonged, in animals at least. Human 
studies have shown post ictal depression of blood flow and metabolism.
Focal epilepsy - interictal studies of ICMR
Regional brain metabolism has been studied using PET, largely with O 15 or 
18FDG. The most common finding is focal hypometabolism in the temporal lobe that is 
the site of a focus, with some patients showing more w idespread or bilateral 
hypometabolism (Kuhl et al., 1980; Engel et al., 1982a; c; d; 1990; Bernardi et al., 
1983; Franck et al., 1986; Abou Khalil et al., 1987; Theodore et al, 1983; 1984; 
1986c; d; 1988). There may be a tendency for left hypometabolism to be greater than 
right (Theodore et al., 1986).
The proportion of patients in whom an abnormality is found appears to be 
higher using FDG PET, than using SPECT to image rCBF, in most series approximately 
80%, as  compared to 50-80% (see below). The reason for this difference is not clear. 
Kuhl et al (1980) studied a group of patients using 18FDG to image LCMR and 13NH3 
to image rCBF, and found similar results with both, and Franck et al (1986) found no 
variation in oxygen extraction ratio (OER) in hypometabolic zones in patients with 
focal epilepsy. By contrast, some PET studies Yamamoto et al., 1983; Leiderman et al.,
1989) have found that rCBF studies are less sensitive. Stefan et al (1987) used 
HMPAO SPECT and FDG PET to image rCBF and ICMRGIc in a group of patients and found 
that PET detected areas of hypometabolism that SPECT did not, albeit that the SPECT 
system was of relatively low resolution. Hypometabolism found using PET appears to
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persist on retesting (Kuhl et al., 1980). As might be expected, changes in the basal 
ganglia and thalam us appear to mirror those in the cortex (Sakai et al, 1978; 
Bernardi et al., 1983; Henry et al., 1990; Sperling et al., 1990).
The site of PET abnormalities correlates well with EEG localisation of the 
epileptic focus, although the extent of hypometabolism tends to be much greater than 
the epileptogenic area (Kuhl et al., 1980; Engel et al., 1982c; d; 1990; Theodore et 
al., 1984; Abou Khalil et al., 1987). It does not correlate with the amount of spike 
activity detected during the scan (Engel et al., 1982d; Theodore et al., 1983). PET 
hypometabolism correlates well with the presence of anatomical lesions on CT and 
MRI, (Engel et al., 1982a; Theodore et al., 1984; 1986c; d; 1988; Stefan et al., 
1985; Latack et al., 1986), although one study (Sperling et al., 1986) noted the 
reverse, i.e. a tendency for for patients with normal MRI to have abnormal PET and 
vice versa. As with interictal hypoperfusion, the hypometabolic area tends to be much 
larger than the anatomical lesion itself. The sam e holds for the finding of pathological 
abnormalities (usually mesial temporal sclerosis) in surgically resected specim ens; 
in most studies the finding of temporal hypometablism is a good predictor of the 
finding of a pathological abnormality (Engel et al., 1982a; Theodore et al., 1984). 
Theodore et al (1988) found that the length of history of epilepsy in a group of 20 
patients correlated inversely with their m ean LCMRGIc, but that there w as no 
correlation with the age of the patient or the age at onset of epilepsy. Anticonvulsant 
drugs such a s  barbiturate and phenytoin tend to reduce LCMRGIc, as  does 
carbamazepine to a lesser extent (Theodore et al., 1983; 1986a; b; 1987; 1988).
Focal epilepsy - interictal studies of rCBF
Initially, rCBF was studied using 133Xe, inhaled, injected intravenously or 
into the carotid artery, in conjunction with multidetector scintillation cam eras. Over 
the last decade, the principal methods used to study rCBF have been the carotid intra- 
arterial and intravenous xenon methods, SPECT (using either rotating gamma cam eras 
or dedicated head imagers, with xenon, IMP (Holman et al., 1984), HIPDM (Holman et 
al., 1984) or latterly HMPAO (Neirinckx et al., 1987) as tracers), and PET, using 
the oxygen inhalation or intravenous ammonia techniques. One study (Fish et al., 
1987) used the XeCT method.
The xenon mutidetector method did give quantitative results, but suffered the 
draw backs of low spatial resolution and poor repeatability. They w ere non 
tomographic, essentially measuring only cortical blood flow. Results were expressed 
as raw figures over a relatively few areas of interest, rather than generating images. 
Studies of complex partial epilepsy found areas of reduced flow (Lavy et al., 1976;
17
Touchon et al., 1983; Valmier et al., 1987; 1989), while one study mainly of 
patients with focal motor epilepsy (Hougaard et al., 1976), by contrast showed focal 
increases in blood flow. Two studies (Touchon et al., 1983; Valmier et al, 1987) 
using the Xe methods have found, as well as focal reductions in rCBF in the temporal 
lobe, either generalised reductions in rCBF or lesser areas of reduced flow distant 
from the focus. There was also a tendency for the reduction to be greater when it was 
on the left (Valmier et al., 1987). Valmier et al. (1989) also used the Xe IV technique 
to investigate the effect of photic stimulation on rCBF in patients with complex partial 
seizures. The patients had no evidence of photic responses on EEG but appeared to show 
increases in rCBF around the sites of foci on stimulation. The patterns seen  were 
different in lesional as opposed to non-lesional cases. Whether the phenomenon was 
anything to do with epilepsy rather than simple activation is uncertain. Tomographic 
imaging has the advantages of greater resolution and visualisation of deep structures. 
SPECT has been most widely used. Although its resolution is rather poorer than PET 
and it produces images which cannot be quatitated absolutely, it is vastly cheaper and 
easier to perform.
SPECT, using 133Xe, 1311 IMP, 1311 HIPDM or Tc99m HMPAO as tracers 
has been carried out on a large number of patients with focal epilepsy, in most cases 
temporal lobe epilepsy. In the majority of c a se s  the main finding is of focal 
hypoperfusion, usually involving all or most of the temporal lobe. The area  of 
hypoperfusion may be larger than this, extending into the ipsilateral frontal lobe or 
involving the whole hemisphere, and may occasionally be bilateral. Abnormalities 
have been found in between approximately 50% and 80% of patients in most series 
(Uren et al., 1983; Bonte et al., 1983; Podreka et al., 1988; Ryding et al., 1988, 
G rasso et al., 1989; Duncan et al., 1990a; c; d; Stefan et al., 1987; 1990). The little 
published da ta  available (Jibiki et al., 1990) su g g es t that focal interictal 
hypoperfusion is a stable finding, although one study did find perfusion deficits in 
some patients in whom SPECT was repeated after an initially normal scan (Shen et al.,
1 9 9 0 ) .
Some series (Uren et al., 1983; G rasso et al., 1989; Stefan et al., 1990; 
Duncan et al., 1990a; c; d) have found a proportion (up to 30%) of patients who 
showed focal hyperperperfusion interictally, or a combination of hypoperfusion and 
hyperperfusion in different areas or even contralateral to each other. In one study 
(Duncan et al. 1990a), 10 patients showing interictal hyperperfusion, were 
rescanned at a later date and the finding was then present in only 5. It has been 
suggested that 'interictal' hyperperfusion is due to subclinical seizure activity, but 
many of the patients with this finding (Duncan et al., 1990a; c; d) have had HMPAO 
injection with concurrent EEG monitoring, and showed no sign of ongoing seizure 
activity, at surface electrodes at least. Occasionally such areas of hyperperfusion are
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large, and it is difficult to believe that they represent areas of increased neuronal 
activity when both behaviour and EEG are normal. Interictal hypermetabolism appears 
to be a less frequent finding in PET studies (Engel et al., 1982d).
The correlation between abnormalities of rCBF and EEG has been variable. In 
general, studies showing a high proportion of patients with localising abnormalities 
(Biersack et al., 1986; Valmier et al., 1987; Podreka et al., 1988) tend to have a 
proportion of patients in whom SPECT localisation disagrees with EEG, while studies 
showing a low abnormality rate tend to have few disagreem ents (Rowe et al., 1989b; 
1990; 1991a; b; Newton et al., 1992). This would appear to suggest that only 
hypoperfusion of unequivocal degree is reliably localising, and that a rea s  of 
hypoperfusion of lesser degree represent variations of normal or are epiphenomena. 
W here CT or MRI have shown a lesion in a patient with abnormal rCBF, the site 
correlates well but the area of hypoperfusion is usually much larger than the lesion. 
This is also true for abnormalities found pathologically in resected surgical specimens 
(Stefan et al., 1987; Rowe et al., 1989b).
The correlation between abnormalities of rCBF and clinical factors has also 
been variable. Valmier et al (1987) found that d ecreases  in in rCBF correlated 
significantly with seizure frequency, but not with age at onset or duration of disease. 
Duncan et al (1990c) found a significant relationship between age at onset of epilepsy 
and abnormal rCBF, finding that patients with early onset d isease were much more 
likely to have abnormal rCBF. No relationship was found with severity of d isease or 
patient age. One study of the effect of the initiation of carbamazepine therapy on rCBF 
(Valmier et al., 1990) showed an initial generalised increase which fell back to basal 
levels at 4 months.
Focal epilepsy - ictal and postictal studies in ICMR and rCBF
PET may be used to study brain metabolism or blood flow during seizures, but 
suffers from the disadvantage that the patient must be scanned while the seizure is 
taking place. Despite this, a few patients have been studied, and have shown 
hypermetabolic zones around the site of epileptic foci (Engel, 1983; Engel et al., 
1983; Franck et al., 1986; Theodore et al., 1983; 1984), in 1 case  extending to 
involve the whole ipsilateral hem isphere (Engel, 1983). Engel et al (1983) also 
found an area  of hypometabolism surrounding the hypermetabolic area. A further 
problem with the use of FDG PET to study ictal metabolism is its relatively long 
temporal resolution, making the interpretation of th e se  changes difficult when 
metabolism may be changing from moment to moment (Engel et al., 1983).
Franck et al. (1986) studied 5 patients during status epilepticus, 2 with
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epilepsia partialis continua, and 2 with continuous lateralised epileptic discharges. All 
showed focal increases in metabolism corresponding to the area of the discharge, and 
including the basal ganglia and thalam us ipsilaterally. The oxygen extraction 
ratioincreased in these areas suggesting that the increase in perfusion was adequate for 
metabolic demand.
SPECT has been used more widely to study blood flow during and soon after 
se izu re s . Amine trace rs  such a s  HIDPM (N,N,N '-trimethyl-N '-(2-hydroxy-3- 
m ethy l-5 -123l-iodobenzy l)-1 ,3 -propaned iam ine 2 HCL) and  IMP (123I-N- 
isopropyl-p-iodoamphetamine) were used initially (Holman et al., 1984), and more 
recently HMPAO (Neirinckx et al., 1987). These tracers are distributed in brain 
according to regional perfusion and are then trapped for a period. Their pattern of 
distribution in the brain, and that of the isotope with which they are labelled, remains 
constant no matter what changes in rCBF subsequently take place. The patient need not 
therefore be in the scanner when the seizure takes place. Using HIPDM SPECT, Lee et 
al (1986; 1987a; b; 1988) and Shen et al.(1990) showed inreases in rCBF in the 
temporal lobes of patients during complex partial and partial onset tonic-clonic 
seizures. They noted that increases in rCBF persisted postictally. HIPDM is distributed 
in brain over a relatively long time frame (up to 10 minutes (Holman et al., 1984)), 
while HMPAO is distributed rapidly following injection, and therefore gives good 
temporal resolution, in the order of a minute or less. This allows more confident 
interpretation of images where, as during or soon after a seizure, the pattern of rCBF 
may be changing rapidly. Although the evidence is built up from a series of 'spot' 
m easurem ents in different patients, data which have been published while this work 
was in progress have suggested that there is a sequence of 3 patterns of alteration of 
rCBF during and after seizures of temporal lobe origin (Rowe et al., 1989b; 1990; 
1991b; Newton et al., 1992). During the seizure, there is hyperperfusion of the 
whole temporal lobe. In the immediate postictal period (up to 2 minutes after the end 
of the seizure) there is persisting hyperperfusion of the mesial temporal cortex, with 
hypoperfusion of the lateral cortex. Up to 15 minutes after the end of the seizure there 
is hypoperfusion only, which again might be localised to the temporal lobe or more 
widespread.
Only two studies have been published including seizures originating in sites 
other than the temporal lobe (Stefan et al., 1990; Marks et al., 1992). Ictal scans in 
these studies showed hyperperfusion at the sites of extratemporal foci in a total of 15 
patients.
2 0
Ictal studies of ICMR and rCBF in animal models of focal epilepsy
Ictal studies in animal models of focal epilepsy have largely been of 
metabolism using the deoxyglucose method, with the aim of delineating the structures 
through which seizure activity spreads. In the main, seizures originating in the motor 
cortex (induced in most cases  by local penicillin injection) or in the amygdala or 
hippocampus (induced by kindling, electroshock, penicillin injection or kainic acid 
in jection).
In the area  of the penicillin focus in the motor cortex, there is a 
circumscribed area whose metabolic rate is increased 2-3 fold. The surrounding 
cortex, has normal or depressed metabolism. Depressed metabolism is also seen  in 
cortical areas distant from the focus. Lesser degrees of increased metabolism are seen 
in columnar patches of the homotopic cortex (Collins, 1976). Increases in 
metabolism are also seen in homolateral and contralateral cingulate gyri, caudate and 
globus pallidus (Collins, 1978).
Where seizures are induced in the limbic area  (medial entorrhinal cortex) 
increases in metabolism are seen  in the dentate gyrus, Ammon's horn (with small 
increases contralaterally), ipsilateral am ygdala and nucleus accum bens. During 
severe seizures the hippocamapal formations are activated bilaterally, as  are 
am ygdala, accu m b en s, su b stan tia  nigra (pars  re ticu la ta), an terio r and 
periventricular thalamic nuclei, septal nuclei (Blackwood et al., 1981; Collins et al, 
1983; Lothman et al., 1985), increases being from 30-180%, highest in limbic 
s truc tu res.
Coupling of blood flow and metabolism in epilepsy
The few studies of both blood flow and metabolism in patients with interictal 
hypometabolism suggest that the tissue is not ischaemic (Kuhl et al., 1980), and that 
reduced perfusion is probably due to reduced function. Early studies attempting to 
determine whether the brain becam e hypoxic during seizures (i.e. was the rise in 
blood flow adequate for metabolic demand) yielded conflicting results (Jasper & 
Erickson, 1941; Davis et al., 1944; Stone et al., 1945; Davies & Redmond, 1947; 
Gurdijan et al., 1947; Meyer et al., 1965), partly because of difficulty in eliminating 
the effects of systemic metabolism. Detailed work by Plum et al (1968) and Posner et 
al. (1969) showed that the increase in CBF during seizures was in excess of that 
required for adequate oxygenation of the brain as a whole. They also showed that the 
venous oxygen tension rose after generalised seizures, giving a counterpart in 
generalised seizures to Penfield's observations of saturated venous blood draining from
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areas of brain involved in focal seizures, and showing that blood flow remained high 
after cessation of seizure activity. Neurological dam age is known to occur during 
prolonged seizure activity, both in animal models and in humans (Norman, 1964; 
Corsellis & Meldrum, 1976). In animal studies the brain areas affected tend to be 
those which becom e hypermetabolic and hyperperfused, in animal studies, both 
neuronal hyperactivity, with concomitant increase in ICMRGIc and rCBF, and its 
persistence for 25-30 minutes appear to be necessary  for the developm ent of 
neuronal necrosis (Ingvar, 1986). (This may parallel the increased incidence of 
chronic temporal lobe epilepsy and its associated medial temporal sclerosis when 
childhood febrile convulsions are prolonged (Nelson & Ellenberg, 1976)). Although 
some studies in rats have shown local mismatches between perfusion and metabolism 
during seizures (Ingvar & Siesjo, 1983; Ingvar et al., 1984; Tanaka et al., 1990), 
differences in timing of the measurements of measure blood flow and metabolism, and 
the known tendency of the IAP method to underestimate high flows (see chapter 4 of 
this work), make the significance of this finding uncertain. PET studies using the 150  
steady state and bolus inhalation techniques in human status epilepticus suggest that 
blood flow is adequate for metabolic demand (Franck et al., 1986), although the 
resolution of in vivo imaging techniques may not be sufficient to show very localised 
changes.
2 2
Rationale for the present work
1. Interictal rCBF in focal epilepsy
The results of studies of rCBF in patients with complex partial seizures have 
varied considerably, in terms of the proportion of patients showing abnormalities, the 
types of abnormality shown, the correlation of these  abnormalities with clinical 
factors and EEG localisation. Possible reasons for these variations include;
1. Relatively small (<40 patients) populations have been studied.
2. The populations studied have in general included only patients who are having 
frequent seizures, making correlation with other factors difficult.
3. Most studies have utilised imaging equipment of insufficient spatial resolution to 
distinguish important anatomical structures.
4. Reporting practices have varied, some groups using visual analysis only, some also 
using numerical analysis. Thresholds for reporting abnorm alities are often not 
defined.
To try to resolve the differences between previous studies, a study with the 
following characteristics has been carried out;
1. The patient population (92) is larger than in previous studies
2. The patient population includes a wide range of clinical characterictics
3. High resolution imaging equipment is used
4. Both visual and numerical analysis of images are performed
2. Ictal and postictal rCBF in focal epilepsy
Seizures cannot be predicted, and m easurement of rCBF during them is made 
very difficult by the acompanying behavioural alterations. The first practicable 
method for studying rCBF during or soon after seizures was therefore SPECT using 
iodine labelled amphetamine compounds. The compound could be injected at the time of 
the seizure. Its pattern of distribution remained after the initial uptake and scanning 
could therefore take place after the patient had recovered from the seizure. Several 
studies were carried out, but amphetamine compounds suffered from the problem that 
contamination of I131 with I133 increased the effective radiation dose and degraded 
images. In addition, uptake into brain tissue was over a period of minutes, blurring 
temporal resolution at a time when rapid changes are taking place. 99mTc labelled
23
HMPAO overcame all these problems, and the results of 3 studies have been published, 
suggesting a series of changes following complex partial seizures of temporal lobe 
origin. These changes have yet to be confirmed, and no helpful data have been presented 
regarding complex partial seizures of extratemporal origin.
A study of ictal and postictal rCBF has therefore been carried out of 42 
patients with complex partial seizures, originating in the temporal lobe in 33 and in 
extratemporal sites in 9, to define patterns of change during and after complex partial 
seizures, and to determ ine whether CPS of extratem poral origin show different 
changes.
3. Validation of 99mTc labelled HMPAO as an indicator of rCBF in epilepsy.
It has been shown that the relationship between HMPAO uptake and rCBF is not 
linear. As flow becomes higher, the rate of increase in HMPAO uptake becom es less. 
This is because the changes from a lipophilic to a hydrophilic compound takes enough 
time for a degree of washout to occur after the first pass  bolus has passed  through 
brain tissue. This effect is clearly more marked at higher flow rates and theoretically, 
once flow has reached a certain level, the amount of HMPAO retained will start to 
decrease as flow rises further, rather than increase. The effect has been modelled 
mathematically and has been detected experimentally in normal rats, and in models of 
ischemia as  a fall-off in the rate of increase of HMPAO uptake as flow rises. A 
correction factor has been derived by Lassen (Lassen et al., 1988) which linearises 
the relationship. During seizures, however, very high flows indeed may occur, in 
human and animal studies up to 5 times normal rates, and no validation of HMPAO has 
been carried out in this situation.
A study of rCBF in penicillin induced focal seizures in the rat has been carried 
out using 14C labelled iodoantipyrine and " mTc labelled HMPAO in a double-label 
technique, to see  whether the relationship between rCBF and HMPAO uptake remains 
linear at the flow rates seen during seizures
Aims of the present work
This work includes studies of interictal, ictal and postictal changes in rCBF in 
a series of patients with complex partial seizures of both temporal and extratemporal 
origin. The aims of these studies are;
1. To define the changes in rCBF seen interictally, ictally and postictally in patients
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with complex partial seizures of temporal lobe origin, and to determine how such 
patterns of change differ from those seen in patients with complex partial seizures of 
extratem poral origin.
2. To determine the clinical, EEG, imaging and pathological associations of rCBF 
changes.
3. To validate the radiotracer used in these studies using an animal model of epilepsy.
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I l lu s t r a t io n s
Figure 1.1.
S urface EEG recording of a  tem poral lobe se izu re  with bilateral su rface 
manifestations. On channels 6 and 15 the initial flattening of the trace followed by the 
gradual appearance of a high frequency discharge can be most clearly seen.
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Figure 1.2
Intracranial EEG recording of a  temporal lobe seizure. On the channel indicated 
(recording from the hippocampus) a flattening of the trace can be seen , followed by 
the progressive appearance of a  high frequency discharge. The discharge is initially 
sinusiodal, but becom es progressively sharper in appearance a s  the frequency 
diminishes and the amplitude increases.
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Figure 1.3
The relationship between potentials recorded on the cellular and macroscopic levels 
during interictal and ictal discharges (From Ayala et al., 1970).
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Figure 1.4
Schematic representation of the pathophysiology of focal epilepsy.
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Chapter 2
Interictal regional cerebral blood flow In patients with complex 
partial seizures 
In tro d u c t io n
Previous studies of interictal rCBF in patients with focal epilepsy are 
described in the general introduction to this work. The majority of patients in these 
studies have had epilepsy of temporal lobe origin. With one exception these studies 
have individually been of relatively small numbers of patients, have been carried out 
using a variety of tracers and scanning methods, or have been carried out using 
equipment of relatively low spatial resolution. Most studies have included patients 
with intractable seizures, few including patients whose seizure control is good. Some 
have included patients with anatomic lesions.
The results of these studies have varied, in terms of the proportion of patients 
in whom abnormal rCBF is found, what abnormalities are seen, and how they correlate 
with clinical factors and the results of such investigations as EEG and structural 
imaging (CT and MRI). One can hypothesise that this is because the of heterogeneity of 
previous studies.
This study sets out to determine, in a population of 92 patients with complex 
partial seizures, without gross anatomical lesions, and with a full range of seizure 
control;
1. What proportion of patients have abnormal interictal rCBF.
2. What types of abnormality are found.
3. What clinical factors correlate with rCBF abnormalities
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Subjects
The subjects were 92 (48 male, 44 female) patients with complex partial 
seizures + secondary generalised seizures. They were divided into temporal and 
extratemporal groups according to their clinical features, and the results of MRI and 
interictal and ictal EEG recordings. All patients had CT, and 0.15T MRI with coronal T1 
and T2 temporal lobe views. Patients with gross anatomic lesions were excluded from 
the study.
The clincal characteristics of individual patients are given in Table 2.1, with 
descriptive statistics of temporal and extratemporal groups in Table 2.2. The patients 
were gathered from 2 sources;
1. General neurology clinics.
2. A clinic for intractable epilepsy, including patients being worked up for surgical 
treatm ent.
Patients from the first source included a majority whose seizures were well 
controlled, while the patients from the second source all had unacceptably high seizure 
frequencies despite the best available medical therapy. Only patients in whom clinical 
localisation of the focus was supported at least by the results of multiple surface EEG 
recordings were included. In 48 patients surface ictal EEG recordings also supported 
the localisation (24 also had sphenoidal recordings, and 20 had foramen ovale 
recordings). In 23 patients localisation was supported by focal areas of signal change 
on MRI, including 9 patients who otherwise had only interictal EEG localisation.
1. Temporal group
All 81 patients in this group had clinical features in the aura, the seizures 
itself or in the postictal manifestations to suggest temporal lobe involvement (e.g. 
abdominal aura, duration of stare of >1 minute, prominent postictal features such as 
automatisms, confusion, drowsiness), and epileptiform abnormalities on interictal 
EEG localised to one or both temporal areas. Ictal EEG recordings supported temporal 
lobe origin for for seizures in 39 patients, with sphenoidal recordings in 28 and 
foramen ovale recordings in 22. MRI supported interictal localisation in 21 patients. 
The clinical characteristics of the temporal group are given in Table 2.2
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2. Extratemporal group
All 11 patients in this group had clinical features suggesting extratemporal 
origin for seizures; ten patients had short (<20s) absences with no prodrome and 
rapid recovery, suggestive of frontal origin. One of these patients also had atonic 
seizures. The remaining patient had complex partial seizures with a  visual prodrome 
suggesting occipital origin. In 9 patients interictal localisation to one or other frontal 
lobe was supported by ictal EEG surface recordings. Frontal signal abnormalities were 
seen on MRI images in two patients. The patient with clinical ictal features suggestive 
of an occipital seizure source had ictal EEG recordings suggesting left occipital origin 
for her seizures. The clinical characteristics of the extratemporal group are given in 
Table 2.1, with descriptive statistics in Table 2.2.
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Methods
SPECT method: HMPAO
HMPAO (hexam ethy lpropyleneam in  oxim e - C e re tec , A m ersham  
International) is a lipophilic oxime (Neirinckx et al., 1987). It is injected 
intravenously. It is distributed throughout the pulmonary and systemic circulation, 
4% of the intravenous dose of 500MBq eventually reaching the brain. Brain uptake is 
in the pattern of rCBF. After intravenous injection, 85% of brain uptake occurs in 30 
seconds, the other 15% occurring substantially in the subsequent 30 seconds (Lassen 
et al., 1988; see Appendix, Fig. 4). Inside brain tissue, by a mechanism unknown, the 
molecule becom es hydrophilic, and cannot recross the blood brain barrier. It is 
therefore trapped in brain tissue in the distribution of rCBF at the time of the first 
pass  through brain tissue after the injection. Because of the small fraction of HMPAO 
taken up into brain in the subsequent 30 seconds, a large change in rCBF during this 
time may be reflected in the final distribution of HMPAO. This final distribution 
remains relatively constant for 8h, and scanning can therefore be carried out during 
that time, although the 6h half life of T c " m means that the sooner the scan is carried 
out, the better the image.
The characteristics of this compound and previous work relating to it are 
further discussed in Chapter 4, methods section, and in the Appendix.
SPECT method - HMPAO injection
Visual and other stimuli may cause neuroactivation and significant focal 
increases in cerebral perfusion (Woods et al., 1991), so the patients were injected 
lying awake in a quiet room with eyes closed.
SPECT method - image acquisition
The scanner used in this work is a Strichmann 810 dedicated head imager. The 
software supplied with the system runs on an Apple computer, which controls the 
gantry, and produces and analyses the images. Scanning was carried out within 2h of 
injection producing 12mm axial slices through the brain. The software used with the 
imager allows reconstruction of these images in any chosen plane including coronal, 
saggittal and axial, with any degree of tilt. Slice acquisition time was 3 minutes, total
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acquisition time 30-60 minutes depending on the number of slices required to image 
the whole head, and depending on whether the slices overlapped (in some patients, 
overlapping slices were acquired -this had the effect of slightly improving image 
quality in the coronal plane, but did not affect data as displayed or analysed in other 
p ianes).
SPECT method - visual analysis of images
The im ages were reported independently by visual interpretation by 2 
investigators (including the author), using orbitomeatal, transaxial and coronal views 
of the whole brain. In eqivocal cases, the final report was determined by consensus 
conference. The images were analysed blind to data other than the diagnosis of epilepsy.
With a non-quantitative technique such as HMPAO SPECT it is not possible to 
say absolutely whether, for example, a volume of uptake higher than that in the rest of 
the brain represents high perfusion in that area or low perfusion in the rest of the 
brain. Reports were therefore based on the assumption that where one volume of the 
brain is different from the rest, then it is the smaller volume which was more likely 
to be the abnormal one. In assessing cortical areas, comparisons were made with both 
contralateral homotopic structures, and with ipsilateral structures, a s  well a s  with 
subcortical and subtentorial structures.
Only those abnormalities which were seen on more than one 12mm slice were 
considered significant. This practice is adopted to prevent over-interpretation of 
abnormalities due to small variations in grey matter density, or the effect of small 
degrees of tilt or anatomic asymmetry, where the boundary between two areas of 
different flow were near-parallel to the plane of the slice.
SPECT method - numerical analysis of images
Numerical analysis of images was carried out using the software supplied with 
the Strichmann system. The regions of interest analysed used were;
1. Frontal - anterior frontal cortex
2. Mesial temporal - hippocampus from anterior midbrain to amygdaloid nucleus
3. Lateral temporal - from 2 cm behind temporal pole to the level of the posterior 
midbrain 4. Basal ganglia - head of the caudate nucleus and surrounding area
5. Thalamus
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6. Parietal - the area posterior to the central sulcus 2cm superior to the level of the 
sylvian fissure
7. Occipital - calcarine cortex, sufficiently superior to include no cerebellum
Typical regions of interest are illustrated in Figure 2.1 -2.3. They were 
determined by reference to an MRI brain atlas in consultation with an experienced 
neuroradiologist.
Each region was analysed on the slice orientation displaying the anatomy best. 
In practice, these were transaxial slices in the case  of temporal lobe regions, and 
orbitomeatal slices for other regions. Analysis was carried out on 24mm (i.e. double 
thickness) slices.
The system software calculated the number of counts per area of the region of 
interest defined. An asymmetry index was calculated for each ROI as follows;
100 * (R  - L) /  ((R + L) / 2)
where R and L were the count density in right and left homotopic regions of 
interest. This index gives a positive value where the count density is greater on the 
right. This obviously may be the case whether this is due to right sided hyperperfusion 
or left sided hypoperfusion.
The upper limit of normal for the asymmetry index was fixed at 9%, based on 
data from a series of 10 normal subjects (Duncan et al., 1990a), and normal data 
from the literature (Rowe et al., 1989b; 1991a; b - see  discussion).
Numerical analysis was carried out blind to the results of visual analysis.
SPECT method - numerical assessm ent of visual analysis
In a separate experiment, mesial and lateral temporal regions were identified 
and a ssessed  visually for symmetry on 54 images by the sam e investigators who 
analysed the images from the main study. Mesial and lateral temporal regions of 
interest were defined on the sam e slices by an investigator who was blind to the 
results of the visual assessm ent of the regions, and asymmetry indices were calculated 
as above.
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Acquisition of clinical data
Clinical data were acquired by means of a combination of review of case notes 
and patient interview. The data acquired were;
1. Patient age
2. Age at onset of epilepsy
3. Length of history of epilepsy
4. History of febrile convulsions or other antecedent for seizures
5. History of secondary generalised convulsions
6. Seizure frequncy in the 3 months before scanning
6. Estimated seizure frequency throughout life
7. Estimated total number of seizures
8. Time between last reported seizure and scan
Defining the 'interictal' period
The term 'interictal' may be defined clinically, or in terms of the results of an 
investigation, such as psychometric evaluation or EEG. The length of time it takes each 
of these  param eters to return to whatever is normal for the patient may be very 
different. Following a seizure the EEG, for example, may remain abnormal even some 
days after the event, and after the patient has returned to feeling and behaving 
normally (Gotman, 1991). How long after a seizure the patients can be said to be 
'interictal' depends on the parameter used, each parameter having its own postictal and 
interictal periods. Ideally, one would define 'interictal' in terms of when the rCBF 
abnormalities seen  during and soon after a seizure return to the resting state. This 
would require multiple rCBF studies and could not, of course be done for each patient, 
or even in any one patient, for reasons of radiation exposure. Nor was it practicable to 
administer multiple EEG recordings or psychometric assessm ents on each patient; the 
relevance of an interictal period determ ined in this way would have uncertain 
applicability to rCBF changes in any case.
Since the great majority of patients are back to normal in terms of how they 
feel, in terms of their behaviour and of their EEG (Gotman, 1991) within 24h of a 
seizure, the term 'interictal' has been defined in this study as  24h from the last 
reported seizure. There were in fact no patients in this study who did not feel 'back to 
normal' by the time the interictal scan was done, but there were 11 patients, with 
seizure frequencies of between 50 and 1100 per year, where the interictal scan was 
done between 2.5 and 24h after a seizure because of practical difficulty (e.g.seizure
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frequency too great, or patient living too far away to justify repeat examination) in 
scanning after a greater interval.
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Chapter 2
Results
Temporal group
The results of visual and numerical analysis of interictal scans in the temporal 
and extratemporal groups are given in Table 2.3, and are summarised in Table 2.4. 
Descriptive statistics relating to asymmetry indices in Table 2.5
rCBF: visual analysis of images
Of the 81 patients, the im ages were reported as normal in 38 (47%) and 
abnormal in 43 (53%). Left temporal hypoperfusion was seen  in 24 patients, right 
temporal hypoperfusion in 12 patients (Figs 24 and 2.5), and bilateral temporal 
hypoperfusion (more profound on the left) in 1 patient (Fig 2.6). There was 
hypoperfusion extending into the ipsilateral frontal lobe in 2 patients, and involving 
the whole hem isphere in a  further 2 patients. In all these cases , the degree of 
hypoperfusion was judged visually to be greatest in the temporal lobe. Two patients 
showed hyperperfusion, one in the mesial temporal cortex, one in the lateral cortex 
(Fig 2.7).
Asyymetry indices associated with the above abnormalities (excluding the 
patients with hyperperfusion - see  below) are shown in Table 2.6. The degree of 
asymmetry was greater in the lateral temporal structures in the majority (24/41) 
of these patients, in medial structures in a  smaller proportion (15/41), and the sam e 
in 2/41, but the difference between the m eans was not statistically significant. The 
proportion of patients with laterally predom inant hypoperfusion on the left w as 
17/24, and on the right 11/17. The difference between these  proportions was not 
significant (Chi2). Comparison of clinical characteristics in patients with asymmetry 
greater in the lateral ROI with those with asymmetry greater in the mesial ROI showed 
no significant differences. In the 4 patients with hypoperfusion extending outside the 
temporal lobe the degree was less than the maximal degree of hypoperfusion in the 
temporal lobe.
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Correlation of rCBF with clinical factors: visual analysis of im ages
The descriptive statistics of clinical characteristics and ROI asymmetry 
iindices for the whole temporal group, and the groups of patients in whom cerebral 
perfusion was judged visually to be normal and abnormal are given in Table 2.2. The 
clinical characteristics listed are patient age, age at onset of epilepsy, length of 
Ihistory, overall seizure frequency, recent (in the three months before scanning) 
seizure frequency, cumulated number of seizures, and time between the scan and the 
Hast reported seizure.
They are given with m eans, medians and ranges (the latter two are given 
becau se  of the skewed nature of some of the data - see  below). The frequency 
distributions of these param eters are shown in Figure 2.8-2.14. The top histograms 
shows the frequency distribution for the whole group, the middle ones show those for 
patients with normal rCBF, and the bottom ones those for patients with abnormal 
irCBF. Non-parametric statistics (Mann-Whitney U test) are used to compare groups, 
and the Chi2 goodness of fit test to test the frequency distribution of data. Where the 
•frequency distribution differed obviously from normal, the curve fit was not tested 
s ta tistically .
Patient age (Fig 2.8)
The frequency distribution of patient age was normal, as was the frequency 
distributions of age for the normal rCBF group (p=0.28, 0.37, respectively). The 
frequency disrtibution of the abnormal group appeared approximately normal, but the 
difference from a normal distribution was significant (p=0.009). Mean age for the 
whole group was 26 years, with a standard deviation of 9.73 and a range of 4-54 
years. The equivalent figures for the normal and abnormal rCBF groups were 28.7,
9.1, 15-53 and 23.8, 9.9, 4-54, respectively. The difference between these m eans 
was marginally significant (p=0.044), until the Bonferoni correction was applied.
Age at onset of epilepsy (Fig 2.9)
The frequency distribution of age at onset of epilepsy was reverse exponential 
(p=0.81) with most patients at the lower end of the range with age at onset of less 
than 10 years. The frequency distribution of age at onset in the group with normal 
rCBF did show a decrease with age, but there was a higher proportion of patients with 
a later age at onset. By contrast, the frequency distribution in patients with abnormal
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rCBF w as again clearly exponential (p=0.28), with almost half (21/44) the patients 
having an age of onset of epilepsy before five years. The median age at onset for the 
whole group was 8 years, with an interquartile range of 15 and a total range of less 
than one year to 45 years. The equivalent figures for the normal and abnormal rCBF 
groups were 13.5, 13.5, 0-41 and 5, 9, 1-45, respectively; age at onset in the 
abnormal group was significantly less than that in the normal group (p=0.003; 
p=0.018 after Bonferoni correction).
Length of seizure history (Fig 2.10)
The frequency distribution of length of history was normal (p=0.19), but 
weighted slightly toward the lower end of the range. The frequency distributions of 
length of history for the normal and abnormal rCBF groups were similar (p=0.86, 
0.30). The mean length of history for the whole group was 16 years with a standard 
deviation of 9.7 and a range of 1-38 years. The equivalent figures for the normal and 
abnormal rCBF groups were 15.3, 7.6, 2-28 and 16.2, 9.5, 1-38, respectively. The 
difference between those means was not significant.
Seizure frequency (Fig 2.11, 2.12)
The frequency distribution of seizure frequency, both overall and recent, 
showed a decrease as seizure frequency increased, with most of the patients at the 
lower end of the range, and more than half having a seizure frequency of less than 
200/year. The median seizure frequency was 150/year, with an interquartile range 
of 350 and an overall range of 2-5000/year. The medians, interquartile and total 
ranges for the normal and abnormal rCBF groups were 295, 325, 2-4000/year and 
150,650, 2-5000/year, respectively. The median recent seizure frequency was 
150, with an interquartile range of 450 and a total range of 0-3500/year. The 
equivalent figures for the normal and abnormal rCBF groups were 150, 345, 2- 
2000/year and 150, 602, 0-3500/year, respectively. The differences betw een 
normal and abnormal groups was not significant.
Cumulated number of seizures (Fig 2.13)
The frequency distribution of cumulated number of seizures in all three rCBF 
groups showed a decrease as the cumulated number of seizures increased, with almost 
half the whole group having had less than 3000 seizures in their lifetime. The range
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was great, however, with 17 patients having had 9000 seizures or more. The median 
cumulated seizure number for the whole group was 2000, with an interquartile range 
of 6100 and a total range of 20-64000. The equivalent figures for the normal and 
abnorm al groups w ere 3850, 5700, 50-64,000 and 7454, 5400, 20-5500, 
repectiveiy. The differences between the groups was not significant.
Time since last seizure (Fig 2.14)
Most patients (55/81) were scanned within 4 days of the last reported 
seizure, although the range was wide, and there were 14 patients at the upper end of 
the range who were scanned at 14 days or more. The median time since last seizure 
was 2 days, with an interquartile range of 5 and a total range of 0.1-180. The 
frequency distribution in the normal and abnormal groups were similar, and the 
m edian, interquartile and total ranges were 2, 3, 0.6-60 and 2, 5, 0.1-80, 
respectively. The difference between the normal and abnormal groups was not 
significant.
The occurrence of secondary generalised seizures
There were no significant differences in any of the clinical factors or in 
asymmetry indices between patients with (52/81) and without (29/81) secondary 
generalised seizures.
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rCBF: numeric analysis
Correlations between asymmetry indices and clinical factors
Individual asymmetry indices are given in Table 2.3, and mean and other 
descriptive statistics of asymmetry indices for frontal, mesial and lateral temporal, 
basal ganglia, thalamus, parietal and occipital ROIs in Table 2.5. Their frequency 
distributions are shown in Figure 2.15
All the ROI frequency distributions were approximately normal (note the 
differing scales on the Y axes of the histograms). With the exception of the frontal, 
basal ganglia and occipital ROIs, there appeared to be a bias toward negative values 
(i.e. left sided hypoperfusion). This was tested by splitting the data for each ROI into 
positive and negative values, removing the signs and comparing the m eans using the 
Mann-Whitney U test. The descriptive statistics of the asymmetries for left and right 
ROIs are given in Table 2.7. The biggest difference was in the lateral temporal ROI, 
with a mean asymmetry index of 4.12 for right sided hypoperfusion and 9.6 for left 
sided hypoperfusion (p<0.001). None of the other differences was significant. The 
lateral temporal ROI also differed in exhibiting a much wider range of asymmetry than 
the other ROIs, with longer 'tails' at the extrem es, more obviously on the left. The 
shape of the histogram also suggested a bimodal distribution, with separate peaks 
around -10 and +5. The mesial temporal ROI showed a more even distribution, and a 
generally flatter curve. The largest absolute asymmetry indices were in the lateral 
temporal ROI (mean 7.9%) and the mesial temporal ROI (mean 5.5%). The other 5 
ROIs had mean asymmetries of 4.3% or less. Analysis of the variance showed that the 
differences between mean ROI asymmetries were significant (p<0.001).
Spearm an rank correlation tests  were used to test correlations between 
asymmetry indices and clinical param eters. For this purpose the sign of asymmetry 
indices were ignored. There was no significant correlation between asymmetry indices 
for any ROI and any of the clinical data. In particular, there was no correlation 
between the degree of asymmetry and age at onset of epilepsy i.e. age at onset of 
epilepsy, while being an important determinant of the presence of hypoperfusion as 
asessed  visually, did not appear to be related to its degree. There were no significant 
differences in asymmetry index betw een patients with and without secondary 
generalised seizures.
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Relationship with the results of visual analysis
The results of the experiment undertaken to define the relationship between 
the reporting of the investigators in this study are illustrated in Fig 2.16. The open 
symbols represent regions judged visually as normal, and the closed ones regions 
judged visually as abnormal.
The asymmetry in regions reported a s  normal ranged from 0-8% for both 
lateral and mesial ROIs. For abnormal regions the asymmetry ranged from 7-51% for 
mesial regions and 7-58% for lateral regions.
On examining visual reports it was apparent that separate judgements as to 
whether hypoperfusion was predominantly mesial or lateral were not made, and that 
asymmetries of the thalamus and basal ganglia were not reported. When comparing 
verbal and visual 'reports', therefore, asymmetries of the thalamus and basal ganglia 
were ignored, and a visual report of temporal hypoperfusion was taken to agree with a 
numerically determined hypoperfusion of either the mesial or the lateral temporal 
ROI, or both.
The results of both types of analysis are summarised for comparison in Table
2.4 .
Visual analysis identified abnorm alities in 43/81 scan s  (53%), while 
numerical analysis identified abnormalities in 39/81 scans (47%). Visual analysis 
identified abnormalities not picked up by numerical analysis in 15 scans, and 
numerical analysis identified abnormalities not picked up by visual analysis in 12 
scans. The reports agreed in 55 (the numbers add up to 82 because in one scan both 
visual and numeric abnormalities were identified, neither of which was detected by the 
other method).
The values for each ROI were divided into groups according to whether the scan 
had been reported visually as normal or abnormal, and the sign of the asymmetry 
index removed. Differences between groups were tested using the Mann-Whitney U 
test. The difference was significant only in the mesial and lateral temporal ROIs, 
where the asymmetry indices associated with scans reported visually as abnormal 
were significantly greater than those associated  with scan s  reported as  normal 
(p<0.001; p<0.02, respectively, corrected for the number of tests done).
Asymmetry of basal ganglia and thalamus
Significant asymmetry of the basal ganglia or thalamic ROIs was seen in 8 
patients. All 8 patients also had temporal hypoperfusion; in 2 cases  the low side was 
ipsilateral to the hypoperfused temporal lobe, in 3 cases  contralateral. Asymmetry of
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the thalamic ROI was seen in 2 patients, both of whom had temporal hypoperfusion 
ipsilateral to the lower thalamic ROI value. One patient had asymmetry of both ROIs, 
the low side ipsilateral to temporal hypoperfusion.
Extratemporal group
The clinical data for the 11 patients with complex partial seizures originating 
outside the temporal lobe are shown in Table 2.1, with descriptive statistics in Table
2.2. None of the means differed significantly from those in the temporal group (Mann- 
Whitney U test).
The results of visual and numeric analysis of the interictal images in the 
extratemporal group are given in Table 2.3., with descriptive statistics in Table 2.5. 
All the images were visually reported as normal. The largest asymmetry index seen in 
this group was 7.5%; numerical analysis was therefore also normal. Frequency 
distributions of the ROI data are shown in Figs 2.17. Small numbers notwithstanding, 
there was no clear evidence of any difference in frequency distribution from the 
temporal group.
Based on absolute values for asymmetry indices, the difference of 1.4 vs 
5.37% betw een lateral temporal ROIs for extratem poral and temporal groups 
respectively was statistically significant (p=0.01, Mann-Whitney U test). None of the 
other differences between the extratemporal and temporal groups was significant.
In view of the small numbers involved and the fact that all the scans were 
normal, no correlations were made between asymmetry indices and clinical factors.
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Chapter 2 
Illustrations and Tables
Figure 2.1
HMPAO SPECT: Orbitomeatal slice illustrating frontal (a,b), basal ganglia (c,d),
occipital (e,f), and thalamic (g,h) regions of interest used in numerical analysis of 
images (patient 2, extratemporal group).
Figure 2.2
HMPAO SPECT: Orbitomeatal slice illustrating parietal region of interest used in 
numerical analysis of images (patient 2, extratemporal group).
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Figure 2.3
HMPAO SPECT: Transaxial slice illustrating the mesial (a,b) and lateral (c,d) 
temporal regions of interest used in numerical analysis of images (patient 2, 
extratemporal group).
Figure 2.4
Interictal HMPAO SPECT: Transaxial slice showing hypoperfusion of the whole of the 
left temporal lobe, more marked in the lateral cortex (patient 62).
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Figure 2.5
Interictal HMPAO SPECT: Orbitomeatal slice showing left temporal hypoperfusion 
more marked in the mesial cortex (patient 63)
Figure 2.6
HMPAO SPECT: Orbitomeatal slice showing bilateral temporal hypoperfusion, more 
profound on the left (patient 59).
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Figure 2.7
Interictal HMPAO SPECT: Transaxial slice through the temporal lobe showing 
hyperperfusion of the right lateral temporal cortex (patient 72).
Figure 2.8
Temporal group: frequency distribution of patient age
Patien t age (years) - w hole group
Patien t age (years) - norm al rCBF
Patient age (years) - abnorm al rCBF
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Figure 2.9
Temporal group: frequency distribution of age at onset of epilepsy
Age at o n se t (years) - all patien ts
Age at o n se t (years) - norm al rCBF
25
Age at o n se t (years) - Abnormal rCBF
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Figure 2.10
Temporal group: frequency distribution of length of history of epilepsy
Length of h istory (years) - w hole group
Length of h istory  (years) - norm al rCBF
Length of h istory  (years) - abnorm al rCBF
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Figure 2.11
Temporal group: frequency distribution of seizure frequency
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Figure 2.12
Temporal group: frequency distribution of recent seizure frequency
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Table 2.13
Temporal group: frequency distribution of cumulated seizure number
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Figure 2.14
Temporal group: frequency distribution of time since last seizure
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Figure 2.15
Tem poral group: frequency distribution of asym m etry indices
Frontal
(O  O )  CVI I A  0 0  
CO CM CM T -  •
Basal ganglia
10
o JUIUI i k
C O O > C \ J I O C O t - < o CO 
CO CM CM ■*— 1 ' 1 -
10
Thalamus
i k
C O O ) C M I O C O ' » - C O C O  
CO CM CM t -  '  • T -
Mesial Temporal
10
ju lllll lU U
C O O ) C M l O C O i - C O C O  
CO CM CM 1 -  ■ • T -
1 0
5
Lateral Ter
L.......1 A t  1 1 1  l l u l l l j  I
np<
I n
oral
llllli .. 11 i
U  .................................................................................
C O O J C M L O C O - r - C O C O  
CO CM CM t -  1 ' T-  
1 1 1 1
57
Figure 2.15
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Figure 2.16
Asymmetry indices of regions of interest visually judged 
symmetric or asymmetric
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Figure 2.17
Extratemporal group: frequency distribution of asym m etry indices
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Figure 2.17
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Table 2.1
PATIENT CUNCAL DATA
Temporal group
Age at Recent Cumulated
Patient Length of onset of Seizure seizure seizure Time since Sec. Gen.
Patient age history epilepsy frequency frequency number last seizure seizures
(years) (years) (years) (/year) (/year) (days)
1 32 17 15 80 250 4500 0.3 +
2 17 16 1 25 20 500 15 +
3 33 31 2 100 20 3000 2 -
4 29 21 8 60 60 1300 4 -
5 17 16 1 30 20 320 3 +
6 9 12 3 25 1 5 400 20 -
7 39 6 33 300 25 2000 4 +
8 31 14 17 360 360 6000 0.3 +
9 42 12 30 20 5 250 70 +
10 24 21 3 144 144 2900 6 +
11 28 22 6 1500 1500 33000 5 +
12 39 26 13 300 400 9000 1 +
13 29 23 6 2 2 50 60 -
14 22 7 15 1000 700 7000 1 -
15 4 1 3 900 900 900 0.1 +
16 52 11 41 400 400 5000 1 +
17 20 18 2 150 250 2700 3 -
18 29 2 27 120 25 250 15 -
19 28 28 0 1600 1600 48000 7 +
20 30 1 5 15 100 120 2000 21 +
21 23 13 10 1100 1100 15000 0.7 +
22 19 15 4 300 150 5000 1 +
23 29 9 20 12 150 500 1 +
24 28 20 8 25 25 500 3 +
25 15 14 1 150 150 1000 5 +
26 47 23 24 50 6 1500 30 +
27 53 22 31 25 25 800 3 -
28 29 13 16 35 25 600 3 +
29 29 26 3 300 600 7800 1 -
30 33 16 17 400 400 7000 1 -
31 15 14 1 360 360 5400 0.6 +
32 31 13 18 100 100 1300 1 +
33 17 11 6 40 40 500 14 +
34 31 26 5 1200 800 30000 1 +
35 22 16 6 2000 2000 32000 1 +
36 19 4 15 4 2 20 180 -
37 23 21 2 150 150 3500 1 +
38 27 26 1 400 300 6500 1.2 +
39 26 16 10 4000 800 64000 7 +
40 29 8 8 50 1700 500 0,25 -
41 22 17 5 360 300 6000 3 +
42 30 29 1 1000 1000 29000 30 +
43 24 16 8 80 80 1500 4 +
44 26 23 3 4 4 100 90 +
45 31 13 18 180 100 1800 2 -
46 23 14 19 300 400 5000 0.6 +
47 36 23 13 290 290 7000 1 +
48 54 9 45 50 50 500 6 -
49 15 11 4 600 600 7000 1,5 +
50 29 27 2 720 500 19000 1 +
51 24 24 1 10 0 500 2 -
52 16 27 25 2 250 100 30 -
53 32 26 20 50 50 1400 2 -
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Table 2.1
Age at Recent Cumulated
Patient Length of onset of Seizure seizure seizure Time since Sec. Gen.
Patient age history epilepsy frequency frequency number last seizure seizures
(years) (years) (years) (/year) (/year) (days)
54 23 3 20 300 300 900 1 +
55 32 6 26 25 25 500 14 -
56 31 31 1 150 1600 5000 1,5 +
57 13 7 6 1000 2000 7000 1 -
58 22 2 20 300 380 600 3 -
59 18 7 11 700 100 5000 2 -
60 25 20 5 100 100 2000 8 +
61 13 2 11 250 250 500 2 +
62 5 4 1 1000 1000 4000 1 -
63 12 6 6 960 960 6000 1 -
64 21 20 1 120 100 2000 0,9 +
65 25 24 1 180 6 5000 1 -
66 29 3 26 100 800 1000 1 +
67 15 7 8 2000 2000 14000 2 +
68 39 37 2 80 10 1000 2 +
69 31 26 5 700 3500 52000 0,7 +
70 19 5 14 360 150 1800 27 -
71 31 8 23 650 1200 6000 1 +
72 24 32 1 60 25 1500 1.5 -
73 21 11 10 5000 150 55000 1.2 +
74 8 7 1 120 120 900 0,7 +
75 21 1 5 6 400 150 2500 2 +
76 22 8 14 150 150 1200 3 +
77 23 22 1 400 400 10000 1 +
78 22 12 10 2000 250 24000 10 -
79 38 38 1 50 50 1700 6 +
80 32 8 24 100 50 800 3 -
81 30 23 7 40 80 1000 0,8 +
Extratemporal group
1 6 1 5 7200 7200 1200 0,5 -
2 26 8 18 300 300 2500 1 -
3 38 19 19 500 500 1000 11 +
4 21 20 1 1000 1000 21000 2 +
5 18 8 10 1750 1750 15000 0,1 +
6 34 25 9 400 400 12000 0,5 +
7 28 20 8 500 1000 16000 0,5 +
8 20 6 14 300 0 1800 90 -
9 35 21 14 1800 1800 40000 1 +
10 24 12 12 50 50 600 49 +
11 24 22 2 150 150 3500 1.5 +
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Table 2.2
CLINICAL DATA: DESCRIPTIVE STATISTICS
TEMPORAL GROUP (n=81)
variable mean median minimum maximum std.dev.
Patient age 26,0 26,0 4,0 54,0 9,7
Length of history 16,0 15,0 1.0 38,0 8,8
Age at onset 10,8 8,0 0,0 45,0 10,1
Seizure frequency 479,7 150,0 2,0 5000,0 808,4
Recent seizure frequency 434,9 150,0 0,0 3500,0 623,8
Cumulated seizure number 7460,0 2000,0 20,0 64000,0 13140,4
Time since last seizure 9,5 2,0 0,1 180,0 24,4
Temporal group-normal rCBF (n=36)
variable mean median minimum maximum std.dev.
Patient age 28,7 29,0 15,0 53,0 9,1
Length of history 15,3 15,5 2,0 28,0 7,7
Age at onset 14,1 13,5 0,0 41,0 10,0
Seizure frequency 453,3 295,0 2.0 4000,0 764,5
Recent seizure frequency 363,7 150,0 2,0 2000,0 472,3
Cumulated seizure number 7763,5 3850,1 50,0 64000,0 13054,0
Time since last seizure 6,6 2.0 0.6 60,0 11.7
Temporal group-abnormal rCBF (n=45)
variable mean median minimum maximum std.dev.
Patient age 23,8 23,0 4,0 54,0 9.9
Length of history 16,2 14,5 1.0 38,0 9,5
Age at onset 8,3 5,0 1,0 45,0 9,5
Seizure frequency 510,9 150,0 2,0 5000,0 856,9
Recent seizure frequency 502,5 150,0 0,0 3500,0 727,7
Cumulated seizure number 7454,4 2950,0 20,0 55000,0 12692,3
Time since last seizure 12,0 2,0 0,1 180,0 31,3
EXRATEMPORAL GROUP (n=11)
variable mean median minimum maximum std.dev.
Patient age 24,9 24,0 6,0 38,0 9,0
Length of history 14,7 19,0 1,0 25,0 8,0
Age at onset 10,2 10,0 1,0 19,0 6,0
Seizure frequency 1268,2 500,0 50,0 7200,0 2057,1
Recent seizure frequency 1286,4 500,0 0,0 7200,0 2060,7
Cumulated seizure number 10418,0 3500,0 600,0 40000,0 12234,0
Time since last seizure 14,3 1,0 0,1 90,0 29,0
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Table 2.3
VISUAL AND NUMERIC ANALYSIS OF IMAGES 
Temporal group
Asymmetry 
Visual index ROI (%)
report of
Patient f scan Frontal Bas Gang Thalamic Mesial Temp Lateral Temp Parietal Occipital
1 0 0 0 -0,8 -1,1 -1,1 -1.2 -3,4 -1,9 -2,7
2 2 0 4 -2 3,5 3,5 -6,3 -10,8 -5 3,1
3 2 0 4 12 6,5 6,5 -11,3 -19,5 1,1 -6,1
4 0 0 0 3,3 2,5 2.5 -0,4 -4,4 2,5 3,4
5 0 0 0 -2,5 -2,2 -2,2 3,1 0,8 -4,7 3,8
6 2 0 4 -7,9 -0,5 -0,5 -13,4 -11,2 -9,1 -1,5
7 0 0 0 1,9 0,0 0 -0,1 0,1 -2,6 -6,8
8 2 0 4 -1,6 2,7 -2,7 -12,1 -8,1 -2 -6,8
9 2 5 4 9,9 -12,3 -12,3 8,8 6,8 -5,3 -3,1
10 2 0 4 -2,1 -12,6 -12,6 5 -13,9 0,6
11 0 0 0 -6,5 4,3 4,3 -5,7 -8,7 6,1 0,4
12 0 0 0 8,6 -2,9 -2,9 3,5 -7,2 -5,1 -2,8
13 0 0 0 4,2 -0,4 -0,4 0,6 -8,5 -3,1 -1,5
14 0 0 0 2,4 9,7 9,7 1 -5,8 -8.7 -6,4
15 2 5 4 -1.8 2,4 2.4 12,8 3 0 -1,6
16 0 0 0 -3,9 4.5 4,5 2,7 0,7 1,3 1.5
17 2 5 9 -1,9 3,0 3 6 10,8 -2,5 0,1
18 0 0 0 1,2 0,8 0,8 0,2 -6,5 -7,6 -1,6
19 0 0 0 -4 -5,9 -5,9 6,1 0,6 3,5 -3,6
20 0 0 0 -6,5 5.2 5.2 1.6 2 0,7 -0,1
21 2 0 4 2,8 -11,3 -5,4 -4,4 11,2 -9,8 -2,6
22 2 5 4 2,5 9,3 9,3 2,8 10,8 1.5 -5,3
23 0 0 0 -0,8 0,0 0 -10,9 -6,8 0 1
24 0 0 0 -10,1 -1,1 -1,1 -5,4 -7,3 -0,5 -1,3
25 2 5 4 4,4 -1,5 -1.5 9.2 0,9 3,4 1,4
26 0 0 0 1,6 4,2 4,2 -2,1 1,8 4,1 1.8
27 0 0 0 2,7 3,3 3,3 -7,5 -7,2 6 -0,3
28 2 0 4 -6,8 -4,0 -4 -4,3 -7,6 -2 -2,3
29 0 0 0 -6,2 -0,6 -0,6 -1,9 -1,9 -9 -0,3
30 0 0 0 2,2 6,9 6,9 1.9 -5,9 1 -5,5
31 0 0 0 4,9 -3,3 -3,3 -1.6 0,8 -3,5 -1,8
32 0 0 0 -6,9 -3,4 -3,4 -4,2 -3,2 -2,1 1,5
33 2 0 4 4.7 -0,2 -0,2 -3,7 -12,3 0,2 -3,8
34 2 5 4 -0,5 12,0 12 13 5,1 -0,3 -0,2
35 0 0 0 0,9 4,2 4,2 -5.3 -5,7 -1 0,7
36 2 5 4 4,7 5,2 5.2 5,1 2,4 -6,1 0
37 2 5 9 5,8 11,1 11,1 6,4 3,4 10,1 0,6
38 0 0 0 -3,4 0,8 0,8 -1,4 -5,2 -3,8 3,5
39 0 0 0 1.3 -2,6 -2,6 -0,4 -17,9 -7,8 1.4
40 2 5 4 3 -5,5 -5,5 15,3 1,1 -0,2 2,6
41 0 0 0 0,9 -7,5 7,5 -3,1 -10,8 0,2 1,3
42 2 0 4 -0,6 -2,1 -2,1 -1.4 -5,1 -2,2 -1.9
43 0 0 0 8,5 -8,2 -8,2 -0,5 -4.8 -5,6 0,3
44 2 0 4 4,9 -2.9 -2,9 -1.7 -9,1 -4,4 -3
45 0 0 0 1.4 -9.4 -9,4 4,6 -2,3 -2,3 1.2
46 0 0 0 -2,8 4,8 4,8 -2,7 -10,1 -3.9 1,1
47 0 0 0 -3 1.1 1,1 -4,2 -2.6 -11,8 0,4
48 2 0 4 1.9 2,0 2 -9,4 -23,6 -5,4 -3
49 0 0 0 -0,2 -3,7 -3,7 -1.2 0.9 -1 0.3
50 2 5 4 8,1 -9,8 -9,8 8,3 4 -3.9 -4.8
51 2 0 4 1.1 -3,1 -3,1 -1 -2,4 -2 -1.1
52 2 0 4 -0,5 -1,2 -1.2 -8,8 -15,1 7,9 0,1
53 0 0 0 7 4.7 4.7 5,1 -2,7 -5,1 -2,3
54 0 0 0 5,3 2,5 2,5 -3 4,7 -8,9 0
55 0 0 0 7,4 7,9 7,9 8,5 -10 -3,7 1.3
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Table 2.3
Asymmetry 
Visual index ROI (%)
report of
Patient f scan Frontal Bas Gang Thalamic Mesial Temp Lateral Temp Parietal Occipital
56 2 5 4 -0,7 -3,5 -3,5 12,1 3,7 -0,9 4,7
57 2 5 4 0.8 5.6 5,6 -1.7 5.7 -3,3 -2,3
58 2 0 4 -1.9 1.7 1.7 -3.2 -7,2 -4,6 5,2
59 2 6 4 -3,8 4,5 4,5 -6 -10,5 2,7
60 2 0 4 3.9 0,3 0,3 -9,5 -11,3 -4,8 2,8
61 2 5 4 0.5 0,4 0,4 13,9 2,7 -1.1 4,6
62 2 0 4 -10,2 -0,3 -7,3 -9 -28,6 -7 -11.9
63 2 0 4 7.2 0,3 0,3 -8,3 -5 -3,8 3,1
64 2 0 4 -5,6 -0,6 -0,6 3,1 -21,7 -8,2 2,1
65 2 7 4 4,4 0,4 0,4 -2 -5,7 2,3 2,1
66 0 0 0 5,3 7,2 7,2 -6,1 -7 -1.8 -0,6
67 0 0 0 -1.3 5,1 5,1 -2 12,8 -7,6 -5,5
68 2 0 4 0.7 -2,8 -2.8 1.2 -1 -0,5 6,4
69 2 0 1 -14,3 -10,0 -0,4 -24,3 -41,6 -34,7 -3,9
70 0 0 0 4,1 5,4 5,4 3,1 -5,8 -5,4 -3,1
71 2 0 4 0,6 0,1 3,1 -3,8 -7,5 4,1 -6,6
72 1 5 9 -6,5 3,8 3.8 2.9 -14,6 -0,3 -0,7
73 2 5 4 8,2 0.8 0,8 -6,1 -4,6 3,1 -1.1
74 2 0 4 5.5 7.2 7,2 -5,9 -14,8 -6,7 -4.7
75 0 0 0 0,3 4.7 4,7 5.9 15,4 1.6 1.9
76 0 0 0 1.6 -8,1 -8,1 8,5 -4,3 -7,3 -2.8
77 2 0 1 -10,9 -7.3 -4,4 0,9 -7,1 1.9 3,3
78 2 0 4 -9,7 8,5 8.5 4,7 -9,8 5.9 -1.3
79 2 0 4 -8,7 10,9 -4,4 1.2 -9.7 -8,8 3,4
80 2 0 4 -0,3 3,1 3,1 -10,9 -26,9 -1.6 -2
81 0 0 0 2,6
oUJ« -5 -3,8 -2,3 -4,9 -2,3
Extratemporal group
1 0 0 0 3,4 6,0 0,0 -2,4 -5,9 0,1 3,6
2 0 0 0 0,8 5,9 0,0 5,6 -0,4 -5,0 -0,9
3 0 0 0 2.1 0,3 -3,8 1.4 -3,6 -1.5 -1,5
4 0 0 0 1.1 -1.3 -7,1 1.7 -6,0 5.4 -4,3
5 0 0 0 0,6 0.7 6,6 -4,6 -3,9 -7,1 -3,7
6 0 0 0 0,1 -2.7 -2,7 -1,5 3,7 -2,5 1,4
7 0 0 0 2,8 5.9 3.8 1.7 -3,5 0,5 -2,7
8 0 0 0 -1,4 -2.0 -1.7 1.2 3,9 1,3 -1.1
9 0 0 0 -4,1 -6,0 0,1 7.7 -0,1 -1.0 2,3
10 0 0 0 -1,6 2.1 -1.5 4,4 -2,3 -7,6 -4,3
11 0 0 0 5,3 -3,8 7.5 2.3 2,3 5,4 0,3
Codes for visual reports
204  Left temporal hypoperfusion
254 Right temporal hypoperfusion
264 Bilateral temporal hypoperfusion
209 Left frontal and temporal hypoperfusion
259 Right frontal and temporal hypoperfusion
201 Left hemisphere hypoperfusion
159 Right temporal and frontal hyperperfusion
274 Right hippocampal hyperperfusion with lateral temporal hypoperfusion
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Table 2.4
VISUAL AND NUMERICAL ANALYSIS OF IMAGES 
Summary of results of intericta! HMPAO SPECT
Temporal group (n=81)
Visual analysis normal - 38/81 =47%
abnormal - 43/81=53%
temporal hypoperfusion - 38 (24 left, 12 right, 1 bilateral) 
frontotemporal hypoperfusion - 2 (both right) 
hemispheric hypoperfusion - 2 (left)
temporal hyperperfusion - 1 (right)
Hippocampal hyperperfusion
with lateral temporal hypoperfusion - 1 (right)
Numerical analysis normal - 42=53%
abnormal - 39=47%
temporal hypoperfusion • 33 (20 left, 13 right) 
frontal hypoperfusion - 1 (left) 
parietal hypoperfusion - 3 (2!eft, 1 right) 
hemispheric hypoperfusion - 1 (left)
temporal hyperperfusion - 1 (right)
Extratemporal group (n=11)
Visual analysis normal - 11 (all)
Numerical analysis normal - 11 (all)
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Table 2.5
NUMERICAL ANALYSIS: DESCRIPTIVE STATISTICS OF ABSOLUTE 
ASYMMETRY INDICES
Whole temporal group (n=81)
RCI mean median minimum maximum std.dev.
Frontal 4,0 3,0 0,2 14,3 3,1
Basal ganglia 4,3 3,5 0.0 12,6 3,4
Thalamus 4,3 3.5 0,0 12,6 3,4
mes Temporal 5,5 4,6 0,1 24,3 4,3
lat Temporal 7.9 5.9 0,1 41,6 7,1
Parietal 4,2 3,5 0,0 34,7 4,5
Occipital 2,5 2.0 0,0 11.9 2,1
Temporal group - normal rCBF (n=38)
RCI mean median minimum maximum std.dev.
Frontal 3,8 3,2 0,2 10,1 2,6
Basal ganglia 4,2 4,3 0,0 9.7 2,7
Thalamus 4.2 4,3 0,0 9,7 2,7
mes Temporal 3,5 3,1 0,1 10,9 2,7
lat Temporal 5,6 5,0 0,1 17,9 4,3
Parietal 4.3 3,9 0,0 11,8 2.9
Occipital 2,1 1,5 0,0 6,8 1,8
Temporal goup - abnormal rCBF (n=43)
n o mean median minimum maximum std.dev.
Frontal 4,1 3,0 0,3 14,3 3,5
Thalamus 4,5 3.1 0.1 12,6 3,9
Basal ganglia 4,5 3,1 0,1 12,6 3.9
mes Temporal 7,2 6,1 1.0 24,3 4,7
lat Temporal 9,8 7,6 0,9 41,6 8,3
Parietal 4,2 3,3 0.0 34,7 5,4
Occipital 2,9 2,6 0,0 11,9 2,3
Extratemporal group (n=11)
F a mean median minimum maximum std.dev.
Frontal 2,1 1,6 0,1 5,3 1,6
Basal ganglia 3,3 2,7 0,3 6,0 2,3
Thalamus 3,2 2.7 0,0 7,5 2,9
mes Temporal 3,1 2,3 1,2 7,7 2,1
lat Temporal 3,2 3,6 0,1 6,0 1,9
Parietal 3,4 2,5 0,1 7,6 2,7
Occipital 2 .4 2,3 0,3 4,3 1,4
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*Table 2.6
NUMERICAL ANALYSIS OF IMAGES
Comparison of asymmetries in images visually reported as abnormal
Region of interest; asymmetry index (%)
Patient mes. Temp lat. Temp Frontal Parietal
2 6,3 10,8
3 11,3 19,5
6 13,4 11,2
8 12,1 8,1
9 8,8 6,8
10 5 13,9
15 12,8 3
17 6 10,8 1,9 2,5
21 4,4 11,2
22 2.8 10,8
25 9,2 0,9
28 4,3 7,6
33 3,7 12,3
34  13 5,1
36  5,1 2,4
37  6,4 3,4 5,8 5,4
40  15,3 1.1
42  1,4 5,1
44  1.7 9,1
48 9,4 23,6
50 8,3 4
51 1 2,4
52 8,8 15,1
56 12,1 3,7
57 1,7 5,7
58 3,2 7,2
59 6 10,5
60  9,5 11,3
61 13,9 2,7
62  9 28,6
63  8,3 5
64  3,1 21,7
68 1,2 1
69  24,3 41,6 14,3 34,7
71 3,8 7,5
73  6,1 4,6
74  5,9 14,8
77  7,1 1,9 8 3
78  4,7 9,8
79  9,7 8,8
80  10,9 26,9
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Chapter 2
D iscussion
Accuracy and limitations of data
The data acquired in this study may be divided into clinical data, data from 
visual analysis of images and data from numeric analysis of images. The methods of 
acquisition of the data entail some potential inaccuracies and uncertainties.
1. Clinical data
Patient age can be regarded as accurate. Age at presentation of epilepsy, and 
therefore the length of seizure history, was a matter of record in all but 6 patients 
whose epilepsies began before their available records (these patients were, however, 
good witnesses). A few patients had suffered clinical events of uncertain nature for 
some time before medical attention was sought, or before a diagnosis was made. In all 
of these cases  in this study, a retrospective diagnosis of seizures could be made with 
confidence, but the patient and/or parents were uncertain of the age of onset in 
several cases, the uncertainty amounting to no more than 1 year in any patient.
Seizure frequency is the most problematic of the clinical data. Although each 
patient's case  notes were gone through carefully, many of the records of admissions or 
outpatient visits did not give a figure for seizure frequency, and the patient's memory 
or that of relatives had to be relied on. Recent seizure frequency figures are certainly 
more likely to have reflected accurately the patient's experience. W here diurnal 
seizures were known to occur without the patient being aware of it, every effort was 
made to obtain good accounts of seizure frequency from relatives. Inevitably, some of 
these will have been missed, as will some nocturnal seizures. These factors will lead 
to a general underestimation of seizure frequency, affecting some patients (e.g. those 
living alone) more than others.
Seizure frequency and cumulated seizure number are therefore regarded as 
representing a general indication of seizure control over the years, and the lack of 
correlations with other data are interpreted in the light of this.
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2. Visual interpretation of im ages
The two observers who interpreted the images in this study were experienced 
in interpreting SPECT images, and interpreted those images according to the sam e 
criteria (see methods section). Few disagreem ents between observers occurred, and 
those were all resolved by consensus conference. Independent analysis followed by 
consensus conference for disagreements is an accepted method for producing consistent 
visual interpretation of im ages (Rowe et al., 1989a; b; 1991a; b; Lee et al., 
1986;1987a; b; 1988; Shen et al., 1990). In visually assessing  scans, observers 
made the assumption that, where two areas of the brain had different signal (e.g. one 
temporal lobe appeared to have lower activity than the rest of the cortex) that it was 
the smaller area which was abnormal. A ssessm ent depended not only on side-to-side 
differences, but on the normal relationship betw een ipsilateral structures. For 
example, in the normal SPECT image, perfusion in the mesial and lateral temporal 
cortex are roughly the sam e, and the sam e as perfusion in the frontal cortex. 
Perfusion in the mesial occipital cortex and cerebellum is higher, but lower in the 
lateral occipital cortex (Fig 4.1). In assessin g  the significance of a possible 
abnormality in perfusion, account was taken of whether it had well defined boundaries 
and whether those boundaries respected those of anatomic structures. The images 
produced were of sufficient spatial resolution to allow confident and precise 
anatomical location of abnormalities in the great majority of cases . Doubtful cases  
were resolved by direct comparison with the patient's anatomical imaging (CT or 
MRI). This type of procedure gave an interictal abnormality rate similar to that found 
in the studies of Rowe et al. (1989b; 1991a), whose numeric asymmetry threshold 
was also similar to that in this study (8.1-10.0% cf 8% in this study).
The experiment carried out to define numerically the method of visual 
analysis, was designed to do so only to a limited extent, that of quantifying (in terms 
of the asymmetry index used) what asymmetry of the color scale was regarded by the 
observers as being outside normal limits. This took no account of other factors such as 
the morphology of an abnormality (see above) which were normally considered as 
part of visual analysis. The upper limit of normal of 8% given by this method was 
remarkably consistent, a consistency which probably reflected the experience of the 
observers. This internal consistency of the results of visual analysis, and their 
consistency with other work producing similar abnormality rates, support the 
accuracy of the observers and the methods used.
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c. Numeric interpretation of im ages
HMPAO SPECT can produce quantified images of cerebral perfusion in three
ways;
1. Absolute quantition of cerebral perfusion. There are no methods available which are 
practicable in the clinical setting.
2. Semiquantitation (Rowe et al., 1989b; Rowe et al., 1991a; b). Regions of interest 
are defined on slices from the scan, and the number of counts per voxel computed. The 
ROIs are expressed as a percentage of a reference area which is assum ed to have a 
constant perfusion. The choice of reference area  is problematic, particularly in 
epilepsy where even subcortical structures and the cerebellum (Sperling et al., 
1990; Sackellares et al., 1990; Henry et al., 1990; Bernardi et al., 1983; Duncan et 
al., 1990b; Theodore et al., 1986b; Rowe et al., 1991a) may be asymmetric. The best 
approach is probably to use the average value for the whole brain, accepting that it 
will contain and be affected by the abnormal area; the larger the abnormality, the 
bigger the error. This approach makes the sam e assumption as visual analysis of 
images i.e. that if the brain consists of two areas of different signal, it is the smaller 
area that is likely to represent the abnormality.
3. Quantitation of asymmetry. ROIs are defined and the number of counts per pixel 
computed. An asymmetry index is calculated. This gives no indication as to whether a 
structure on one side is hypoperfusion or the homotopic structure is hyperperfused.
While the second approach does give an indication of which is the abnormal 
side where there is an asymmetry, the abnormality will be underestim ated to a 
greater extent as  its size increases, therefore making correlation of numerical 
analysis with clinical and other factors difficult. Because of this problem, and because 
visual analysis was also carried out, the third type of numerical analysis was chosen 
for the present study as being the simplest that would permit assessm ent of the degree 
of an abnormality, and correlation of perfusion abnormalities with other factors. A 
comparison of localisation using simple asymmetry indices and normalised data has 
shown the former to be a better predictor of the side of the focus (Rowe et al., 
1 9 9 1 a ).
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Temporal group
Comparison with previous SPECT work and with PET studies of 
regional cerebral blood flow and local cerebral metabolic rate
1. Proportion of patients showing abnormalities of rCBF
In this series 53% of patients had abnormal rCBF. This com pares with the 
range for previous studies of temporal lobe epilepsy of 46-80% (Bonte et al., 
1983a; G rasso et al 1989; Rowe et al, 1991a; Ryding et al., 1988; Shen et al., 
1990; Uren et al., 1983). Only the study at the lower end of this range showed a 
lower proportion than the present study (Rowe et al., 1991a). There may be several 
reasons for these differences.
The present study was of patients with a wide range of seizure frequencies, 
while those previous studies which were of reasonably large size and used comparable 
imaging methods (i.e. those using tomographic imaging of the distribution of IMP, 
HIPDM or HMPAO: (Bonte et al., 1983; Uren et al., 1983; Ryding et al., 1988; 
G rasso et al 1989; Rowe et al, 1991a; Shen et al., 1990)) have been of patients with 
intractable d isease , and presumably higher seizure frequencies. Mean seizure 
frequency in the present study was higher in patients with abnormal rCBF (511/year 
c.f. 453/year), albeit the difference did not reach statistical significance. Rowe et al. 
(1991) suggested that one reason for these differences in abnormality rate could be 
the fact that their study consisted of only presurgical patients with 'hard' EEG 
localisation data. This was the case in 40/81 of the temporal group of patients in the 
present study. Of these patients 23/40 (57.5%) had abnormal rCBF, compared with 
20/41 (49%) of the non presurgical patients. This provides no support for 
differences in seizure frequency as an explanation for the differences in abnormality 
rate found in different studies.
Differences in analysis of images could also account for differences in the 
proportion of patients with abnormal rCBF. Comparisons in this respect are difficult. 
The group of Rowe et al., (1989b; 1991a; b) and that of Lee et al. (Lee et al., 1986; 
1987a; b; 1988; Shen et al., 1990) use the sam e procedure as this study, that of 
reporting by independent observers. Their rates of abnormality differ substantially, 
at 46% for Rowe's (1991) study and 73% for Lee's (Shen et al, 1990). Both had 
similar patient populations. Some of the results of Shen et al. were based on multiple 
interictal studies, which might explain a higher abnormality rate if interictal 
hypoperfusion were a variable (in time) phenom enon. Rowe et al., (1990a) 
documented two patients in whom this appeared to be the case, although other evidence
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suggests that both interictal hypometabolism and hypoperfusion are stable findings in 
some patients at least (Kuhl et al., 1980; Jibiki et al., 1990).
The use of different perfusion tracers might result in different sensitivity to 
abnormalities. The studies of Lee et al., and Shen et al., use HIPDM as a tracer. They 
report a high abnormality rate (e.g. 73% for Shen et al.), while the present study and 
those of Rowe et al. used HMPAO, both groups finding a lower abnormality rate. 
However, Shen et al. performed multiple studies in some patients. Other series finding 
such a high abnormality rate (Biersack et al., 1986; Podreka et al., 1988; G rasso et 
al., 1989) have also found a relatively high proportion of false localising (with 
respect to EEG data) abnormalities. The threshold for reporting abnormalities was not 
numerically defined in any of these studies, and so could not be excluded as an 
explanation for this difference.
Differences in the spatial resolution of the imaging equipment used do not in 
them selves explain differences in abnormality rate. The study with the highest 
resolution equipment is the present one (53%), then Rowe et al. (46%), then Shen et 
al. (73%), then G rasso et al. (74%).
No single factor can explain these differences in abnormality rate. However, the 
present study and that of Rowe et al., (1991a) used similar methods (tracer, spatial 
resolution of imager, reporting practice) and have similar results despite differing 
patient populations (a full spectrum of d isease severity vs. presurgical patients with 
severe disease only). Shen et al., (1990) used a different tracer, repeated SPECT in 
som e patients, used an imager with slightly poorer spatial resolution, a similar 
reporting practice, in a patient population with severe d isease, and obtained a high 
abnormality rate.
Considering the three groups with most experience of SPECT cerebral perfusion 
studies in epilepsy, then, it appears that the use of different tracers and the practice 
of repeating interictal studies remain likely explanations for the differences seen . 
Relative over-reporting may be responsible for high abnormality rates in studies 
which also have high false-localisation rates.
Type of abnormality of rCBF
Rowe's (1991a) study included only 2/51 patients with abnormalities other 
than unilateral temporal hypoperfusion (bilateral temporal hypoperperfusion). Lee 
et al., (1988) had 9/13 patient with extensive hemispheric hypoperfusion, but Shen 
et al. (1990) only had 2/34 with extensive hypoperfusion. Adding these series 
together, this makes 11% of patients with hypoperfusion extending outside the
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temporal lobe, compared with 4.5% in the present study. This difference may be due 
to the imaging methods used. The highest proportions of patients with extensive 
hypoperfusion were seen  in studies using low resolution equipm ent and slice 
orientations where (in particular) the distiction between temporal lobe and adjacent 
frontal lobe might be difficult to make. Rowe's group used equipment with resolution 
close to that in this study (12mm c.f. 10mm), and found 4% of patients with 
extensive hypoperfusion, similar to the proportion in this study.
This study found interictal hyperperfusion in only two patients. In one, who had 
hyperperfusion of the hippocamus with lateral hypoperfusion, the scan was repeated 
with the sam e result. No EEG recording was carried out at the time of the injection, so 
subclinical seizure activity could not be ruled out as a cause, although there was no 
clinical indication of it. In the other case  hyperperfusion involved the lateral 
temporal and posterior frontal cortex. EEG was recorded at the time of the injection, 
no seizure activity was recorded, and none had been reported in the previous 3 weeks. 
This phenomenon has been reported previously (Duncan et al., 1990a; G rasso et al., 
1989; Stefan et al., 1990; Uren et al., 1983), and is of uncertain significance. It is 
difficult to believe that the hyperperfusion is secondary to the metabolic dem and of 
electrical activity, when the patient is clinically normal with no discharges on EEG. 
Postictal metabolic debt would also seem  an unlikely explanation, given that the 
phenomenon is seen hours or days after the last seizure.
A previous study using HMPAO SPECT where the images were reported by the 
sam e observers as  in the present study (Duncan et al., 1990a) found interictal 
hyperperfusion in 30% of a series of 40 patients with complex partial seizures. The 
software used to construct the images from raw data in the present study was more 
sophisticated, and it may be that the difference is due to the change. Since this early 
study the images have been reconstructed using the new software. Only in 3/12 cases 
did the sam e observers think there was unequivocal hyperperfusion. A change in 
reporting practice (e.g. an increase in threshold for reporting an asymmetry as 
significant) might also explain this difference, and could not be ruled out.
Comparison with PET studies of ICMR
In general SPECT studies of cerebral perfusion, have given similar results to 
PET studies of metabolic rate, but with a lower proportion of patients showing 
abnorm alities, and som e SPECT stud ies showing patien ts with interictal 
hyperperfusion (for review of PET and SPECT studies, see  Chapter 1). The sam e 
applies to the present study, the only minor exception being that 2 patients showed 
hypoperfusion of only part of the temporal lobe, a feature not reported in PET studies.
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Such abnormalities might not be detectable using PET or SPECT system s of lower 
spatial resolution than in the present study.
Numeric analysis of images
Comparison with the results of visual analysis
The method of numeric analysis employed in this study could not in itself 
provide a 'report' in the way that visual analysis could, in that it could identify 
structures in which the asymmetry in perfusion was outside the chosen normal 
limits, but could not in itself identify the abnormal side, or detect bilateral and 
symmetric abnormalities. Comparison between visual and numerical analysis was 
therefore made on the basis of whether the results of the numeric analysis of an image 
w as compatible with the results of visual analysis, rather than w hether the two 
methods provided exactly the sam e information.
Numeric analysis identified fewer abnorm alities overall than did visual 
analysis, 39/81 (47%) as opposed to 43/81 (53%). The visual/numerical analysis 
experiment showed that, disregarding the morphology or extent of an abnormality, the 
two observers regarded asymmetries of 8% and more as abnormal. The upper limit of 
normal that had been chosen for numerical analysis was 9%. Lowering the limit of 
normal to 8% would have made abnormal 6 scans  which had been visually and 
numerically interpreted as  normal. It would have identified abnormalities in 3 scans 
interpreted numerically as normal and visually as abnormal, the site in 2 cases  
agreeing with numerical analysis, and in 1 ca se  disagreeing. It would appear, 
therefore, lowering the upper limit of normal would have made agreem ent between the 
methods worse, that the discrepancy in limit of normal was therefore not in itself the 
cause of the difference in the number of scans identified as abnormal.
There are two other possible sources for discrepancies. Firstly, the regions of 
interest used were made up of double thickness slices, and therefore included a 
reasonably large volume of brain. This volume (as indicated by the area of the region 
of interest) was relatively constant from patient to patient, and was usually smaller 
than the total volume of the structure being m easured. In contrast, the volume of 
brain which was considered visually to be abnormal varied. At minimum, it had to 
involve more than one slice, but the area considered as significantly abnormal varied 
according to amount by which the signal differed from surrounding tissue. Secondly, 
an abnormality was more likely to be considered significant on visual analysis if its 
boundaries respected those of an anatomical structure and if they were well defined, 
even if the difference in signal looked quite small. In the study of Rowe et al. (1991a)
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21/46 (46%) were reported visually to have abnormal rCBF com pared to 27/46 
(58%) of patients who had asymmetry indices outside their normal range of -10 to 
+8.1% (based on 10 normals). These results were based on temporal ROIs only, and 
are similar to those in the present study. There are currently no other studies with 
results comparable to the present one.
Mesial vs lateral temporal hypoperfusion
Until the present study, the difference in degree of mesial and lateral 
hypoperfusion has not been addressed. One small PET (Sackellares et al, 1990) study 
showed the degree of hypometabolism tends to be greater in the lateral temporal 
cortex in most (13/17) of their patients, but with 2 patients showing the reverse, a 
higher proportion than in the present study (25/41). Their 17 patients all had 
confirmation of a mesial rather than lateral temporal focus, a confirmation available 
in 38 of the patients in this study, 23 of whom had temporal hypoperfusion. 
Hypoperfusion was greater in the lateral cortex in 14/23, a proportion not 
statistically diferent from the results of the group as a whole or that obtained by 
Sackelleres et al (Chi2).
Differences in left-right asymmetry
Absolute asymmetry was greater for the left lateral temporal ROI as compared 
to the right, seen  both as a statistically significant difference in m eans, and in the 
shape of the frequency distribution (Fig 2.15) (and was probably reflected in the 
higher number of patients in whom left temporal hypoperfusion was visually 
reported). This asymmetry in abnormality of rCBF was also found by Valmier et al
(1987) Rowe et al. (1991a), and has been found to be true for local metabolic rate 
(Theodore et al., 1988).
The reason for the difference is unclear. It has been suggested  that lateral 
temporal hypoperfusion in patients with mesial temporal foci is due to deafferentation 
effects (Rowe et al., 1991b). The functional importance of the hippocampus is greater 
on the dominant side (Goldstein & Polkey, 1993), and it may be that dysfunction 
causes greater distant effects. In this study there was no difference in the proportion 
of patients with hypoperfusion predominant in mesial and lateral ROIs between groups 
with right and left sided abnormalities which might support this explanation. Patients 
with temporal lobe epilepsy do have a high incidence of anomalous dominance (see 
below), which might account for individual variations.
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Asymmetry of the basal ganglia and thalamus.
Previous studies of cerebral perfusion have not addressed  the m atter of 
abnormalities of subcortical structures such as the basal ganglia and the thalamus, in 
most case s  because the imaging methods have lacked the spatial resolution to 
distinguish these structures. Studies of metabolic rate have shown that changes in the 
basal ganglia and thalamus tend to mirror those in cortical structures i.e to show 
hypometabolism when the temporal cortex is hypometabolic (Bernardi et al., 1983; 
Henry et al., 1990; Sackellares et al., 1990; Sperling et al., 1990). There were two 
patients in this study where the changes were opposite in direction, but most agreed.
Correlation of regional cerebral blood flow with clinical data
Correlations can be made on the basis of visual interpretation of images by 
dividng patients into normal and abnormal groups and comparing clinical param eters 
in the groups, or by simply correlating data from numerical analysis of images (e.g. 
absolute values for ICMR or symmetry indices) with clinical param eters.
Two studies, one of 89 patients (Duncan et al., 1990c) and one of 63 patients 
(Duncan et al., 1992) have used the first method. The former study found that 
patients with abnormal cerebral perfusion had longer histories of epilepsy, and 
earlier age at onset, and a higher seizure frequency, i.e the sam e as in the present 
study, although the only statistically significant difference was in age at onset. The 
latter study found the sam e types of difference, but only the difference in length of 
history was significant in this instance.
The striking and statistically significant difference in this study was in age at 
onset of epilepsy. Not only were the means of age at onset different for the two groups, 
but the frequency distributions looked different: although both tended to decrease with 
time, the normal group could be viewed as a normal distribution biased toward early 
onset. It differed significantly from an inverse exponential distribution (p=0.980), 
while the abnormal group did not (p=0.280). Rowe et al. (1991a; b), Theodore et al.
(1988) and Valmier et al. (1987) used numerical data to correlate clinical data with 
the degree rather than incidence of abnormality, and found correlations with age at 
onset of epilepsy (Rowe et al., 1991), length of history (Theodore et al., 1988) and 
seizure frequency (Valmier et al., 1987). In the p resen t study there w as no 
correlation between degree of abnormality and any of the clinical param eters. 
Numerical data did however support the association between the occurrence (rather
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than degree) of hypoperfusion to the extent that there was a good correlation 
(R2=0.670, p=0.001) between age at onset and the sum of asymmetry indices for all 
the patients of a given age at onset.
The present study and that of Duncan et al. (1990c) are the largest to make 
correlations between clinical factors and focal abnormalities of cerebral perfusion, 
and the present study is the only one to correlate clinical factors with both the 
incidence and the degree of abnormality, using both visual and numerical data. Both 
studies include patients with a wider range in these param eters than previous studies. 
In the present study, visual and numerical methods agreed in identifying age at onset 
as the most important factor in determining the occurrence of abnormal cerebral 
perfusion. While most evidence therefore points to age at onset as being the most 
important association, there is some evidence of associations with length of history 
and seizure frequency. The latter in particular cannot be ruled out, given the 
inaccurate nature of seizure frequency data (see above).
Correlation between the site of abnormality In cerebral perfusion 
and the site of the epileptic focus
The majority of temporal lobe seizures originate in the hippocampus (Quesney,
1986; Wieser, 1983). Most patients with complex partial seizures have a mesial 
temporal lobe focus, and most of the remainder have frontal lobe foci (Williamson et 
al., 1987). All patients with complex partial seizures presenting to an epilepsy clinic 
will have some estimation of the site of the focus made, usually based on clinical 
factors and surface interictal EEG data. Figures for the former are not available, but 
false lateralisations based on surface interictal EEG vary from 34% to 5% depending 
on the methods used and patient selection (Lieb et al, 1981)). However, in patients 
responding well to drug treatment, the localisation of the focus has no therapeutic 
implications, and further investigations to establish localisation are not justified (in 
term s either of cost or of invasiveness). For these reasons approximately half 
(41/81) of the patients in this study had localisation based  only on clinical factors 
and interictal EEG. The errors most likely to result from this are that some patients 
with frontal foci might be are misplaced in the temporal group, and that patients in 
either group might be falsely lateralised. In the event, the only clear inconsistency 
between interictal HMAPO SPECT localisation and other localising data was in patient 
59, who had bilateral temporal hypoperfusion but a unilateral focus, and patient 28 
who had unilateral temporal hypoperfusion and bilateral temporal foci. Both patients
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had localisation based on videotelemetry with foramen ovale recordings, although 
obviously in only one case was localisation confirmed by an operative result. This low 
false localisation rate is consistent with previous studies, in that those studies (Rowe 
et al., 1989b;1991a; b) with low proportions of patients showing abnormal cerebral 
perfusion tend to have low proportions of patients with false localising SPECT 
abnormalities. This study included no patients with evidence of a lateral temporal 
focus, and therefore did not provide any evidence that abnormalities of cerebral 
perfusion are different in mesial and lateral foci.
The data for the lateral temporal ROI were different from the others in having an 
obviously different frequency distribution, being the only ROI to show a significantly 
asymmetric distribution, and having a larger mean asymmetry than the others. The 
mesial temporal ROI showed the second largest mean asymmetry. The results of 
numeric analysis for the temporal group as a whole were therefore consistent with 
the focus localisation.
Possible reasons for interictal hypoperfusion
1. Anomalous location of function
Right hemisphere dominance, mixed dominance, and anomalous localisation of 
memory and speech function (e.g. where both verbal and visual memory are located in 
the sam e temporal lobe, or where there is representation of speech  in both 
hemispheres) are relatively common in patients with temporal lobe epilepsy (Rausch 
& Walsh, 1984), particularly in temporal lobe epilepsy of early onset. The reason is 
thought to be that where seizures originate in one temporal lobe function which would 
normally develop in that temporal lobe develops in the contralateral temporal lobe. 
Motor dominance may also be affected, resulting in an excess incidence of left 
handedness in patients with temporal lobe epilepsy of early onset (Rausch & Walsh, 
1984). This m eans that the temporal lobe that is the site of the focus does not 
function, and would therefore be expected to have lower metabolic rate and blood flow. 
This explanation is consistent with the correlation found in this study between 
hypoperfusion and epilepsy of early onset.
Where the anatomic location of neuropsychological function is uncertain, one 
would not expect to find a good correlation between the anatomic location of focal 
neuropsychological deficits and areas of reduced cerebral perfusion (e.g. in a patient 
with a  left temporal focus and left temporal hypoperfusion both visual and verbal 
memory might be located in the right temporal lobe, with no neuropsychological 
deficit). This does appear to be the case; Homan et al. (1989) found a good correlation
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between neuropsychological and perfusion deficits in a large group of patients, but not 
on the individual level. Such a finding might also indicate that more than one factor 
was responsible for hypoperfusion.
2. Interictal and subclinical ictal epileptiform activity
Interictal spiking activity has been shown to be associated  with neuronal 
inhibition in surrounding tissues; ictal discharges are also associated with surround 
inhibition (Prince e t al., 1967; Gumnit & T akahash i, 1975), and with 
hypometabolism and hypoperfusion in surrounding tissues, in man (see Chapter 3) 
and in animals (see Chapter 4). However, in 2 studies (Engel et al., 1982b; Theodore 
et al., 1983) no correlation was found between interictal hypometabolism and spiking 
on EEG. Since seizures are often followed by increases in spike activity which may last 
from a few hours up to 2 days (Gotman, 1991), a correlation between either seizure 
frequency or the time of scanning in relation to the most recent seizure, and 
hypoperfusion might be regarded as supporting a causal relationship between 
hypoperfusion and spiking, but there were no such relationships in the present study.
3. Neuronal loss
Neuronal loss occurs in the hippocampus of patients whose seizures originate in 
the mesial temporal lobe (Sommer, 1880, Meldrum & Corsellis, 1984; Babb & 
Brown 1986). It may also occur at sites distantly activated by seizure discharges 
(Duncan et al., 1990b; Leifer et al., 1991). This is thought to relate to the 
production of excess excitotoxic neurotransmitters such as glutamic acid (Cotman & 
M onaghan,1986; G reenam yre, 1986) during seizures. An association between 
hypoperfusion and length of seizure history, and possibly seizure frequency would be 
compatable with this mechanism. Such correlations were not found in this study but 
have been in other studies (Theodore e t al., 1988; Valmier e t al., 1987). 
Hippocampal neuronal loss might therefore contribute not only to low metabolism and 
blood flow locally, but more distantly in the lateral temporal lobe and its connections. 
Such neuronal loss is particularly conmmonly found in patients with temporal 
hypometabolism (Engel et al., 1982a). Of the 14 patients in the present series who 
had pathologically confirm ed m esial tem poral sc lero sis , 11 had tem poral 
hypoperfusion on interictal SPECT. This may simply be a selection effect; a history of 
febrile convulsions and the finding of unilateral temporal hypoperfusion were both 
factors which positively biased selection for surgical treatment. Rowe et al., (1991)
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found mesial temporal sclerosis in only 54% of their cases  with ipsilateral temporal 
hypoperfusion. N onetheless, the distribution of temporal hypoperfusion weighted 
toward early age at onset of epilepsy found in the present study shows an interesting 
parallel with that of hippocampal sclerosis found by Sagar & Oxbury (1987).
Possible reasons for Interictal hyperperfusion
In a previous study (Duncan et al., 1990a) where HMPAO injection was carried 
out with concurrent EEG recording, no evidence of subclinical seizure activity was 
found. There was no history of recent seizures, and no evidence of postictal change on 
EEG. In the present study EEG was not recorded, but there was no clinical evidence of 
recent or ongoing seizure activity.
Recent data suggest the possibility that HMPAO uptake overestimates blood flow 
in a rea s  of reperfusion after cerebral infarction (Sperling & Lassen, 1993). It is 
possible that this happens in other circum stances, such as  following repeated or 
lengthy seizures, and that these areas of high HMPAO uptake do not represent high 
flow at all. Duncan et al. (1990a) found that interictal hyperperfusion did not persist 
on rescanning in 50% of cases. In view of the point made earlier in this discussion 
regarding the effect on such findings of changes in image reconstruction software (and 
possibly of changes in reporting practice), the significance of this finding must be 
regarded as questionable. There are no other data available regarding interictal 
hyperperfusion, allowing little discussion of other possible causes, beyond pointing 
out the evidence against the involvement of ongoing seizure activity.
Extratemporal group
The small size of the extratemporal group, and the fact that all the scans were 
normal made comparisons between temporal and extratemporal patients difficult, in 
particular with respect to frequency distribution of asymmetry indices. While a 
larger se ries  may well have found som e patien ts with localised a re a s  of 
hypoperfusion, the fact that none out of the 11 in this study showed abnormalities 
made the group significantly different from the temporal group in this respect 
(p=0.005), and does constitute evidence that interictal cerebral perfusion is 
different in patients with temporal and extratemporal foci.
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Conclusions
1. Approximately half of patients with complex partial seizures of temporal lobe 
origin have significantly abnormal regional cerebral perfusion.
2. Most abnormalities consist of hypoperfusion in, or of g reatest degree in, in the 
temporal lobe.
3. Hypoperfusion is greater in degree in the lateral rather than the mesial temporal 
lobe in most patients.
3. Patients whose epilepsy started at an early age are much more likely to have 
abnormal cerebral perfusion, but there is no correlation between age at onset of 
epilepsy and the degree of hypoperfusion. There may be weaker relationships with 
length of seizure history and seizure frequency.
4. The method of numerical analysis used has limitations but was useful in allowing 
correlation with other data. In this study it was in good agreem ent with the results of 
visual analysis.
5. The fact that no abnormalities were seen  in the small extratemporal group of 
patients was statistically significant, and suggests that abnormal cerebral perfusion 
may be less common in such patients.
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Chapter 3
Ictal and postictal regional cerebral blood flow in complex 
partial seizures
In tro d u c tio n
Penfield (1933; 1937) made the first observations of changes in rCBF during 
and after focal seizures. These observations had the advantage of being continuous in 
time, but the disadvantages of involving patients with focal motor epilepsy only, and of 
including only a relatively small area of the surface of the brain. With the advent of 
EEG in the thirties, intraoperative induction of seizures ceased. Further study of rCBF 
changes during and soon after seizures then awaited the advent of in vivo imaging 
techniques, such as PET and SPECT. The utility of these was, however, limited by the 
need to have the patient in the scanner while the seizure was taking place, and by the 
relatively long time resolution of PET techniques. Amine tracers of rCBF such as IMP 
and HIPDM (Holman et al., 1984) overcame this problem to som e extent. These 
compounds are taken up into brain tissue in the distribution of rCBF. The distribution 
is then fixed for several hours, allowing acquisition of images of rCBF at the time of 
injection to take place during that time.
The more recent development of HMPAO (Neirinckx et al., 1987: hexamethyl 
propyleneam ine oxime - se e  introduction section, Chapter 4) improved on the 
temporal resolution of these compounds. The image given by 123I-HIPDM, for 
example, reflects 75% of uptake over the first 2 minutes after injection and 25%
over a  further 30 minutes (Holman et al., 1984), while the image given by HMPAO
reflects 90% of uptake over the first minute (Neirinckx et al., 1987). The
distribution of HMPAO remains stable for longer than the amine compounds, allowing a 
longer time between injection and scanning. Labelling with " mTc also makes HMPAO 
technically easier to use.
During the period of the present study series of patients have been studied 
using HIPDM (Lee et al., 1987a;1988; Shen et al., 1990). These have shown focal
increases in rCBF, but have produced images lacking, in spatial resolution, partly 
because of the use of low resolution scanning equipment, but also partly because a 
protracted period of tracer uptake will blur the morphology of any change in rCBF 
which has changed in extent during that time (much in the way that a long exposure 
will cause blurring of a photograph of a rapidly moving subject). Three studies using 
HMPAO have been carried out (Rowe et al., 1989b; 1991b; Newton et al., 1992 ) 
which have shown changes in rCBF in complex partial seizures of mesial temporal lobe
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origin and have suggested a time course for these changes, i.e. that during the seizure 
the whole temporal lobe is hyperperfused, that in the early postictal period the lateral 
temporal cortex becom es hypoperfused, and that only in the late postictal period does 
the mesial temporal cortex becom e hypoperfused. Most complex partial seizures 
originate in the temporal lobe (Williamson et al., 1987). Of the rest, most originate 
in the frontal lobe. Complex partial seizures of extratemporal origin have not been 
studied, and the disturbances in perfusion associated with them are unknown.
The aims of the present study are:
1. To define the morphology of changes in cerebral perfusion during and soon after 
complex partial seizures of temporal origin, and to determ ine w hether different 
changes are seen during and after seizures originating elsewhere in the brain.
2. To define the time course of any changes seen
3. To determine the relationship of ictal/postictal changes in cerebral perfusion with 
the location of the epileptic focus as defined by EEG and MRI.
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S ub jects
The subjects for this study were 42 (17 male, 25 female) patients with 
medically intractable complex partial seizures being a sse sse d  for suitability for 
surgical treatment. They were between 5 and 53 years of age, length of history 1-31 
years, age at onset of epilepsy 1-37 years and seizure frequency 150-3500 per year. 
26/42 patients had secondary generalised as well as complex partial seizures. All the 
patients were from the series described in the previous chapter (33 from the 
temporal group and 9 from the extratemporal group), and the patient identification 
numbers are the same.
All the patients had MRI with axial and coronal T1 and T2 weighted images. All 
had interictal EEG surface recordings. All but 2 patients had localising ictal surface 
EEG recordings, and those 2 had localised signal changes on MRI compatible with 
interictal EEG localisation and the clinical appearances of the seizure, as well as 
operative confirmation of localisation (i.e. a good result from anterior temporal 
lobectomy). Nineteen patients had sphenoidal recordings, and 20 had foramen ovale 
recordings (14 with multiple contact electrodes). In 26 patients localisation was 
confirmed by the results of temporal lobectomy. Abnormal pathology was found in the 
resected specimen in 22 patients. The patients were being asse sse d  for temporal 
lobectomy only (operative treatment for extratemporal seizures was not offered) so, 
if ictal surface EEG suggested an extratemporal source for seizures, no invasive 
recording was done, and no operation carried out. The data supporting localisation of 
the focus in each patient is given in Table 3.1.
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Methods
SPECT methods - HMPAO
HMPAO is discussed in Chapter 2, methods section, and chapter 4.
SPECT methods - HMPAO injection and image acquisition
The subjects were admitted to a neurological ward. They were observed for 3 
days, during which time their medication was reduced. The extent to which this was 
done depended on the pre-admission seizure frequency, and on the history of change in 
seizure frequency during previous adm issions (it is usual but not universal for 
seizure frequency to diminish during admission to hospital).
On the third day, a cannula was inserted into a vein in one arm and heparinised. 
The patient stayed in the day room of the ward, so that the alarm could be given quickly 
should a  seizure occur. On feeling a seizure was about to occur the patient would press 
the alarm button and notify a nurse, who would note the time and summon a member of 
the medical staff. If the patient had no warning of an impending seizure, then other 
patients or staff in the day room would raise the alarm.
The 99niTc and HMPAO were stored in separate containers in a shielded box in 
the ward sideroom. The doctor quickly mixed the two, injecting the appropriate amount 
intravenously. The time between the end of the ‘motionless stare' phase of the seizure 
and the injection, as well as the seizure manifestations themselves, were noted. The 
patient was taken to the scanner and the image acquired within 2 hours of the 
injection.
Acquisition of the image was carried out in the manner described in Chapter 2, 
methods section, as  was visual and numerical analysis. Postictal images were analysed 
visually with the interictal image (which had been analysed previously, blind to all 
data but the diagnosis of epilepsy and the time of the last reported seizure) so that 
changes could be assessed . The investigators were blind to all data except the diagnosis 
of epilepsy, which scan was interictal and which was postictal, and the time of the 
injection.
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Chapter 3
Results
The results of visual analysis of interictal and ictal/postictal scans is given in 
Table 3.2. The results of numerical analysis of ictal/postictal scans in Table 3.3, and 
the ictal/postictal change in asymmetry index in Table 3.4. The results of visual and 
numerical analysis of images are summarised in Table 3.5 Tables 3.1 and 3.3 also 
include the timing of ictal/postictal injections. Patient identification num bers 
correspond with those in Chapter 2.
Temporal group - visual analysis
Interictal results
Of the 33 patients 13/33 had normal interictal cerebral perfusion. The 
rem ainder had hypoperfusion of part or all of one temporal lobe (15), bilateral 
temporal hypoperfusion (1), temporal hypoperfusion extending into the ipsilateral 
frontal lobe (1) or into the ipsilateral hem isphere (2), or frontotem poral 
hyperperfusion (1).
Ictal/postictal results
Timing of injections
The timing of injections ranged from during the seizure (n=8), up to 1 minute 
postictally (n=15), up to 2 minutes postictally (n=6), up to 3 minutes postictally 
(n=3) and more than 3-15 minutes postictally (n=5).
8 8
Most of the changes seen fell into 3 groups;
1. Hyperperfusion of the whole temporal lobe (Figure 3.1).
2. Hyperperfusion of the hippocampus, with hypoperfusion of the ipsilateral lateral 
temporal cortex. Patients were included in this group if perfusion in the hippocampus 
w as equal to that of the contralateral hippocampus (and therefore hyperperfused 
relative to lateral structures). Patients were also included in this group if lateral 
temporal hypoperfusion extended into the ipsilateral frontal lobe or hem isphere, but 
where hypoperfusion was most marked in the lateral temporal lobe (Figure 3.2).
3. Hypoperfusion of the whole tem poral lobe. Patients in whom there was 
hypoperfusion of the hippocampus only, and patients in whom hypoperfusion of a 
lesser degree extended into the ipsilateral frontal lobe or hemisphere were included in 
this group (Figure 3.3).
These changes are referred to as Types 1, 2 and 3 change.
Type 1 change was seen in 4 scans, all following injection during the seizure.
Type 2 change was seen in 21 scans, following injection during the seizure or 
up to 6 minutes after. The hippocampal area was thought to hyperperfused relative to 
the contralateral hippocampus in 7 of these scans, and isoperfused compared to the 
contralateral hippocampus but hyperperfused com pared to the ipsilateral temporal 
cortex in the remainder. Type 2 change occurred bilaterally in 2 patients (Figure 
3.4). Hypoperfusion of the lateral temporal cortex was judged to extend into the 
frontal lobe in 9 scans (Fig. 3.5), and to involve the whole hemisphere in 3 (Figure 
3.6). Type 3 change was seen  in 4 scans, following injection between 1.5 and 15 
minutes after the seizure. Hypoperfusion involved only the mesial temporal cortex in 
1 patient, the temporal lobe only in one patient and extended into the ipsilateral 
frontal lobe in the remaining two.
In three cases the interictal scan showed temporal hypoperfusion (in two cases 
of the whole temporal lobe, in one of the mesial temporal lobe only), and the postictal 
scan showed resolution of the hypoperfusion. The timing of the injections ranged from
0.5 to 5 minutes postictally.
Five postictal scans (2 in the sam e patient) showed no change ictally or 
postictally. Two of the interictal scans in these patients were normal, three abnormal. 
The timing of the injections ranges from during the seizure to 3 minutes postictally.
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Extratemporal group - visual analysis
Interictal results
All 9 interictal scans in this group were normal.
Timing of injections
Injections were carried out during the seizure (n=2) or up to 5 minutes 
postictally (n=8).
Ictal/postictal results
Three patients, injected during the seizure and 0.5 and 2 minutes postictally, 
had unilateral frontal hypoperfusion (Figure 3.7). Two patients, injected during the 
seizure and 2 minutes postictally, had hyperperfusion of the anterior frontal lobe 
with diffuse hypoperfusion of the contralateral hemisphere (Figures 3.8 and 3.9). One 
patient, injected 0.5 minutes postictally, had hyperperfusion most intense in the 
calcarine cortex, extending into the neighbouring lateral occipital cortex, accompanied 
by diffuse hypoperfusion of the ipsilateral hemisphere (This patient's postictal image 
is shown with regions of interest in Figures 2.1-2.3).
Correlation of Interictal and postictal SPECT with other data 
localising the epileptogenic zone
Temporal group
1. Type 1 change: in all 4 cases this occurred in the temporal lobe that was the site of 
the focus.
2. Type 2 change: Hippocampal hyperperfusion (relative either to the contralateral 
hippocampus or to the ipsilateral lateral cortex) occurred at the site of the focus. 
Where the accompanying lateral hypoperfusion extended outside the temporal lobe, it 
did so  in all cases to a lesser degree. Two patients showed Type 2 change bilaterally. In 
one ca
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se  there were bilateral independent mesial temporal foci. In the other, seizure activity 
spread rapidly (within 1 second) from one temporal lobe to the other.
3. Type 3 change: This occurred only or maximally in the temporal lobe that was the 
site of the focus.
4. Resolution of interictal abnormality: The interictal abnormalities seen  in all 3 
cases were at the site of the focus.
Extratemporal group
1. Unilateral frontal hypoperfusion. In all 3 cases  this occurred in the frontal lobe 
that was the site of the focus.
2. Frontal hyperperfusion  with co n tra la te ra l (frontal or hem ispheric) 
hypoperfusion. In both cases  the hyperperfusion occurred in the frontal lobe that was 
the site of the focus.
3. Left occipital hyperperfusion with hypoperfusion of the rest of the ipsilateral 
hemisphere. Surface EEG onsets confirmed occipital origin, but suggested a right sided 
focus. The MRI abnormality was in the left lateral occipital cortex, although 
hyperperfusion was maximal in the calcarine cortex.
Comparison of results of visual and numerical analysis of 
ictal/postictal scans
The results of visual and numerical analysis are summarised in Table 3.5. 
Patients 28, 46 and 80 are excluded from numerical analysis, as the method is 
insensitive to bilateral symmetric changes.
Using the sam e criteria as in Chapter 2, Asymmetry indices were compatible 
with visual analysis in 20 of the 34 scans (59%).
In the temporal group, asymmetry indices were compatible with Types 1, 2 
and 3 change in 1, 13 and 4 patients respectively, compared with 4, 21 (including 3 
with bilateral change excluded from numeric analysis) and 4 for visual analysis. 
Asymmetry indices were compatible with resolution of hypoperfusion in 1 patient (3 
patients on visual analysis ), and with no change in 1 (5 patients on visual analysis ).
There were therefore 9 abnormalities identified visually which were not 
detected  by numeric analysis, in all 9 c a se s  lateral tem poral hypoperfusion. 
Asymmetry indices identified abnormalities not seen on visual analysis in 4 scans. The 
asymmetry index was lower on the side of the focus in all 4 cases, involving the
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frontal lobe in 1, the parietal lobe in 2 and the mesial temporal lobe in 1 case.
Numerical and visual analysis were compatible in all the ictal/postictal scans 
in the extratemporal group.
Ictal/postictal changes in asymmetry indices
Ictal/postictal changes in asymmetry indices are given in Table 3.3. In 
deciding the polarity of the change, it was assum ed that the change took place on the 
side of the focus as determined by EEG and structural imaging data. In the two 
extratemporal cases  where visual analysis suggested hyperperfusion in one frontal 
lobe and hypoperfusion in the other, the change in asymmetry index is given as 
positive i.e. reflecting the whole change in asymmetry as being due to hyperperfusion. 
The data had a normal frequency distribution.
The relationship between ictal/postictal changes and the timing of injections is 
illustrated in the form of scatter diagram s in Figs 3.10-3.16. The scans in the 
temporal group were sorted into subgroups (ictal (=0), up to 1 minute, up to 2 
minutes, up to 3 minutes and more than 3 minutes) according to the timing of 
injections. The mean asymmetry indices for each epoch are shown in Fig 3.17. No 
error bars have been included, but the m eans and standard errors are given in the 
table included in the figure.
Temporal group
In the following, the terms 'increase' and 'decrease' refer to the side ispilateral to the 
focus.
1. Frontal ROI (Fig 3.10). Changes ranged from 21.9 to -20.2%, though most were 
between 10 and -10%. There was a tendency toward a gradual decrease in perfusion as 
time postictally increased (R2=0.-366, p=0.033), though the m ean % change 
remained near zero until 3 minutes postictally (Fig 3.17).
2. Basal ganglia ROI (Fig 3.11). Changes ranged from 17.9 to -8.8%, the majority 
lying between 10 and -10%. There was no apparent difference with time. Mean % 
changes were small (Fig 3.17). They appeared to becom e less positive immediately 
postictally, and become gradually and slightly more positive thereafter.
3. Thalamic ROI (Fig 3.12). Changes ranged from 12.6% to -16.1%. There was no 
apparent difference with time, and mean % changes were small (Fig 3.17), again 
showing no apparent trend.
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4. Mesial temporal ROI (Fig 3.13). Changes ranged from 57.5 to -19.2%. All but one 
of the changes up to 30 seconds postictally were positive, indicating hyperperfusion on 
the side of the focus. After this time the scatter was wide, but there was a tendency for 
changes to becom e more negative as time postictally increased (R2= 0 .-3 4 4 , 
p=0.046). However, the mean % change remained positive until after 3 minutes 
postictally (Fig 3.17), only then becoming negative.
4. Lateral temporal ROI (Fig 3.14). Changes ranged from 60.2 to -37.7%. During the 
seizure most indices were positive (4 vs. 3), and there was a distinct tendency for 
indices to decrease as  time postictaly increased (R2=0.-363, p=0.035), the mean % 
change becoming negative after 1 minute postictally, (Fig 3.17).
5. Parietal ROI (Fig 3.15). Changes ranged from 48 to -25.3%. During the seizure all 
changes were positive, although a single change of 48% was to a great extent 
responsible for the mean ictal change being as high as 13.4%; the rest of the ictal 
increases were between 0.8 and 16.9%. There was a tendency for changes to become 
more negative with time, 6/7 changes after 180 seconds being negative. The mean % 
change also becam e more negative a s  time postictally increased (R2= -0 .4 6 8 , 
p=0.007)(Fig 3.17).
6. Occipital ROI (Fig 3.16). Changes ranged from 16.3 to -11.7%. Individual and 
mean (Fig 3.17) changes were small, and there was no apparent difference in change 
with time.
Summary of postictal ictal/postictal changes in asymmetry index, and of differences 
between ROIs in the temporal group
The biggest changes were seen in the mesial temporal, lateral temporal and 
parietal ROIs. Differences are assessed  using the paired t-test.
In all three, most perfusion changes were positive during the siezure (all in 
the mesial temporal and parietal ROIs), the mean change being highest in the mesial 
temporal ROI. None of the differences beteween means was statistically significant.
In frontal, lateral temporal and parietal ROIs changes becam e negative more 
quickly than in the mesial temporal ROI; the mean change up to 1 minute postictally 
w as more positive in the mesial temporal ROI than in the frontal (p=0.005), lateral 
temporal (p=ns) and parietal (p=0.006) ROIs. The change after 3 minutes postictally 
w as less negative in the mesial temporal ROI than in the frontal (p=ns), lateral 
temporal p=0.040) and parietal (p=0.04) ROIs.
Changes in the basal ganglia and thalamic ROIs were relatively small; the 
biggest was in the thalamus at 7.27%.
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Extratemporal group
Scatter diagrams illustrating ictal/postictal changes in asymmetry index are 
shown in Figs 3.18-3.24. The small numbers in this group did not give a sufficient 
spread of data to a ssess  any possible changes with time. The changes seen were small, 
only 4 changes being outside the +15 to -15% range, the great majority between +10 
and -10%. These were seen  in the frontal lobe (1 patient), the thalamus (2 patients) 
and the occipital lobe (the 1 patient in whom localising evidence suggested an occipital 
focus).
Differences between temporal and extratemporal groups
Differences in change of asymmetry index between temporal and extratemporal 
groups were significant only for the mesial temporal ROI (p=0.010, unpaired t-test).
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Chapter 3 
Illustrations and Tables
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Figure 3.1
Ictal HMPAO SPECT, left mesial temporal seizure: transaxial slice showing 
hyperperfusion of the whole temporal lobe (patient 69, scan 3)
Figure 3.2
Postictal HMPAO SPECT, 2 minutes following right mesial temporal seizure: 
transaxial slice showing hyperperfusion of the right hippocampus with hypoperfusion 
of the rest of the ipsilateral temporal lobe (patient 56)
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Figure 3.3
Postictal HMPAO SPECT, 3 minutes following left mesial temporal seizure: transaxial 
slice showing left temporal hypoperfusion, with some sparing of the mesial temporal 
cortex (patient 11)
Figure 3.4
Postictal HMPAO SPECT, 2 minutes after right mesial temporal seizure: transaxial 
slice showing bilateral mesial temporal hyperperfusion with bilateral hypoperfusion 
of the lateral temporal cortex (patient 46)
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Figure 3.5
Postictal HMPAO SPECT, 15 minutes following left mesial temporal seizure: 
orbitomeatal slice showing left temporal and frontal hypoperfusion (patient 62, first 
postictal scan).
Figure 3.6
Postictal HMPAO SPECT, 2 minutes following right mesial temporal seizure: 
transaxial slice showing hypoperfusion of the right hemisphere and hyperperfusion of 
the right mesial temporal lobe (patient 27)
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Figure 3.7
Ictal HMPAO SPECT, right frontal seizure: orbitomeatal slice showing right frontal 
hypoperfusion (patient 1, extratemporal group)
Figure 3.8
Interictal HMPAO SPECT: orbitomeatal slice showing normal perfusion (patient 7, 
extratemporal group)
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Figure 3.9
Postictal HMPAO SPECT, 2 minutes following right frontal seizure in the same patient 
as illustrated in Figure 3.8: orbitomeatal slice showing right frontal hyperperfusion 
and left frontal hypoperfusion
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Figure 3.10: Temporal group
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Figure 3.11: Temporal group
Basal ganglia ROI
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Figure 3.12: Temporal group
Thalamic ROI
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Figure 3.13: Temporal group
Mesial temporal ROI
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Figure 3.14: Temporal group
Lateral temporal ROI
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Figure 3.15: Temporal group
Parietal ROI
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Figure 3.16: Temporal group
Occipital ROI
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Figure 3.17
NUMERIC ANALYSIS OF IMAGES
Mean ictal/postictal changes in asymmetry index (% - Y axis) 
during siezure (n=7) and up to 1 (n= 14), 2(n=5), 3 (n=3) 
and more than 3 (n=5) minutes postictally (X axis)
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Figure 3.17
Basal ganglia
25
>3
-25
Thalamus
25
U  —u
0 1 2 3 >3
-25
Mean and standard errors of asymmetry indices for 0, <1, <2, <3 and >3 
minutes postictally
Ictal (=0) <1 minute <2 minutes
Mean SEM Mean SEM Mean SB/1
Frontal 4 ,24 3,24 0,5 1,83 -1,98 4 ,17
Basal ganglia 5,99 2,64 2,31 1,6 2,2 2
Thalamus 2,4 3,19 -0,79 1,84 4,92 2 ,46
mes. Temp 21,77 9,19 7,78 2,42 -0,46 5,27
lat. Temp 11,26 9,25 1,74 3,32 0,86 5,42
Parietal 14,8 6,99 -3,59 1,8 -0,68 4 ,34
Occipital 0,99 2,9 1,95 1,61 -0,02 1,67
<3 minutes >3 minutes
Mean SEM Mean SEM
Frontal -1,37 2,22 -9,54 3,56
Basal ganglia 3,2 3,13 4,4 2 ,73
Thalamus 2,67 3,73 0,3 2,58
mes. Temp 4,83 8,7 -4,32 2,98
lat. Temp -13,9 2,91 -17 ,56 6,2
Parietal -7 ,37 9,9 -14,6 2 ,86
Occipital -2,27 3,43 1,02 4 ,17
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Figure 3.18: Extratemporal group
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Figure 3.19: Extratemporal group
Basal ganglia ROI
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Figure 3.20: Extratemporal group
Thalamic ROI
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Figure 3.21: Extratemporal group
Mesial temporal ROI
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Figure 3.22: Extratemporal group
Lateral temporal ROI
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Figure 3.23: Extratemporal group
Parietal ROI
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Figure 3.24: Extratemporal group
Occipital ROI
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Table 3.1
DATA SUPPORTING FOCUS LOCALISATION 
Temporal group
P a t ie n t  Ictal su r face  Sphenoidal Foram en ovale N/R Operative Pa tho logy
S 3 recording recording resu lt
1 + + + + AHS
8 + + + + AHS
1 1 + + +
1 7 + + + + + AHS
21 + +
25 + + + + AHS
27 +
28 + +
31 + + + + AHS
32 + + + Normal
41 +
45 + + + + MTS
46 + + + + H am a rto m a
47 + + + + + Normal
49 +
56 + + + + MTS
58 + + + + Normal
59 + + + AHS
60 + + + + Normal
61 + + Inflam m atory  infiltrate
62 + + V ascu la r  malformation
63 + + AHS
64 + + + + AHS
67 + + Inflam m atory  infiltrate
68 + + + AHS
69 + + + + + Extensive gliosis
70 + + Benign cyst
71 + + AHS
72 + + + + AHS
75 + + + Small glioma
77 + + + + Normal
78 + + + Failed AHS
80 + + + + Normal
MTS=Mesial temporal sc lerosis  AHS=Ammon's horn sc leros is
Extratemporal group
1 + +
2 + +
3 +
4 +
5 +
6 + +
7  + +
8 +
1 1 +
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Table 3.2
VISUAL ANALYSIS
Results  of ictal/postictal S PECT: c h a n g e  from interictal im age  
Tem poral group
P a t ie n t Interictal im age Postictal im age Time (s)
1 Normal 2L 3 0
8 Left tem pora l  hypoperfusion 2L 6 0
1 1 Normal 2L 3 0 0
17 (1) Right f rontotem poral hypoperfusion No c h a n g e 0
17 (2) Right f rontotem poral hypoperfusion No c h a n g e 0
21 Left tem pora l  hypoperfusion 2L 1 5 0
2 5 Right tem poral hypoperfusion 1R 0
2 7 Normal 2R 1 2 0
2 8 Left tem pora l  hypoperfusion 2B 0
31 Normal 2R 3 6 0
3 2 Normal No c h a n g e 3 0
41 Normal 2L 1 2 0
4 5 Normal 2R 1 0
4 6 Normal 2B 1 2 0
4 7 Normal 2L 10
4 9 Normal No ch a n g e 1 8 0
5 6 Right tem poral hypoperfusion 2R 1 2 0
5 8 Left tem pora l  hypoperfusion 2L 15
5 9 Bilateral tem poral hypoperfusion 3L 9 0
6 0 Left tem pora l  hypoperfusion 1 L 0
61 Right tem poral hypoperfusion 3R (mesial) 1 2 0
62 (1) Left tem pora l  hypoperfusion 3L 9 0 0
62 (2) Left tem pora l  hypoperfusion No c h a n g e 6 0
6 3 Left m esia l tem poral hypoperfusion Normal 3 0 0
6 4 Left tem pora l  hypoperfusion 2L 10
6 7 Normal 2R 1 0
6 8 Left tem pora l  hypoperfusion 1 L 0
69 (1) Left hem isphe r ic  hypoperfusion 2L 5 0
69 (2) Left hem isphe r ic  hypoperfusion 2L 0
69 (3) Left hem isphe ric  hypoperfusion 1 L 0
7 0 Normal 3L 240*
71 Left tem pora l  hypoperfusion Normal 6 0
7 2 Right frontotem poral hyperperfusion 2R 6 0
7 5 Normal 2R 1 5
7 7 Left hem isphe ric  hypoperfusion 2L 1 8 0
7 8 Left tem pora l  hypoperfusion Normal 3 0
8 0 Left tem pora l  hypoperfusion 2B 9 0
Key to changes in temporal group:
1 Hyperperfusion of whole temporal lobe
2 Hippocampal hyperperfusion with hypoperfusion of lateral structures
3 Hypoperfusion of whole or part of temporal lobe
L=left R=right B=bilateral
1 1 8
Table 3.2
Extratemporal group
P atien t Interictal im age Postictal im age Time (s)
1 Normal Right frontal hypoperfusion 0
2 Normal Left occipital hyperperfusion 
& left hem ispheric hypoperfusion
3 0
3 Normal Right frontal hypoperfusion 3 0
4 (1) Normal No change 3 0 0
4 (2) Normal No change 120
5 Normal No change 6 0
6 Normal Right frontal hyperperfusion 
& left hem ispheric hypoperfusion
12 0
7 Normal Right frontal hyperperfusion 
& left frontal hypoprfusion
0
8 Normal No change 9 0
1 1 Normal Left frontal hypoperfusion 12 0
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Table 3.3
NUMERICAL ANALYSIS OF IMAGES 
Ictal/postictal scans: asymmetry indices (%)
Temporal group
ient Frontal Basal ganglia Thalamus mes. Temp lat. Temp Parietal Occipital
1 -2,2 11.2 -0,6 3,3 -8,3 -17,0 -6,1
8 -4,4 3.1 -5,1 -6,8 -6,1 -1.9 9.5
1 1 -1.5 7.3 8,6 -14,6 -46,4 -14,4 -11,3
17 (1) -5,6 2.9 -4,4 10,2 3,0 7,9 -3,3
17 (2) 3,3 2,8 4,9 10,3 6,6 2,3 2,5
21 1.4 -1.9 5,8 19,6 -1.3 -11.2 -9.6
25 6,3 -6,1 3,1 -10,7 -11,1 11,3 2.7
27 13,8 1.7 -0,4 2,7 6,9 13,1 -1.4
31 8,5 2.5 0,2 -4,7 11.9 12,8 7.4
32 -8,5 12,3 -1.1 -2,3 -1.8 -1.7 4,3
41 -11,5 1.8 13,9 5,2 -24,7 -12,9 -0,3
45 -2,4 -3,4 0,1 -8,4 -6,3 4,0 -1,7
47 -2,9 3,6 8,5 8,1 -5,5 -11,5 -6,3
49 2,3 -2,9 5,3 -12,4 -8,8 5,0 4,1
56 6,7 -3,6 4,5 -7,1 16,2 1.3 0,8
58 -7,2 -2,0 -7,4 5,4 -11,8 -2,5 4,1
59 2.1 8.3 2,1 -9.5 -12,8 -6,9 6,4
60 0,2 12,6 3,5 -0,4 4,9 -6,6
61 0,8 -0,2 5,2 15,8 -3,4 0,0 -0,2
62 (1) -26,9 10,4 0,0 -15,7 -36,7 -27,2 -2,6
62 (2) -3,3 -6,7 1.9 2,7 -19,3 -13,8 -4,9
63 10,0 8,1 -1.3 -1.6 -0,7 6,1 -2,4
64 5,5 4,3 -10,6 -3,0 -14,7 6,4 1.9
67 -1.4 -0,2 -1.5 -1.2 13,6 -10,4 -0,9
68 4.3 -2,5 2.2 -1.1 -5,8 0,3 4,5
69 (1) -8,6 -0,7 0.4 7.1 -48,3 -35,9 -3,0
69 (2) -10,2 -2,9 2.6 33,2 -21,8 -17,8 -0,8
69 (3) 7,6 7,9 12,5 30,8 18,6 13,3 11.7
70 -15,5 1.0 3,8 -6,5 -31,7 -11,5 0,7
71 -3,9 1.1 0,8 -2,1 -10,5 -4,5 2,1
72 -13,7 0,1 1.3 -5,6 5,0 -4,4 4,4
75 14,2 0,2 -5,5 7,8 16,4 2,7 1.2
77 -16,1 -7,9 -1.5 8.0 -17,6 -23,4 -3,3
78 -1.3 -0,3 -7.6 3,0 -6,2 3,0 -2.1
Extratemporal group
1 16,2 13,4 -0,2 -4,4 -4,9 6,8 -4,7
2 -2,1 0,9 2,3 3.4 -25,5 -4,5 12,9
3 11.3 7,1 0,1 2,6 5,5 1.2 -0,1
4 (1) -1.3 -1,2 -1.4 1.2 0,6 -1.0 -5,7
4 (2) -5,4 0,6 2.1 -0,4 5,5 -5,4 -9,2
5 -1.1 3.5 -4,8 -2,1 5,2 -8,7 -0,1
6 -20,9 5,8 6,2 3,5 -4,2 -2,9
7 2,0 -3,0 1.7 2.0 -2,7 -13,9 -5,5
8 2,4 1.7 1.4 1.4 1.0 -3,2 -3,9
1 1 5,9 0.2 2.0 0.4 0,9 -3,7 -4,0
1 2 0
Table 3.4
NUMERICAL ANALYSIS: ICTAL/POSTICTAL SCANS 
Change in asymmetry index from interictal image (%)
Temporal group: ROI
Patient Frontal Bas.Gang Thalamus mes. Temp lat. Temp Parietal Occipital time
1 ■1.4 12,3 -1,8 4,5 11,7 -18,9 -3,4 30
8 -2,8 5.8 -2,4 5,3 2,0 0,1 16,3 60
11 5,0 3,0 4,3 -8,9 -37,7 -20,5 -11.7 300
17 (1) -3,7 -0,1 -7,4 4,2 -7,8 10,4 -3,4 0
17 (2) 5,4 -0,2 1,9 4,3 -4,2 4,8 2,4 0
21 -1,4 9,4 11.2 24,0 -12,5 -1,4 -7,0 150
25 1.9 4.6 -4,6 19,9 -11,1 7,9 1.3 0
27 11,1 -1.6 -3,7 10,2 14,1 7,1 -1,1 120
31 3,6 5,8 4,5 -3,1 11,1 16,3 9,2 360
32 -1,6 15,7 -2.3 1.9 1,4 -2,8 2,8 30
41 -12,4 9,3 6,4 8,3 -13,9 -13,1 -1.6 120
45 -3,8 6,0 9,5 13,0 -4,0 6,3 -2,9 10
47 0,1 2,5 7,4 12,3 -2,9 0,3 -6,7 10
49 2,5 0,8 9,0 -11,2 -9,7 6,0 3,8 180
56 7,4 -0.1 8,0 -19,2 12,5 2,2 -3,9 120
58 -5,3 -3,7 -9,1 8,6 -4,6 2,1 -1.1 15
59 5,9 3.8 -2,4 -3,5 -2,3 -6,9 3,7 90
60 -3,7 12,3 -3,2 9,1 16,2 4,8 -9,4 0
61 0,3 -0,5 4,8 1.9 -6,1 1,1 -4,8 120
62 (1) -16,7 10,7 0,3 -6,7 -8,1 -20,2 9,3 900
62 (2) 6,9 -6,4 2.2 11.7 9.3 -6,8 7,0 60
63 -2,8 7,8 -1,6 6,7 4,3 9,9 -5,5 300
64 11,1 4,9 -10,0 6,1 7,0 7,0 -0,2 10
67 -0,1 -5,3 -6,6 0,8 0,8 -2,8 4.6 10
68 3,6 0,4 -5,0 -2.3 -4,8 0,8 -1,9 0
69 (1) 5.7 9,3 10,4 31,4 -6,7 -1,2 0,9 50
69 (2) 4,1 7,1 12,6 57,5 19,8 16,9 3,1 0
69 (3) 21,9 17,9 12,5 55,1 60,2 48,0 15,6 0
70 -19,6 -4,5 -1.6 -9,6 -25,9 -6,1 3,8 240
71 -4,5 1.0 0,7 1.7 -3,0 -8,6 8,7 60
72 -20,2 -3,8 -2,5 -8,5 19,6 -4,1 5,1 60
75 13,9 -4,5 -10,2 13,7 1,0 1,1 -0,7 15
77 -5,2 -0,5 2,9 7,1 -10,5 -25,3 -6,6 180
78 8,4 -8,8 -16,1 -7,7 3,6 -2,9 -0,8 30
Extratemporal group
1 -12,8 -7,4 -0,2 -2,0 1.0 6,7 -8,3 0
2 -2,9 5,0 2,3 -2,2 -13,8 0,5 25,1 30
3 -9.2 6,8 3,9 1,2 9,1 2,7 1.4 30
4 (1) -2.4 0,1 45,7 -0,5 6,6 -5,5 -1,4 300
4 (2) -4.3 1,9 49,2 -2,1 9,5 -10,8 -4,9 120
5 -1.7 2,8 -11,2 2,5 9,1 -1,6 3,6 60
6 30,0 6,5 -8,9 -0,2 -7,9 4,3 120
7 0,8 -8,9 -2,1 0,3 0,8 -13,4 -2,8 0
8 3,8 3,7 3,1 0,6 -2,9 -4,5 -2,8 90
11 -0,6 5,8 -5,5 -1.9 -1,4 -9,1 -4,3 120
1 2 1
Table 3.5
VISUAL AND NUMERICAL ANALYSIS OF IMAGES 
Summary of ictal/postictal changes in cerebral perfusion
Temporal group (33 patients, 37 scans)
1. Visual analysis
Timing of injections
Change Number (seconds postictal)
1 4 (3L, 1R) 0
2 21 (11L, 7R, 3B) 0 -360
3 4 (3L, 1R) 90-900
Abnormal > normal 3 30 -300
No change (normal) 2 30, 180
No change (abnormal) 3 0-60
2. Numerical analysis 
Change
1 1 Sides agreed with
2 13  visual analysis
3 4
Abnormal > normal 1
No change (normal) 1
No change (abnormal) 0
3. Disagreements between visual and numerical analysis 
Hypoperfusion identified numerically
but not visually: 5 (1 frontal, 1 mesial temporal,
1 lateral temporal, 2 parietal)
Hypoperfusion identified visually
but not numerically: 8 (all lateral temporal)
Key to changes in tem poral group:
1 Hyperperfusion of whole temporal lobe
2 Hippocampal hyperperfusion with hypoperfusion of lateral structures
3 Hypoperfusion of whole or part of tem poral lobe
L=left R=right B=bilateral
1 2 2
Table 3.5
Extratemporal group (9 patients, 10 scans)
1. Visual analysis
Frontal hypoperfusion 3 (2R,1L)
Frontal hyperperfusionwith
contralateral hypoperfusion 2 (hyperperfusion on R)
Occipital hyperperfusion with
ipsilateral hemispheric hypoperfusion 1 (L)
No change 4
L=left R=right B=bilateral
2. Numerical analysis
Results as for visual analysis - no disagreements
0-120
0-120
3 0
6 0 -3 0 0
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Chapter 3
D iscussion  
Control studies
In this study, the interictal im ages (visual analysis and asymmetry indices) 
acted a s  control values for ictal and postictal studies. This practice entailed the 
assumption that any change seen on ictal or postictal images was due to the seizure. As 
has been discussed in Chapter 2, there is evidence that HMPAO SPECT findings may 
change independent of known seizures, and that interictal rCBF may be normal on some 
occasions and abnormal on others. For example, in the present study there were 3 
patients in whom rCBF was abnormal interictally, and becam e normal postictally. This 
is open to at least two interpretations.
1. That the change is due to the seizure, i.e. rCBF has increased from a low level to a 
normal level because of the metabolic activity associated with the seizure, or the 
injection has been carried out during an intermediate phase of rCBF changes in a 
temporal lobe which has just been or is about to be hyperperfused.
2. That the change represents a variability in interictal hypoperfusion that would have 
taken place in any event, and is nothing to do with the seizure.
The issue of intra-individual variability in rCBF in normals or in patients 
with focal epilepsy has not been adequately addressed  in this work or elsewhere, 
because of the ethical problems relating to radiation dosage. As discussed in Chapters 1 
and 2, those small studies that have been done suggest that interictal hypoperfusion is 
s tab le , while there are nonetheless well docum ented individual exam ples of 
variability, even where injections have been EEG controlled to exclude recent or 
ongoing  se izu re  activity (Shen e t al, 1990; Berkovic e t al., 1992). 
Hyperperperfusion is occasionally seen  in apparently interictal studies, and is also 
variable (Duncan et al., 1990a). The question should therefore be addressed  of 
whether ictal and postictal changes are consequent on the seizure or are coincidental.
Hyperperfusion of the whole temporal lobe has never been seen  interictally in 
any study, so is highly likely to be truly associated with the seizure. The sam e 
reasoning can be applied to the early postictal (type 2) finding, excepting that this 
type of abnormality was found interictally in one patient in the present study (see 
Chapter 2), albeit that no EEG recording was carried out during injection of HMPAO, 
and subclinical seizure activity could not be ruled out as a cause in that case. There are
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no instances of this finding occurring interictally in any study in the literature. It is 
therefore likely that it is also relatively specific for the postictal (or late ictal) 
period.
The late postictal (type 3) change consists of hypoperfusion of the whole 
temporal lobe, which is commonly seen  interictally. Even examining numeric and 
visual data in retrospect, there was no clear distingushing feature between interictal 
and postictal hypoperfusion (e.g. in the relative degree of mesial and lateral 
hypoperfusion). There are now many exam ples of this type of postictal change 
docum ented in the literature, but where such changes seen  at relatively long time 
periods after a seizure, their connection with that seizure remains in doubt.
It would be useful to have a range of 'normal' for variability in asymmetry 
indices. Ethical permission was not sought and would not have been given for repeat 
studies in normal volunteers. The meaning of normal data based on epileptic patients 
would be doubtful, since they may show changes in rCBF between one examination and 
the next which might be of similar magnitude to postictal changes (Berkovic et al., 
1992). The number of subjects required would also pose ethical problems.
Timing of injections
Previous ictal and postictal studies of regional cerebral perfusion have timed 
the injections of radionuclide with reference to EEG-recorded ictal onsets. In the 
present study EEG recording was not available, so HMPAO injections were timed with 
reference to the clinical features of the seizure; a study was labelled 'ictal' if the 
patient was injected during the 'motionless stare ' phase of the seizure. Times of 
postictal injections are given with respect to the end of this phase. This method has 
potential inaccuracies, since the end of the stare phase was not always clear cut and, 
depending on the manifestations of the seizure, was not always clearly observable. 
While patients were observed as closely as possible, it was not always possible for a 
nurse or doctor to be present by the end of brief seizures. Although the geography of 
the ward and situation of the patients within it was such that nursing staff were 
usually on the scene within 30 seconds of the alarm being given, patient care took 
precedence over noting and recording times. This is likely to have resulted in some 
errors, particularly in patients whose seizures included autom atism s and florid 
behavioural disturbances, in which case times were not recorded until the patient's 
safety had been secured.
In the early phase of the study, the nursing and medical staff were not used to 
the procedure, and the injections carried out at this time were all late in the postictal 
period, and times were recorded only to the nearest 30 seconds. As the study
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progressed, all injections were carried out either ictally or within the first minute 
(since the data were used for clinical purposes, and it was already known that 
injection closer to the seizure was more likely to yield useful localising information, 
it would not have been ethically acceptable to delay injections for the sake of obtaining 
a  better spread of injection times, or to obtain more late postictal studies with more 
accurate timing). Even then ward staff were usually not able to record the time of the 
end of the stare to the nearest second, even when it was reasonably clearcut, and would 
normally note it to the nearest 10-15 seconds, while taking care of the patient, and 
record it as soon as other members of staff arrived. In terms of accuracy, this was not 
ideal but it was felt that the practical problems of patient care did not allow any more 
elaborate procedure.
Notwithstanding these sources of error, with the exception of two patients, the 
changes labelled as ictal and postictal in this study were the sam e as those in the 
studies of Rowe et al. (1989b; 1991b) and Newton et al. (1992), where EEG timing 
with reference to seizure onset was used. Allowing for the usual 1-2 minute duration 
of a temporal lobe complex partial seizure, the timing of postictal changes was also 
similar, given the different reference points used. Type II change seen  within 5 
minutes of seizure onset in the studies of Rowe and Newton, and within 2 minutes of the 
end of the seizure in the present study. To determine the accuracy of clinical timing, 
one would have to use it in patients who were also EEG monitored, comparing the 
results. The above figures do, however, suggest that any inaccuracy in timing was not 
large.
Blinding of observers
The results of this study hinge on the changes in pattern of cerebral perfusion 
seen  in association with a clinical event, i.e. the seizure. Ideally, one would have 
reported interictal and ictal/postical images separately, and blind to the result of the 
other scan. However, prior to this study the observers had found by comparing 
interictal and ictal/postictal images after separate  reporting that the latter method 
resulted in some changes not being detected. It was considered justifiable, therefore, to 
sacrifice a degree of 'blindness1 of reporting for the sake of accuracy, and to report the 
interictal scan first, then report the ictal/postictal scan with reference to it.
Other issues impinging on the visual analysis of im ages are d iscussed in 
Chapter 2.
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Temporal group
Visual analysis of images
Comparison with results of previous studies
The temporal characteristics of HMPAO make it difficult to compare the results 
of the present study to those using amine type tracers such as HIPDM. The problem is 
that where the shape or size of an area of alteration of cerebral perfusion is altering 
rapidly (as during a seizure it appears to do), the long uptake time of HIPDM and the 
consequent lack of temporal resolution of the images produced, is translated into lack 
of spatial resolution. Similarly, where an area is hyperperfused at the beginning of the 
uptake period and becomes hypoperfused before the end of it, the average uptake may 
be the sam e as parts of the brain which are normally perfused throughout.
A further difficulty as regards comparison with studies using other methods is 
compatability of the slices used to view and analyse images. The transaxial slices used 
in this study were originated by Rowe et al. (1989a; b). They are logically the best for 
seeing temporal lobe structures, allowing easy differentiation between mesial and 
lateral temporal cortex, and between mesial cortex and the adjacent frontal lobe. The 
studies of Lee et al. (1986; 1987a; b; 1988) and Shen et al. (1990) as  well as  using 
the tracer HIPDM, used standard orbitomeatal slices, which make it difficult to 
appreciate temporal lobe anatomy. Such difficulties of anatomy and resolution are 
reflected in the fact that in these studies abnormalities are reported as regions of 
increased or decreased uptake, rather than as structures. Given these problems, only 
the studies of Rowe et al. (1989b;1991b) and Newton e t al. (1992) are directly 
comparable with those of the present study.
The ictal and postictal changes seen in other studies are compared with those in 
the present study in the light of the above factors.
1. Ictal changes
Lee et al. (1986; 1987a; b; 1988) found a reas  of increased cerebral 
perfusion in the temporal lobe in 12/14 patients with temporal lobe foci. All their 
patients were injected during the seizure, so no postictal changes were shown. They 
comment that 'in a few patients' rCBF was decreased  in areas  adjacent to the 
hyperperfused areas, and suggested this might be due to a steal phenomenon. The later 
study from the sam e group (Shen et al., 1990) found areas of increased perfusion in 
the temporal regions of 33/34 patients with temporal lobe foci. In neither of these 
studies do they comment on the morphology of the areas of increased perfusion, and it
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is not clear whether the whole or part of the temporal lobe is involved in all cases. The 
limitations of their method makes it unlikely that they could make such a distinction 
clearly (see  above). Rowe et al. (1991b) and Newton et al. (1992) found 
hyperperfusion of the whole temporal lobe on ictal images, as in the present study. 
They also commented on hypoperfusion of the frontal and parietal lobes ipsilateral to 
the focus. Hypoperfusion was seen during the ictal phase by Penfield et al. (1939). It 
was not noted on visual analysis in the present study, but was detected in 2 patients by 
numeric analysis.
Two patients injected ictally in the present study had hyperperfusion of the 
hippocampus with lateral hypoperfusion (i.e.) the pattern found more typically in the 
early postictal period. This would be compatible with the finding of Shen et al. (1990) 
of hypoperfusion 'adjacent to' ictal hyperperperfusion, given the relatively poor 
anatomical definition in their study, but given differences in timing methods, it may be 
that our own patients showing this were actually in the early postictal phase. However, 
one patient was in the clonic phase of a secondary generalised seizure at the time of 
injection, and one had EEG coincidentally recorded at the time (showing continuous 
spike/wave discharge), making inaccurate timing an unlikely explanation in these 
cases. Both had seizures which were prolonged, so it may be that the 'postictal' pattern 
of perfusion occurs in the late stage of long periods of seizure activity, as well as after 
shorter periods.
The studies of Lee et al. (1988), Shen et al. (1990), Rowe et al. (1991) and 
Newton et al. (1992) detected changes in a  total of 54/57 (96%) of patients studied 
in the ictal phase. Changes were detected in 6 of the 8 ictal images in the present study 
(both scans showing no change were in the same patient).
In contrast to the above changes, one patient (patient 61) in the present study 
showed ictal hyperperfusion confined to the hippocampus, with no hypoperfusion. 
There w as no obvious difference between this patient and the others, clinically, 
interms of EEG findings or in term s of postoperative pathology (Ammon's Horn 
sclerosis was found). As in all the patients, injection followed the habitual type of 
seizure, which was of the complex partial type. It is possible that the seizure 
discharge remained very localised, and that the associated metabolic disturbance was 
therefore also small in extent, but only depth EEG recordings would be able to establish 
this, and these were not available.
2. Postictal changes
The only studies comparable with the present one are those of Rowe et al. (1989; 
1991) and Newton et al. (1992). Early in the postictal period, these studies found
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hyperperfusion in the hippocam pus with hypoperfusion of lateral tem poral 
structures, corresponding to the type 2 change found in the present study. In the 
studies of Rowe et al., and Newton et al., the hypoperfusion sometimes extended into the 
parietal and occipital regions. In the present study, extensive postictal hypoperfusion 
extending outside the temporal lobe occurred in most patients, although it was often of 
a relatively minor degree. The timing the changes relative to the HMPAO injections in 
the two studies were compatible; Rowe et al. found that hippocampal hyperperfusion 
resolved 5-8 minutes after the beginning of the seizure, compared to up to 6 minutes 
after the end of the seizure in this study (according both to visual and numeric 
analysis of images).
Type 3 change, or hypoperfusion only, was seen up to 15 minutes after the end of 
the seizure. This has been seen in other studies up to 20 minutes postictally Berkovic 
et al., 1991) but clearly, given the fact that up to 30% of patients injected later in 
the postictal period to show no changes in rCBF (Rowe et al., 1989b; 1991b), it is 
likely that the duration of this phase is highly variable.
Postictal HMPAO SPECT localised the epileptic focus correctly in Rowe's 
(1989b; 1991b) studies in 72% and 69% of patients, with 1 patient apparently 
localised incorrectly. In the present study 24/26 (92%) were localised correctly, 
with no false localisations. It is not clear why relatively few of Rowe's patients showed 
localising changes, as one would expect changes in perfusion to occur in association 
with all seizures. Rowe et al. (1989b) did find a tendency for injections closer in time 
to the seizure to be more likely to show changes in rCBF, as one would expect to be the 
case. Our injections may have been closer to the seizure than Rowe's (the difference in 
timing method makes exact comparison impossible), and it may be that the superior 
resolution of the imager allowed confident reporting of less obvous abnormalities.
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Causes of ictal and postictal hyperperfusion and hypoperfusion
It is probable that ictal hyperperfusion is the result of metabolic dem and of 
electrical activity (increased local metabolic rate has been shown in the limited PET 
studies done during seizures (Engel, 1984; Engel et al., 1983; Franck et al., 1986; 
Theodore et al., 1984; Theodore et al., 1983), and that hyperperfusion persisting 
postictally is the result of metabolic debt built up during the seizure as a  result of 
non-oxidative glucose metabolism (Ackerman et al., 1989), and persisting metabolic 
activity taking place to restore ion gradients, activity which had been shown to persist 
for several minutes postictally in animal experiments (Leninger & Follett 1984). It 
seem s likely that the area most metabolically active will have the greatest metabolic 
debt, and that given that the patients had mesial temporal foci, persistence into the 
postictal period of hyperperfusion in the hippocampus is consistent with seizure 
origin in that structure.
While ictal hypoperfusion was not noted on visual analysis of images in the 
present study, numerical analysis shows that hypoperfusion occurred during the 
seizure in the parietal and frontal lobes in 3 patients, and the phenomenon has been 
observed in several patients since completing the above study. Hypometabolism 
surrounding ictal hypermetabolism was noted in one PET study (Engel, 1983), and 
animal studies of metabolism and blood flow have also shown the sam e phenomenon 
(see  Chapter 4). It is therefore likely that metabolism as  well as perfusion is 
depressed. The phenomenon may be related to the inhibition seen around epileptic foci 
in animal models (see Chapter 4; Prince & Wilder, 1967).
Presumably postictal hypoperfusion relates to the sam e effect. PET studies of 
metabolic rate in generalised seizures have found postictal depression of metabolism 
(Engel, 1983a,b; Engel, 1984; Engel et al., 1982b; Engel et al., 1983; Mazziotta & 
Engel, 1984), so postictal depression of blood flow is also likely to be secondary to 
depression of metabolism. No attempt was m ade in this study to relate postictal 
confusional s ta tes  to postictal hypoperfusion, but postictal hypoperfusion has been 
related to the slowing of EEG rhythms which is associated with postictal confusion 
(Rowe et al., 1991b).
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Temporal group
N um erical a n a ly s is  of Im ages 
Ictal changes
In the present study, the largest increase in asymmetry index was found in the 
lateral temporal cortex in patient 69. The interictal asymmetry index was -41.6, and 
the ictal index was 18.6, giving an increase in asymmetry index of 60.2. Without 
knowing absolute rCBF it is not possible to say what percentage increase in perfusion 
this change represents, as the perfusion in the contralateral side may also have 
changed in either direction. Assuming it did not, then rCBF in the lateral temporal 
cortex approximately trebled in this patient, even without allowing for the fact that 
HMPAO underestimates high flows. Studies of blood flow and metabolism in generalised 
seizures have shown rises of up to 350% in humans (Engel, 1983;1984; Engel et al., 
1982a; Engel et al, 1983; Mazziotta & Engel, 1984) and of up to 900% in rats 
(Meldrum & Nilsson, 1976). Studies of metabolism using rat models of epilepsy have 
found rises of 2-300% in seizures originating in the motor cortex (Collins, 1976; 
1978) and rises of 30-180% in se izu res originating in the limbic system  
(Blackwood et al., 1981; Collins et al., 1983; Lothman et al., 1985). It appears that 
the range of changes seen in the present study is consistent with these data.
The 95% confidence interval of the mean ictal change in asymmetry index for 
the lateral temporal cortex found by Newton et al. (1992) was 21.8-48.4%. The total 
range in the present study was -10.2-60.2, with a 95% confidence interval of 
-11.9-34.4. The smaller confidence interval probably reflects the fact that som e 
patients in our series showed ictal hypoperfusion of the lateral cortex. The 95% 
confidence interval in the study of Newton et al. for the mesial temporal cortex was 
22.4-39.2, compared to the present study, where the total (ictal) range was 2.3- 
57.5, with a 95% confidence range of -1.2-44.8. The difference at the lower end of 
this range might also be explained by 2 patients showing the typical postictal (Type 2 
change) pattern of perfusion (the degree of mesial hyperperfusion was less in these 
patients, both in the present study and that of Newton et al.), and by 2 patients showing 
no change. The range of change in the parietal ROI was greater in the present study than 
in that of Newton et al., at 0.8-48.0 with a 95% confidence interval of -2.7-32.2, 
the larger range being entirely due to the single patient at its top end. The frontal ROI 
used by Newton et al. was laterally placed, and not comparable with those found in the 
present study which was anterior. The frontal changes seen in the present study were 
more prominently positive (95% confidence intervals of -13.9-2.5 for Newton et al. 
com pared with -3.9-12.3% in the present study). If the negative changes seen  by
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Newton et al. were due to 'surround hypoperfusion' then the greater proximity of their 
lateral ROI to the temporal lobe may have been responsible for the greater negativity 
of the changes seen.
Postictal changes
Changes in asymmetry index in frontal, lateral temporal and parietal ROIs all 
showed greater negativity from the ictal period on, decreasing in the first minute to 
around or below zero, suggesting a more or less immediate decrease  in perfusion, 
continuing several minutes into the postictal period. By contrast, the first negative 
change in the mesial temporal ROI did not appear until 1 minute postictally, and even 
late into the postictal period mean changes were only slightly negative. This difference 
reflects the tendency noted on visual inspection of im ages for mesial temporal 
structures to remain hyperperfused longer into the postictal period than lateral 
cortical structures. Obviously in interpreting m ean values of postictal changes 
differences in the size of the time groups should be taken into account; most injections 
(14) were carried out up to 1 minute postictally, while only 3 were carried out 
between 2 and 3 minutes postictally.
The greater prominence of hypoperfusion into the postictal period may reflect 
increasing inhibition; one would expect neuronal exhaustion to recover in the postictal 
period, rather than worsen. Hypoperfusion tended to affect the lateral temporal ROI 
most prominently of the lateral ROIs, which one would expect given the abundant 
connections between the mesial and lateral temporal structures thought to be 
responsible for rapid propagation of seizure impulses (Van Hoesen, 1982; Van Hoesen 
et al., 1979).
Compatability of numeric data with the results of visual analysis
There are no control data for ictal or postictal change in asymmetry index. For 
the purposes of comparison with visual analysis, therefore, the change in rCBF 
according to numeric analysis was determined by noting which ROIs had asymmetries 
of 9% or more on interictal scans, and doing the sam e on the ictal or postictal scan. The 
change in rCBF was defined as the difference between the two.
There were only 4 scans in which numeric analysis detected abnormalities 
which visual analysis did not, compared with a total of 9 scans in which there were 
discrepancies in the other direction. Agreement between the two methods was similar 
to that in the interictal study (Chapter 2).
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Ictal and postictal changes in asymmetry index in the basal ganglia
The changes seen in asymmetry indices in the basal ganglia and thalamus were 
similar to those seen by Newton et al. (1992). In all the ictal images which showed 
changes, the direction of the change was the sam e as that in the temporal lobe. 
Postictally, while the average change was in the sam e direction as cortical changes, 
there were individual patients in whom the direction of change disagreed. There are 
projections in both directions between limbic structures (particularly the amygdala) 
and the basal ganglia (Alheid & Heimer, 1988), and one might expect changes in 
temporal cortical structures to be mirrored in subcortical structures postictally as 
well as ictally. Why this is not always the case  is unclear. It may be that the precise 
topography of inhibitory discharges in the early postictal period causes depression of 
function in subcortical structures while the hippocampus remains hyperfunctional.
Extratemporal group
In contrast to the situation in the temporal lobe, where the great majority of 
seizure foci are in the hippocampus, seizures may originate in a wide variety of 
locations in the frontal lobe (Bancaud & Talairach, 1992), which is a  much larger 
structure. Patients 6 and 7 both had epileptogenic lesions (manifested as  signal 
changes on MRI) in the frontopolar area, and both showed ispilateral adjacent 
hyperperfusion with contralateral hypoperfusion, albeit one injection was during a 
seizure, the other 2 minutes postictally. The 3 patients showing hypoperfusion only 
had EEG onsets recorded over the hypoperfused frontal lobe, but had no evidence of the 
location of the focus within the frontal lobe. The patients showing no change had no 
localisation within the frontal lobe.
One might hypothesise that the different changes in rCBF seen  (i.e. 
hypoperfusion alone c.f. hyperperfusion with contralateral hypoperfusion) were 
because the location of the foci within the frontal lobe were different. However, the 
possibility should be considered that the three patients showing hypoperfusion only 
had a  small focus of hyperperfusion in the contralateral frontal lobe, beyond the 
resolution of the imaging technique (the area of hyperperfusion seen in patient 6 was 
small, and may well have been missed using an imager of lesser spatial resolution). 
One study of postictal rCBF including patients with frontal seizures has been published 
(Stefan et al., 1990), and it included one patient in whom such a finding was false
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lateralising. While the side of the hypoperfusion agreed with surface EEG ictal onsets 
in the patients in the present study, such onsets may be false lateralising (Swartz et 
al., 1991), and do not exclude the above explanation for there being different findings 
in these patients. A recent study of rCBF including som e patients with frontal lobe 
seizures (Marks et al., 1992) has shown different changes accoring to site of origin in 
the frontal lobe.
The observation that hypoperfusion associated with frontal seizures may be 
contralateral to the focus is in marked contrast to the temporal seizures and the single 
occipital se izu res observed where it w as without exception ipsilateral. The 
observation has been repeated on several occasions since completing this study. One of 
the patients in this study (patient 6) and one subsequent patient had complete corpus 
callosum sections, making it unlikely that the effect is mediated by callosal pathways. 
It may be mediated through bulbocortical pathways and the locus ceruleus or other 
brainstem structures, known to have cerebrovascular regulatory effects (Lance et al., 
1986 others). W hether it is related to postictal slowing or to postictal inhibition is 
unknown. While conclusions regarding patterns of ictal and postictal rCP cannot really 
be drawn from these limited data, they were completely different from those seen  in 
the temporal group in the present study. The difference was confirmed by the results 
of numerical analysis of images, showing that ROI data for the groups as a whole were 
differed mainly in the mesial temporal ROI, which showed virtually no changes in the 
extratemporal group.
Comparison of the results of the present study with animal studies
Studies of local cerebral metabolic rate in the rat have some obvious parallels 
with the ictal and postictal changes in regional cerebral perfusion found in the present 
study. Studies of focal motor seizures (e.g. using intracortical injection of penicillin) 
have shown local increases of up to 300%, with secondary activation of the homotopic 
motor cortex, the cingulate gyrus, the caudate and globus pallidus (Collins, 1976; 
1978). Prominent depression of metabolism is seen  throughout the rest of the cortex. 
Rat models of limbic seizures show increases in metabolism of up to 180% in the 
limbic structures them selves, with lesser increases in the contralateral limbic 
structures, the substantia nigra, thalamus and septal nucleus (Blackwood et al., 1981; 
Collins et al., 1983; Lothman et al., 1985). Depression of metabolism has been seen 
only to a small extent in these studies (Lothman & Collins, 1981).
In rat models of limbic seizures, increases in local metabolic rate and blood 
flow are seen in the ipsilateral thalamic nuclei and substantia nigra (Blackwood et al.,
134
1981; Collins et al., 1983; Lothman et al., 1985; Tanaka et al., 1990). Basal ganglia 
changes seem to be more prominently described in models of focal motor seizures 
(Collins, 1976a; b; 1978). It is, however, interesting to note that in the present 
work (see chapter 4) changes in blood flow secondary to focal motor seizures were 
seen in the thalamus and substantia nigra, but not in the basal ganglia.
Studies in the rat and their relationship to human studies are further discussed 
in Chapter 4.
Comparison of results of the present study with the 
observations of Penfield
Penfield (1933; 1937) observed changes in perfusion at the site of the focus 
starting seconds after seizure onset, and lasting several minutes after the end of the 
seizure. These changes corresponded well with those seen in the present study. He 
observed ictal increases in perfusion starting seconds after seizure onset, focal 
blanching and arterial spasm of the pia during and after the seizure, and showed that 
ictal perfusion fell at sites distant to the focus. These latter changes are likely to 
correspond to the ictal 'surround1 hypoperfusion, and more w idespread postictal 
hypoperfusion seen in the present study.
135
C o n c lu s io n s
1. In seizures originating in the mesial temporal lobe, the whole temporal lobe is 
hyperperfused during the seizure. The lateral temporal cortex becom es hypoperfused 
early in the postictal period, while hyperperfusion pers is ts  longest in the 
hippocampus. Such changes were seen in the majority of seizures studied.
2. Postictal hypoperfusion may be very extensive, and may involve the whole 
hemisphere ipsilateral to the focus.
3. The anatomical correlation with interictal findings was good, but ictal and postictal 
changes are seen in a higher proportion of patients.
4. Seizures of extratemporal origin showed different patterns of change in rCBF during 
and after seizures, but numbers of patients were too small for definite conclusions to 
be drawn. In some patients at least, hypoperfusion may appear ictally or postictally in 
the hemisphere contralateral to the focus.
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Chapter 4
Validation of HMPAO as a tracer of cerebral perfusion during 
seizures  
In tro d u c tio n
HMPAO
HMPAO (Neirinckx et al., 1987) is hexam ethylpropyleneamineoxime. It is a 
lipophilic compound which can be labelled with 99m jc to form 99mTc-HMPAO. When 
injected intravenously it is distributed throughout the body, with approximately 4% of 
the dose going to brain in man and animals (Costa et al. 1986; Andersen et al., 1988a). 
Being lipophilic, it crosses the blood-brain barrier freely. Inside brain tissue it 
undergoes a chemical change (the precise nature of which remains uncertain (Costa et al., 
1989; El Shibirny et al., 1989)), and becom es hydrophilic and therefore unable to cross 
cellular m em branes and the blood brain barrier. Its distribution in brain therefore 
remains stable for some hours. Studies in the rat (Costa et al 1989) have shown that it 
distributes largely in the neurones in the neocortex (92%) and in the paleocortex 
(85%), and to a lesser extent in the cerebellum (70%). The remainder is localised in the 
glia. Within the neurones, it is concentrated in the lysosomes.
The brain distribution of microspheres and 9 9 i t i t c  HMPAO correlate well in the 
dog (Costal et al, 1987), and previous autoradiographic studies using iodoantipyrine 
(IAP) have also shown good agreement (Lear, 1988; Bullock et al., 1991). Initial uptake 
in the normal human brain appears to be proportional to rCBF (Lassen et al., 1988), and 
to correspond well with rCBF as shown by other in vivo methods such as 133Xe (Andersen 
et al., 1988) and PET (Yonekura et al., 1988: Inugami et al., 1988).
The conversion of HMPAO to a hydrophilic compound takes place with an 
exponential half life of 40 seconds so, at high flow rates, there is a  'wash out' effect, 
causing HMPAO uptake to underestimate flow. This can be corrected using the correction 
factor of Lassen et al. (1988). The expression used to derive the correction relates the 
corrected HMPAO uptake, hence the true CBF, to the m easured HMPAO uptake by the 
expression;
f /f r= o x C /C r) /(1 + o -C r)
137
where f is the true CBF, C is the measured HMPAO uptake in the brain area of interest, 
and fr and Cr are the flow rate and measured 99™Tc HMPAO concentration, respectively, 
in a reference region of the brain. The constant o is the ratio of the rate of conversion to 
the rate of back-diffusion and clearance in the reference region (the reference flow rate 
in this study is 100ml/100g/min and the value for o is 2.0 (Igunami et al., 1988)). The 
function is illustrated in Fig 4.1. HMPAO and its kinetics are further d iscussed in the 
Appendix.
This correction has been applied in normal rats and in low flow rodent models of 
ischemia, but has not so far been applied at flows as high as those seen during seizures in 
rats and in humans. This study aims to compare HMPAO uptake with rCBF as  measured by 
14C iodoantipyrine IAP uptake in the normal rat and during focal motor seizures, using 
the penicillin model of focal epilepsy, to verify that the Lassen correction linearises the 
relationship at very high flows. A recent publication (Sperling & Lassen, 1993) suggests 
that HMPAO uptake may be spuriously high in areas  reperfused following cerebral 
infarction, underlining the need to verify the accuracy of the technique in specific 
pathological situations.
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M e th o d s
Ten male Sprague Dawley rats weighing between 375g and 595g (mean 480 ±  
21 g) were used, 5 for control studies and 5 for seizure studies. The procedure was as 
follows;
Induction of focal motor seizures using intracortical injection of penicillin
1. The rat was anaesthetised using halothane and nitrous oxide. Anaesthesia was continued 
during the procedure using a plastic face mask.
2. Cannulae were inserted into both femoral arteries and veins. One arterial catheter was 
used for monitoring of blood pressure and pulse rate, and for obtaining arterial gases for 
blood gas estimation.
3. The rat was placed in a plaster of paris hip brace, and secured to lead bricks.
4. An incision was made over the skull, and a 1mm burr hole of sufficient size to expose
0 .5 .m  of dura was made 2mm anterior and lateral to bregma.
5. The skin was resutured.
6. One venous catheter was connected to the syringe pump containing 125uCi/kg of 14C 
IAP in 1.5ml, the other to a syringe containing 500MBq of 99^T c HMPAO in 1ml. The 
remaining arterial catheter was used for sampling during the IAP procedure.
7. Blood pressure and gasses were checked.
8. The skull suture was divided, and the burr hole re-exposed.
9. A fine needle attached to a 500pl microsyringe was inserted into the cortex through the 
dura to a depth of 1.5mm from the outer dural surface. A volume of 200pmol of penicillin 
in 200pl of pH-balanced artificial CSF was injected. Control animals were injected with 
200pl of artificial CSF.
10. The scalp wound was resutured, and the anaesthesia discontinued.
11. The rat was observed and the first manifestations of seizure timed.
Injection of HMPAO and measurement of rCBF
1. After 7 minutes of seizure activity 200MBq of 99™Tc labelled HMPAO was injected 
intravenously over 1 minute.
2. Two minutes were allowed between the injection of HMPAO and the IAP procedure to 
allow time for any back-diffusion of HMPAO to occur. After 10 minutes of seizure 
activity, therefore, the IAP procedure was commenced. The procedure and the method of
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calculation of rCBF are described in detail by Sakurada et al. (1978), Tamura et al. 
(1981), and Gotoh et al. (1986). It is carried out by 3 operators, 1 who collects and 
times (by speaking into a tape recorder) the arterial sam ples, 1 who regulates the 
ramped infusion of 14C iodoantipyrine, and one who monitors the condition of the animal 
during the 30 seconds of the infusion (in particular to ensure that blood pressure does not 
drop below the limit of autoregulation during the procedure) and operates the guillotine at 
the end of the infusion. Just prior to commencing the IAP procedure:
1. The rate of flow through the arterial catheter was regulated to give approximately 50 
drops over 30 seconds.
2. Blood gasses, pulse and blood pressure were checked. The experiment proceeded if pC02 
was 60mmHg or less and p02  was 70mmHg or more. Systolic blood pressures of 100- 
200mmHg were considered acceptable.
The IAP procedure was then commenced as follows;
1. At the same moment, the arterial catheter was opened and the IAP infusion started.
2. The IAP was injected at a progressive rate, the whole dose being given over 30s.
3. During the period of the injection 15-18 drops were collected from the arterial 
cannula on pre-weighed 1cm filter paper discs.
4. At the moment the infusion was terminated, the animal was decapitated.
5. The brain quickly dissected out and frozen (to prevent tracer diffusion (Williams et al, 
1991) by immersion in isopentane chilled to -42deg.C in dry ice.
6. The blotting paper discs were transferred to pre-weighed scintillation counter vials 
which were immediately capped to prevent evaporation and re-weighed.
4. Immediately following the procedure, the brain w as cut into 20pm coronal sections 
with a cryostat. Three consecutive sections every 13 were mounted on cover slips. Within 
1 hour of decapitation the sections were placed on autoradiographic film (Amersham 
Hyperfilm) for 4 hours, with a series of 6 standards from 2.5-19.00 pCi/g.
4. IAP was eluted from the arterial samples contained on the blotters. The sam ples left for 
4 days to allow 99rn-pc activity to diminish, were placed in a scintillation counter, and 
counted 3 times and the counts averaged. The concentration of tracer in the blood was 
calculated from the detected radioactivity and the sample volume.
5. After a gap of 4 days to allow " mTc activity to diminish, the sections were then placed 
on 14C sensitive film (Kodak GRL, Rochester, NY) for 14 days, along with a se t of 12 
standards from 44-1475nCi/g, to produce the 14C IAP autoradiograph.
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6. Quantitative autoradiography was carried out on both films using a Quantimet 970 
densitometer (Cambridge lnstruments).The structures m easured were;
1. the centre (low flow area) of the focus
2. the high flow area of the focus (penumbra) around the injection site
3. lateral frontal cortex adjacent to the focus 4. cingulate cortex
5. subcortical white matter
6. caudate nucleus
7. septal nucleus
8. globus pallidus
9. lateral amygdaloid nucleus
10. lateral habenular nucleus
11. medial habenular nucleus
12. ventral thalamic nucleus
13. dorsomedial thalamic nuclei
14. lateral thalamic nucleus
15. entopeduncular nucleus
16. hypothalamus
17. parietal cortex
18. auditory cortex
19. hippocampus
20. substantia nigra pars reticulata
21. inferior colliculus
22. pontine reticular formation
23. visual cortex
24. cerebellar hemisphere
For control animals, structures 1 and 2 were omitted. Each structure was 
measured on three adjacent sections, and the m easurem ents were then averaged. Each 
structure was measured with its contralateral homotopic structure. Structures were 
measured at the same position on the sam e section in IAP and HMPAO films. The se t of 
standards on each film were measured before and after the measurement of the structures.
rCBF was calculated as described by Sakurada et al. (1978) from the arterial IAP 
curve and the local tissue 14C concentration, using a partition coefficient for IAP of 0.78.
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Optical density values from HMPAO films were converted to 99mTc counts using 
the known standards. The Lassen correction factor was then applied.
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Chapter 4
Results
Physiological parameters.
p02, pC02, pH, systolic and diastolic blood pressures, and rectal temperatures are 
given for all 10 animals in Table 4.1. B ecause the animals were semi-conscious and 
breathing spontaneously, because of the time frame of the experim ents (i.e. rCBF 
measured within 10 min of withdrawal of anaesthetic), and because of seizure activity in 
the animals injected with penicillin, physiological variables were difficult to control. In 
particular, it proved difficult to achieve stable blood gas concentrations. Despite 
relatively wide variations being accepted, some experiments had to be aborted for this 
reason. Blood pressure rose sharply during seizures in animals 8,9 and 10. This was 
accepted since rises in blood pressure appear to contribute to the large rises in rCBF seen 
during seizures (during generalised seizures, at least (Plum et al., 1968)), and the main 
aim of the experiment required the production of high blood flows.
Seizures.
Control animals awoke normally 2-3 minutes after withdrawal of anaesthetic, and 
showed no abnormality of behaviour. Seizure animals exhibited subtle twitching of the 
right (contralateral to the seizure focus) whiskers from the moment of regaining 
consciousness. The twitching gradually spread to the muzzle, then to the foreleg, the 
hindleg and tail. The seizure remained unilateral and affected face, legs and tail in all 5 
animals, although the jerking movements were of obviously lesser amplitude in animal
10. EEG recordings showed a high amplitude spike and slow wave discharge of greater 
amplitude on the left (Fig 4.2).The autoradiographic films showed a similar site and depth 
of injection in all the animals, and there was no other obvious technical reason for the 
difference in intensity of seizure activity in animal 10.
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Blood flow as determined by the 1 4 C iodoantlpyrine method.
a. Non seizure animals.
Blood flows in non-seizure animals are shown with means and ranges for each structure in 
Table 4.2. Percentage side to side differences are given in Table 4.3. Cerebellar sections 
were not obtained for Rat 2. The blood flows for the group as a whole were compatable with 
those found in normal rats in previous studies using the sam e methods (McCulloch et al., 
1982a; Mohamed et al., 1985; McCulloch et al., 1982b). Inter-animal variability was, 
however, great; the smallest inter-animal range was 18ml/100g/min (subcortical white 
matter, left side) and the largest 251 ml/1 OOg/min (inferior colliculus, right side).
The pattern of regional cerebral blood flow was similar to that seen  in the normal 
rat, with the exception that in animals 1,3,4 and 5 there was an asymmetry in cortical 
blood flow (Fig 4.3), the flow on the side of the craniotomy being relatively low. The 
difference was maximal posteriorly: side to side differences in the parietal cortex in these 
4 animals were 84, 55, 76 and 81 ml/1 OOg/min, and in the auditory cortex, 61, 44, 50 
and 31 ml/1 OOg/min, respectively. These com pare with frontal side-to-side differences 
of -19, 19,-37 and 1 ml/1 OOg/min. Over the group a s  a whole, left-right differences 
were statistically significant only in the parietal cortex and visual cortex (p=0.019 and 
0.014, respectively; paired Student's t-test).
b. Seizure animals.
Flows in seizure animals are shown with m eans and ranges for each structure in Table 
4.4, with percentage side-to-side differences in Table 4.5. Cerebellar sections were not 
obtained in Rats 6 and 10. Mean flows were higher in seizure than in control animals in 
all structures except for the amygdalar and entopeduncular nuclei bilaterally, where 
flows were slightly higher in the control group (amygdalar nucleus control m eans 114 
and 119 ml/1 OOg/min, seizure m eans 100 and 109 ml/1 OOg/min; entopeduncular 
nucleus control m eans 92 and 89 ml/1 OOg/min, se izure m eans 98 and 74 
ml/1 OOg/min) and for the parietal and auditory cortex on the side of the focus, where 
flows w ere lower in seizure anim als (left parietal cortex control m ean 156 
ml/1 OOg/min, seizure mean 110 ml/1 OOg/min; left auditory cortex control mean 138 
ml/1 OOg/min, seizure mean 132 ml/1 OOg/min).
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The pattern of distribution of rCBF in seizure animals was different from that in 
the control animals. Side to side differences are assessed  using the paired Student's t-test, 
and differences between the groups using the unpaired Student's t-test.
The needle track could be seen  as an axial area of low flow, (mean side to side 
difference 35ml/1 OOg/min: p=ns), in contrast to control rats where the needle track was 
difficult to visualise (Fig 4.4). Around this was an area of flow higher than that in the 
surrounding frontal cortex (mean difference 170ml/1 OOg/min; p=0.035), and higher 
than the homotopic cortical area (mean difference 110.4ml/1 OOg/min; p=0.049). This 
area extended over an area of cortex 3-5mm in diameter, and extended into the cingulate 
cortex bilaterally in animals 8,9 and 10. (Fig 4.5). In animal 10 the septal nucleus 
showed high flow bilaterally (287 (left) and 216 (right) ml/1 OOg/min) (Fig 4.6). The 
frontal cortex surrounding the focus tended to have low flow (Fig 4.4) although the 
difference was relatively small over the group (mean difference 17.2ml/1 OOg/min; 
p=ns). More posteriorly, however, in the parietal, auditory and visual cortical areas 
hypoperfusion was more obvious (m ean d ifferences 136ml/1 OOg/min; p=0.027, 
181.4ml/1 OOg/min; p=0.002, 89.6ml/100g/nim ; p=0.046, respectively) (Figs 4.7 
and 4.8).
In subcortical structures, the tha lam us ipsilateral to the focus w as 
h y p erperfu sed , principally in the  do rso m ed ia l nu c leu s  (m ean  d ifference 
287ml/100g/min, p=0.001), but also in the ventral nucleus (m ean difference 
142ml/1 OOg/min, p=0.003)(Fig 4.7). There was slight relative hyperperfusion of the 
contralateral medial thalamus in animals 6,7 and 8, although the difference between 
seizure and control groups was not significant. In animals 7-10 there was visually 
apparent hyperperfusion of the substantia nigra pars reticularis, with a mean asymmetry 
for the group of 78ml/1 OOg/min (p=0.007) (Fig 4.8). Although the differences were not 
easy to see on visual inspection of the films, increases in flow ipsilateral to the focus were 
also seen in the medial and lateral habenula (mean differences 56 and 52ml/1 OOg/min, 
p=0.008 and 0.049, respectively). Significant left-right differences in seizure animals 
are shown in Fig 4.9.
Percentage side-side differences - control vs seizure animals
S ide-side differences were ex p re ssed  a s  p e rce n tag es  ((focus side - 
contralateral)/contralateral x 100), to eliminate inter-animal variability in general 
levels of blood flow, and are shown in Fig 4.10.
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a. Cortical a reas
Significant differences between seizure and control groups were seen  in the focus 
penum bra (increase on focus side of 56.7% in seizure rats vs decrease  of 3.3% in 
controls, p=0.028), the adjacent septal nucleus (increase of 19.5%in seizure animals vs 
decrease of 3.8% in controls, p=0.020) Significant decreases on the focus side were seen 
in the aditory (decrease of 56.8% in seizure animals vs decrease of 28.9% in controls, 
p=0.040) and visual (decrease of 39.7% in seizure animals vs decrease  of 6.9% in 
controls, p=0.001) cortices.
b. Subcortical areas
Significant increases on the focus side in seizure animals were seen  in the 
dorsomedial thalamic nucleus (increase of 161.3% in seizure animals vs increase of 
7.8% in controls, p=0.004), the ventral thalamic nucleus (increase of 72.0% in seizure 
animals vs increase of 2.9% in controls, p=0.002), the lateral habenular nucleus 
(increase of 21.8% in seizure animals vs increase of 2.3% in controls, p=0.042), the 
medial habenular nucleus (increase of 20.8% in seizure animals vs decrease of 1.7% in 
controls, p=0.002), and the substantia nigra pars reticulata (increase in 63.2% in 
seizure animals vs decrease of 0.5% in controls, p=0.004).
Assuming that, for any structure, the difference in asymmetry between control and 
seizure groups indicates the degree of perfusion changes occurring in association with the 
seizure, then the above figures show that the magnitude of such changes (whether positive 
or negative) was greater in in some areas distant from the focus than in the area of the 
focus itself.
Correlation of 14C IAP and " mTc HMPAO uptake.
The main aim of this experiment was to test the correlation between blood flow and 
HMPAO uptake at very high flows. Overall, the flows seen included 4 areas over 600 
ml/1 OOg/min, 13 areas between 400 and 600 ml/1 OOg/min, and 30 areas between 300 
and 400 ml/1 OOg/min.
The HMPAO films showed a pattern of uptake identical in detail to that on the IAP
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films, with 3 exceptions. Firstly, uptake in the choroid plexus was much higher in the 
HMPAO films in all 10 animals (Figs 4.3 and 4.7). Secondly, in the rhinal fissure uptake 
of IAP was higher than in the surrounding cortex, while on the HMPAO films it was lower. 
There were also some (but not all) areas where sections had been inadvertently folded 
during preparation where HMPAO uptake was relatively high (Fig 4.5). Thirdly, in 
animal 8 uptake of HMPAO was relatively high in the supramamillary nucleus (Fig 4.8).
In general there was very little difference in resolution between IAP and HMPAO 
films, although some showed superior resolution with IAP (Figs 4.3, 4.4, 4.7 and 4.8), 
and some with HMPAO (Figs 4.5 and 4.6). This relative lack of spatial resolution on some 
of the HMPAO films included bubble artefacts, which appeared blurred. Bubble artefacts 
are produced during preparation of sections, and therefore appear at the sam e location on 
both types of film (see Figure 4.8 for comparison). In contrast, the spatial resolution of 
scratches, which are produced after the sections are exposed and developed, but before 
they are photographed, was the sam e on both types of film, whether the resolution for 
anatomic detail was poorer on the HMPAO film (e.g. Figure 4.7) or whether there was no 
obvious difference between the two (e.g. Figure 4.5).
" mTc activity for control animals is shown in Tables 4.6 (uncorrected) and 4.7 
(corrected), and for seizure animals in Tables 4.8 (uncorrected) and 4.9 (corrected). 
Figs 4.11-4.20 show the within-animal correlation between rCBF a s  determined by the 
IAP method, and " mTc activity before (above) and after (below) the Lassen correction is 
applied. The curves fitted to the data are based on the second order binomial relationships 
shown on the graphs.
R2 for these curves are shown on the graphs, and ranged from 0.542-0.847. The 
uncorrected curves show a tendency for the rise in HMPAO uptake as represented by 
Tc99m activity to become less at high flows. In Rats 1,6 and 7 the curves fitted to the data 
acually fall off within the range of flows shown (minimally in the case  of Rat 1), although 
the shape of the data itself suggested a plateau effect, not predictable by a second order 
binomial fit. Even uncorrected, the relationship between blood flow and " mTc activity 
remained almost linear in most of the animals up to 200ml/1 OOg/min, and in some up to 
300m l/1  OOg/min.
The linearity of the relationship was improved by the application of the Lassen 
correction in all the rats. In Rat 4 the corrected curve was similar to the uncorrected 
curve, but in the opposite direction. In all the rats, however, a straight line fit gave 
higher R2 values than the second order polynomial fit illustrated on the graphs (R2 
0.740-0.944, p<0.001 in all rats).
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Figure 4.1
Graph illustrating the shape of the function defined by the Lassen Correction.
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Figure 4.2
Two-channel EEG recording of 3 epochs during right focal motor seizure in animal 6. The 
lower trace is the left channel. The first (upper left) epoch is early in the seizure when 
the right whisker and snout are twitching. The second (upper right) is when seizure 
activity has spread to the forepaw, and the third (lower) when seizure activity involves 
face and both limbs. The spike-wave discharge typical of the penicillin focus can clearly 
be seen, at greater amplitude on the left.
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Figure 4.3
IAP (top) and HMPAO (bottom) images of rCBF (section through the frontal lobe and 
caudate nucleus) in animal 5 showing increased HMPAO uptake in the choroid plexus, and 
reduced IAP and HMPAO uptake in the left frontal cortex.
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Figure 4.4
IAP (top) and HMPAO (bottom) images of rCBF (section through the frontal lobe in animal
6) showing the seizure focus (left side). There is and area of low HMPAO and IAP uptake in 
the area of the needle track, which is surrounded by an area of high uptake which also 
involves the contralateral cingulate cortex. On the IAP film uptake in the rhinal fissure is 
lower than that in the surrounding cortex, whereas on the HMPAO film it is higher.
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Figure 4.5
IAP (top) and HMPAO (bottom) images of rCBF (section more posteriorly situated in the 
frontal lobe in animal 6). There is increased uptake of IAP and HMPAO in the area 
posterior to the focus (left side) and in the cingulate cortex bilaterally. The frontal cortex 
inferior to the focus shows reduced uptake.
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Figure 4.6
IAP (top) and HMPAO (bottom) images of rCBF (section through the frontal lobe in animal 
10). There is increased uptake of IAP and HMPAO to a slight degree in the cingulate cortex 
and more markedly in the septal nucleus bilaterally.
|BPP|
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Figure 4.7
IAP (top) and HMPAO (bottom) images of rCBF (section through the thalamus in animal
7) showing increased uptake of IAP and HMPAO in the thalamus ipsilateral to the focus 
(left) principally affecting the dorsolateral nucleus. There is slightly increased uptake in 
the contralateral mesial thalamus. There is decreased uptake in the parietal cortex 
ipsilateral to the focus (left). The HMPAO film shows relatively high uptake in the choroid 
plexus.
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Figure 4.8
IAP (top) and HMPAO (bottom) images of rCBF (section through the hippocampus in 
animal 8) showing increased IAP and HMPAO uptake in the substantia nigra pars 
reticultata ipslateral to the focus (left) and decreased uptake in the ipsilateral auditory 
cortex.
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Figure 4.11a: Animal 1
Uncorrected 99mTc activity vs rCBF
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Figure 4.11b: Animal 1
Corrected 99mTc activity vs rCBF
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Figure 4.12a: Animal 2
Uncorrected 99mTc activity vs rCBF
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Figure 4.12b: Animal 2
Corrected 99mTc activity vs rCBF
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Figure 4.13a: Animal 3
Uncorrected 99mTc activity vs rCBF
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Figure 4.13b: Animal 3
Corrected 99mTc activity vs rCBF
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Figure 4.14a: animal 4
Uncorrected 99mTc activity vs rCBF
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Figure 4.14b: animal 4
Corrected 99mTc activity vs rCBF
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Figure 4.15a: Animal 5
Uncorrected 99mTc activity vs rCBF
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Figure 4.15b: Animal 5
Corrected 99mTc activity vs rCBF
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Figure 4.16a: Animal 6
Uncorrected 99mTc activity vs rCBF
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Figure 4.16b: Animal 6
Corrected 99mTc activity vs rCBF
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Figure 4.17a: Animal 7
Uncorrected 99mTc activity vs rCBF
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Figure 4.17b: Animal 7
Corrected 99mTc activity vs rCBF
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Figure 4.18a: animal 8
Uncorrected 99mTc activity vs rCBF
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Figure 4.18b: Animal 8
Corrected 99mTc activity vs rCBF
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Figure 4.19a: Animal 9
Uncorrected 99mTc activity vs rCBF
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Figure 4.19b: Animal 9
Corrected 99mTc activity vs rCBF
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Figure 4.20a: Animal 10
Uncorrected 99mTc activity vs rCBF
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Figure 4.20b: Animal 10
Corrected 99mTc activity vs rCBF
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Table 4.1
PHYSIOLOGICAL PARAMETERS 
All animals
RAT WEIGHT BLOOD PRESSURE pC02 p02 pH TEMPERATURE
(9) (mmHg) (mmHg) (mmHg) DEGC.
1 400 150 /120 47,6 79,7 7,39 37,3
2 497 165/100 55 88,2 7,34 39
3 515 165 /110 48,6 82,8 7,33 36,4
4 520 135/115 54,6 85,1 7,3 38,1
5 515 125 /85 60,3 98,5 7,4 35,9
6 510 135 /85 60,5 146,4 7,38 37,2
7 423 125 /90 45,7 84,7 7,31 36,4
8 450 195/110 52,5 139,2 7,38 38,2
9 375 195/135 45,9 69,3 7,41 37,7
10 595 200 /110 58,8 108,2 7,37 35,8
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Table 4.2
REGIONAL CEREBRAL BLOOD FLOW (ml/100g/min)
Control animals
RAT 1 RAT 2 RAT 3 RAT 4 RAT 5 MEAN SEM Max Min
LEFT (FOCUS)
FRONTAL CORTEX 191 110 87 244 145 155 28 244 87
QNGULATE CORTEX 154 170 71 157 165 138 18 170 71
SUBCORTICAL WHITE MATTER 53 53 31 52 51 47 4 53 31
CAUDATE NUCLEUS 149 105 106 284 140 157 33 284 105
SEPTAL NUCLEUS 106 108 79 158 114 113 13 158 79
GLOBUS PALUDUS 120 95 126 296 144 156 36 296 95
AMYGALCHD NUCLEUS 97 87 79 201 103 113 22 201 79
LATERAL HABENULA 154 103 162 197 141 151 1 5 197 103
MEDIAL HABENULA 221 114 157 205 135 166 20 221 114
VENT. THALAMIC NUCLEUS 196 125 154 185 147 161 1 3 196 125
DORSOMED. THALAMIC NUCLEUS 250 163 132 236 193 195 22 250 132
LATERAL THALAMIC NUCLEUS 192 133 54 208 155 148 27 208 54
ENTOPEDUNCULAR NUCLEUS 121 72 91 111 61 91 1 1 121 61
HYPOTHALAMUS 173 124 101 112 71 116 17 173 71
PARIETAL CORTEX 196 141 94 158 108 139 18 196 94
AUDITORY CORTEX 198 89 67 173 162 138 25 198 67
HIPPOCAMPUS 147 92 85 210 105 128 23 210 85
SUBSTANTIA NIGRA (PR) 162 115 95 203 65 128 25 203 65
INFERIOR COLUCULUS 429 185 255 325 190 277 46 429 185
PONTINE RETICULAR FORMATION 131 102 86 129 70 104 12 131 70
VISUAL CORTEX 144 97 121 237 120 144 24 237 97
CEREBELLUM 140 105 181 92 130 18 181 92
RIGHT
FRONTAL CORTEX 172 125 106 207 146 153 18 207 106
QNGULATE CORTEX 190 167 99 169 188 134 17 169 99
SUBCORTICAL WHITE MATTER 56 54 36 79 55 56 7 79 36
CAUDATE NUCLEUS 165 105 104 304 150 166 37 304 104
SEPTAL NUCLEUS 105 120 87 161 113 117 1 2 161 87
GLOBUS PALUDUS 163 108 113 191 146 144 16 191 108
AMYGALCHD NUCLEUS 114 102 87 187 108 120 17 187 87
LATERAL HABENULA 171 97 145 193 139 149 16 193 97
MEDIAL HABENULA 234 111 154 198 152 170 21 234 111
VENT. THALAMIC NUCLEUS 201 128 134 174 150 157 13 201 128
DORSOMED. THALAMIC NUCLEUS 171 169 123 277 186 185 25 277 123
LATERAL THALAMIC NUCLEUS 190 137 54 118 166 133 23 190 54
ENTOPEDUNCULAR NUCLEUS 121 75 88 100 66 90 10 121 66
HYPOTHALAMUS 172 113 120 118 77 120 15 172 77
PARIETAL CORTEX 280 141 151 234 189 199 26 280 141
AUDITORY CORTEX 259 89 162 323 193 205 40 323 89
HIPPOCAMPUS 141 113 90 203 129 135 19 203 90
SUBSTANTIA NIGRA (PR) 154 118 82 226 73 131 28 226 73
INFERIOR COLUCULUS 433 183 225 311 249 280 43 433 183
PONTINE RETICULAR FORMATION 130 108 91 127 68 105 12 130 68
VISUAL CORTEX 156 101 139 250 126 154 26 250 101
CEREBELLUM 144 100 181 106 133 17 181 100
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Table 4.3
SIDE-TO-SIDE DIFFERENCES IN REGIONAL CEREBRAL BLOOD FLOW (%) 
Control animals
RAT 1 RAT 2 RAT 3 RAT 4 RAT 5 MEAN SEM MAX MIN
FRONTAL CORTEX 11,0 -12,0 -17,9 17,9 -0,7 -0,3 6,7 17,9 -17,9
QNGULATE CORTEX -18,9 1,8 -28,3 -7,1 -12,2 -13,0 5,1 1,8 -28,3
SUBCORTICAL WHITE MATTER -5,4 -1.9 -13,9 -34,2 -7,3 -12,5 5,8 -1,9 -34,2
CAUDATE NUCLEUS -9,7 0,0 1.9 -6,6 -6,7 -4,2 2,2 1.9 -9,7
SEPTAL NUCLEUS 1.0 -10,0 -9,2 -1.9 0,9 -3,8 2,4 1.0 -10,0
GLOBUS PALUDUS -26,4 -12,0 11.5 55,0 -1,4 5,3 13,9 55,0 -26,4
AMYGALOID NUCLEUS -14,9 -14,7 -9,2 7,5 -4,6 -7,2 4,1 7.5 -14,9
LATERAL HABENULA -9,9 6,2 11.7 2,1 1.4 2,3 3,6 11,7 -9.9
MEDIAL HABENULA -5,6 2,7 1,9 3,5 -11,2 -1.7 2,9 3,5 -11,2
VENT. THALAMIC NUCLEUS -2,5 -2,3 14,9 6,3 -2,0 2,9 3,4 14,9 -2,5
DORSOMED. THALAMIC NUCLEL 46,2 -3,6 7,3 -14,8 3,8 7,8 10,3 46,2 -14,8
LATERAL THALAMIC NUCLEUS 1.1 -2,9 0,0 76,3 -6,6 13,6 15,7 76,3 -6,6
ENTOPEDUNCULAR NUCLEUS 0,0 -4,0 3,4 11,0 -7,6 0,6 3,2 11,0 -7,6
HYPOTHALAMUS 0,6 9.7 -15,8 -5,1 -7,8 -3.7 4,3 9,7 -15,8
PARIETAL CORTEX -30,0 0,0 -37,7 -32,5 -42,9 -28,6 7,5 0,0 -42,9
AUDITORY CORTEX -23,6 0,0 -58,6 -46,4 -16,1 -28,9 10,5 0,0 -58,6
HIPPOCAMPUS 4,3 -18,6 -5,6 3,4 -18,6 -7,0 5,0 4,3 -18,6
SUBSTANTIA NIGRA (PR) 5,2 -2,5 15,9 -10,2 -11,0 -0,5 5.0 15,9 -11,0
INFERIOR COLUCULUS -0,9 1.1 13,3 4,5 -23,7 -1,1 6,1 13,3 -23,7
PONTINE RETICULAR FORMATIC 0,8 -5,6 -5,5 1,6 2,9 -1.2 1,8 2,9 -5,6
VISUAL CORTEX -7,7 -4,0 -12,9 -5,2 -4,8 -6,9 1,6 -4,0 -12,9
CEREBELLUM -2,8 5,0 0,0 -13,2 2,2 1,0 5,0 -13,2
1 8 1
Table 4.4
REGIONAL CEREBRAL BLOOD FLOW (ml/100g/min)
Seizure animals
RAT 6 RAT 7 RAT 8 RAT 9RAT 1C MEAN SSVI Max Min
LEFT (FOCUS)
CENTRAL FOCUS 173 206 126 268 109 176 29 268 109
PENUMBRA 321 451 346 252 151 304 50 451 151
FRONTAL CORTEX 156 158 129 143 91 135 12 158 91
QNGULATE CORTEX 114 370 416 279 185 273 56 416 114
SUBCORTICAL WHITE MATTER 52 87 80 72 69 72 6 87 52
CAUDATE NUCLEUS 491 380 300 170 82 285 73 491 82
SEPTAL NUCLEUS 130 137 119 220 287 179 32 287 119
GLOBUS PALUDUS 317 248 305 156 104 226 42 317 104
AMYGALOID NUCLEUS 97 93 124 107 80 100 7 124 80
LATERAL HABENULA 156 204 371 268 325 265 39 371 156
MEDIAL HABENULA 199 281 661 287 270 340 82 661 199
VENT. THALAMIC NUCLEUS 370 717 265 354 193 380 90 717 193
DORSOMED. THALAMIC NUCLEUS 501 606 608 385 390 498 49 608 385
LATERAL THALAMIC NUCLEUS 148 480 311 193 145 255 64 480 145
ENTOPEDUNCULAR NUCLEUS 62 165 85 66 66 89 19 165 62
HYPOTHALAMUS 102 142 101 104 237 137 26 237 101
PARIETAL CORTEX 93 118 166 69 105 110 16 166 69
AUDITORY CORTEX 108 128 155 139 129 132 8 155 108
HIPPOCAMPUS 130 172 291 241 121 191 33 291 121
SUBSTANTIA NIGRA (PR) 265 282 254 169 138 222 29 282 138
INFERIOR COLUCULUS 441 345 480 327 173 353 53 480 173
PONTINE RETICULAR FORMATION 138 140 143 112 220 151 18 220 112
VISUAL CORTEX 138 111 141 102 78 114 12 141 78
CEREBELLUM 145 170 114 143 13 170 114
RIGHT
CENTRAL FOCUS 116 175 284 338 144 211 43 338 116
PENUMBRA 171 207 247 192 142 192 18 247 142
FRONTAL CORTEX 159 160 166 174 110 154 11 174 110
QNGULATE CORTEX 159 407 506 197 162 286 72 506 159
SUBCORTICAL WHITE MATTER 63 74 65 57 72 66 3 74 57
CAUDATE NUCLEUS 397 266 265 150 93 234 53 397 93
SEPTAL NUCLEUS 119 111 125 161 216 146 19 216 111
GLOBUS PALUDUS 216 181 222 179 80 176 25 222 80
AMYGALOID NUCLEUS 109 101 131 127 75 109 10 131 75
LATERAL HABENULA 157 180 280 218 231 213 21 280 157
MEDIAL HABENULA 177 237 577 212 219 284 74 577 177
VENT. THALAMIC NUCLEUS 169 542 173 200 108 238 77 542 108
DORSOMED. THALAMIC NUCLEUS 181 363 216 190 103 211 43 363 103
LATERAL THALAMIC NUCLEUS 166 208 220 173 92 172 22 220 92
ENTOPEDUNCULAR NUCLEUS 50 134 90 57 41 74 17 134 41
HYPOTHALAMUS 101 117 104 105 201 126 19 201 101
PARIETAL CORTEX 237 200 405 269 120 246 47 405 120
AUDITORY CORTEX 331 316 373 327 219 313 25 373 219
HIPPOCAMPUS 133 174 271 228 124 186 28 271 124
SUBSTANTIA NIGRA (PR) 130 226 191 89 84 144 28 226 84
INFERIOR COLUCULUS 451 325 505 328 186 359 56 505 186
PONTINE RETICULAR FORMATION 125 147 144 105 168 138 11 168 105
VISUAL CORTEX 181 194 349 187 107 204 40 349 107
CEREBELLUM 136 197 123 152 18 197 123
1 8 2
Table 4.5
SIDE-TO-SIDE DIFFERENCES IN REGIONAL CEREBRAL BLOOD FLOW (%) 
Seizure animals
RAT 6 RAT 7 RAT 8 RAT 9 RAT 10 MEAN SEM MAX MIN
CENTRAL FOCUS 49,1 17,7 -55,6 -20,7 -24,3 -6,8 18,2 49,1 -55,6
PENUMBRA 87,7 117,9 40,1 31,3 6,3 56,7 20,2 117,9 6,3
FRONTAL CORTEX *1.9 -1.3 -22,3 -17,8 -17,3 -12,1 4,4 -1.3 -22,3
QNGULATE CORTEX -28,3 -9,1 -17,8 41,6 14,2 0,1 12,5 41,6 -28,3
SUBCORTICAL WHITE MATTER -17,5 17,6 23,1 26,3 -4,2 9.1 8,5 26,3 -17,5
CAUDATE NUCLEUS 23,7 42,9 13,2 13,3 -11,8 16,2 8,9 42,9 -11,8
SEPTAL NUCLEUS 9.2 23,4 -4,8 36,6 32,9 19,5 7,7 36,6 -4,8
GLOBUS PALUDUS 46,8 37,0 37,4 -12,8 30,0 27,7 10,5 46,8 -12,8
AMYGALOID NUCLEUS -11,0 -7,9 -5,3 -15,7 6,7 -6,7 3.8 6,7 -15,7
LATERAL HABENULA -0,6 13,3 32,5 22,9 40,7 21,8 7,2 40,7 -0,6
MEDIAL HABENULA 12,4 18,6 14,6 35,4 23,3 20,8 4,1 35,4 12,4
VENT. THALAMIC NUCLEUS 118,9 32,3 53,2 77,0 78,7 72,0 14,5 118,9 32,3
DORSOMED. THALAMIC NUCLEUS 176,8 66,9 181,5 102,6 278,6 161,3 36,6 278,6 66,9
LATERAL THALAMIC NUCLEUS -10,8 130,8 41,4 11.6 57,6 46,1 24,2 130,8 -10,8
ENTOPEDUNCULAR NUCLEUS 24,0 23,1 -5,6 15,8 61,0 23,7 10,7 61,0 -5,6
HYPOTHALAMUS 1.0 21,4 -2,9 -1.0 17,9 7,3 5,1 21,4 -2,9
PARIETAL CORTEX -60,8 -41,0 -59,0 -74,3 -12,5 -49,5 10,7 -12,5 -74,3
AUDITORY CORTEX -67,4 -59,5 -58,4 -57,5 -41,1 -56,8 4.3 -41,1 -67,4
HIPPOCAMPUS -2,3 -1.1 7,4 5,7 -2,4 1.5 2,1 7,4 -2,4
SUBSTANTIA NIGRA (PR) 103,8 24,8 33,0 89,9 64,3 63,2 15,4 103,8 24,8
INFERIOR COLUCULUS *2,2 6,2 -5,0 -0,3 -7,0 -1.7 2,3 6,2 -7,0
PONTINE RETICULAR FORMATION 10,4 -4,8 -0,7 6,7 31,0 8,5 6,2 31,0 -4,8
VISUAL CORTEX -23,8 -42,8 -59,6 -45,5 -27,1 -39,7 6,5 -23,8 -59,6
CEREBELLUM 6,6 -13,7 -7,3 -2,8 -1,25 6,6 -7,3
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Table 4.6
UNCORRECTED Tc99m ACTIVITY (uCi/g)
Control animals
LEFT RAT 1 RAT 2 RAT 3 RAT 4 RAT 5 MEAN SBM Max Min
FRONTAL CORTEX 7,97 7,84 5,73 11,40 6,85 8,23 0,95 11,40 5,73
QNGULATE CORTEX 6,63 9,39 2,71 9,71 5,71 7,11 1,29 9,71 2,71
SUBCORTICAL WHITE MATTER 2,79 3,64 6,35 4,05 2,11 4,21 0,72 6,35 2,11
CAUDATE NUCLEUS 7,64 6,81 5,83 14,50 5,30 8,69 1,67 14,50 5,30
SEPTAL NUCLEUS 5,76 7,07 6,38 8,52 4,65 6,93 0,65 8,52 4,65
GLOBUS PALUDUS 7,93 5,96 5,27 15,93 6,17 8,77 1,97 15,93 5,27
AMYGALOID NUCLEUS 3,6 5,72 8,17 12,20 4,28 7,42 1,56 12,20 3,60
LATERAL HABENULA 9,19 7,74 7,64 12,06 6,10 9,16 1,01 12,06 6,10
MEDIAL HABENULA 7,48 7,94 6,25 12,63 6,53 8,57 1,16 12,63 6,25
VENT. THALAMIC NUCLEUS 7,38 7,29 7,24 13,27 5,89 8,79 1,29 13,27 5,89
DORSOMED. THALAMIC NUCLEUS 8,56 11,37 4,27 13,77 6,49 9,49 1,69 13,77 4.27
LATERAL THALAMIC NUCLEUS 7,18 7,48 6,28 11,65 6,07 8,15 1,01 11,65 6,07
ENTOPEDUNCULAR NUCLEUS 3,51 5,11 6,55 7,91 3,21 5,77 0,89 7,91 3,21
HYPOTHALAMUS 6,24 8,23 5,89 12,63 4,51 8,25 1.41 12,63 4,51
PARIETAL CORTEX 8,2 8,92 6,78 12,63 6,95 9,13 1,06 12,63 6,78
AUDITORY CORTEX 7,51 6,81 7,21 14,10 7,58 8,91 1,37 14,10 6,81
HIPPOCAMPUS 8,36 6,49 6,51 16,38 6,00 9,44 1,95 16,38 6,00
SUBSTANTIA NIGRA (PR) 6,05 7,45 9,58 13,52 4,48 9,15 1.57 13,52 4,48
INFERIOR COLUCULUS 11.4 7,82 5,21 16,42 8,63 10,20 1,90 16,42 5,21
PONTINE RETICULAR FORMATION 6,21 7,81 6,25 9,57 4,34 7,46 0,88 9,57 4,34
VISUAL CORTEX 8,13 7,71 6,48 13,16 4,95 8,87 1,38 13,16 4,95
CEREBELLUM 6,53 6,21 13,16 5,96 8,63 1,55 13,16 5,96
RIGHT
FRONTAL CORTEX 6,99 8,56 6,98 12,98 5,05 8,88 1,34 12,98 5,05
QNGULATE CORTEX 7,87 9,66 6,51 11,03 6,07 8,77 0,94 11,03 6,07
SUBCORTICAL WHITE MATTER 2,52 3,58 3,12 5,76 2,32 3,74 0,62 5,76 2,32
CAUDATE NUCLEUS 7,8 7,87 6,42 15,08 5,43 9,29 1,70 15,08 5,43
SEPTAL NUCLEUS 5,82 7,19 5,47 9.77 4,71 7,06 0,89 9,77 4,71
GLOBUS PALUDUS 5,4 7,07 6,42 11,37 6,17 7,57 1,06 11,37 5,40
AMYGALOID NUCLEUS 3,76 6,40 5,63 11,92 4,38 6,93 1,45 11,92 3,76
LATERAL HABENULA 9,15 7,42 8,94 11,20 5,09 9,18 1,02 11,20 5,09
MEDIAL HABENULA 7,84 7,77 8,04 12,63 5,16 9,07 1,21 12,63 5,16
VENT. THALAMIC NUCLEUS 7,21 6,65 7,11 12,73 5,78 8,43 1,23 12,73 5,78
DORSOMED. THALAMIC NUCLEUS 8,89 12,10 7,31 14,97 6,28 10,82 1,60 14,97 6,28
LATERAL THALAMIC NUCLEUS 7,67 7,77 4,14 12,56 6,46 8,04 1,38 12,56 4,14
ENTOPEDUNCULAR NUCLEUS 3,51 5,69 6,22 7,82 3,11 5,81 0,88 7,82 3,11
HYPOTHALAMUS 6,34 8,30 6,48 13,09 4,41 8,55 1,48 13,09 4,41
PARIETAL CORTEX 8,69 9,80 7.74 14,39 6,67 10,16 1.34 14,39 6,67
AUDITORY CORTEX 9,29 7,07 8,77 18,24 7,77 10,84 2,04 18,24 7,07
HIPPOCAMPUS 7,9 6,46 7,27 16,23 6,31 9,47 1,87 16,23 6,31
SUBSTANTIA NIGRA (PR) 6,24 7,32 6,75 12,24 4,44 8,14 1,30 12,24 4,44
INFERIOR COLUCULUS 11,7 7,17 9,95 17,90 7,77 11,67 1,93 17,90 7,17
PONTINE RETICULAR FORMATION 5,72 7,08 5,63 10,18 4,58 7,15 0,97 10,18 4,58
VISUAL CORTEX 6,82 7,44 7,51 13,70 5,47 8,87 1.43 13,70 5,47
CEREBELLUM 7,05 6,35 12,17 5,57 8,52 1,33 12,17 5,57
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Table 4.7
CORRECTED Tc99m ACTIVITY (uCi/g)
Control animals
RAT 1 RAT 2 RAT 3 RAT 4 RAT 5 MEAN S B A Max Min
LEFT
FRONTAL CORTEX 9,95 8,34 5,90 12,76 8,42 9,24 1,13 12,8 5,9
QNGULATE CORTEX 7,22 11,33 5,41 9,87 6,15 8,46 1.13 11.3 5,41
SUBCORTICAL WHITE MATTER 2,23 2,94 2,10 3,15 1,64 2,41 0,28 3,15 1,64
CAUDATE NUCLEUS 9,21 6,72 6,28 19,88 5,46 9,51 2,67 19,9 5,46
SEPTAL NUCLEUS 5,78 7,10 5,54 8,14 4,49 6,21 0,64 8,14 4,49
GLOBUS PALUDUS 9,87 5,55 6,33 24,42 6,99 10,6 3,52 24,4 5,55
AMYGALOID NUCLEUS 3,04 5,24 4,82 14,34 3,99 6,29 2,05 14,3 3,04
LATERAL HABENULA 13,2 8,17 9,38 14,06 6,86 10,3 1.41 14,1 6,86
MEDIAL HABENULA 8,86 8,51 8,37 15,24 7,71 9,74 1,39 15,2 7,71
VENT. THALAMIC NUCLEUS 8,65 7,44 6,13 16,70 6,46 9,08 1,96 16,7 6,13
DORSOMED. THALAMIC NUCLEUS 11,4 46,53 7,68 17,94 7,63 12,2 2,16 17,9 7,63
LATERAL THALAMIC NUCLEUS 8,25 7,75 3,64 13,23 6,79 7,93 1,55 13,2 3,64
ENTOPEDUNCULAR NUCLEUS 2,94 4,50 6,18 7,33 2,72 4,73 0,9 7,33 2,72
HYPOTHALAMUS 6,55 9,02 6,57 16,29 4,30 8,55 2,08 16,3 4,3
PARIETAL CORTEX 10,5 10,35 5,63 15,24 9,23 10,2 1,54 15,2 5,63
AUDITORY CORTEX 8,92 6,72 6,93 18,79 10,13 10,3 2,22 18,8 6,72
HIPPOCAMPUS 10,9 6,27 7,62 26,06 6,66 11.5 3,73 26,1 6,27
SUBSTANTIA NIGRA (PR) 6,24 7,70 6,52 17,31 4,26 8,41 2,29 17,3 4,26
INFERIOR COLUCULUS 22,5 8,23 12,55 26,20 13,56 16,6 3,34 26,2 8,23
PONTINE RETICULAR FORMATION 6.5 8,11 4,73 9,66 4,08 6,62 1,04 9,66 4,08
VISUAL CORTEX 10,3 7,97 6,13 16,45 4,93 10,2 2,04 16,5 4,93
CEREBELLUM 7,05 6,47 16,45 6,59 9,99 2,18 16,5 6,47
RIGHT
FRONTAL CORTEX 7,87 9,63 7,24 16,04 5,08 9,17 1,86 16 5,08
CINGULATE CORTEX 9,72 11,93 6,52 12,07 6,79 9,41 1,2 12,1 6,52
SUBCORTICAL WHITE MATTER 1,97 2,88 2,48 4,83 1,83 2,8 0,54 4,83 1,83
CAUDATE NUCLEUS 9,57 8,39 6,37 21,61 5,68 10,3 2,91 21,6 5,68
SEPTAL NUCLEUS 5,88 7,29 5,06 9,97 4,58 6,56 0,97 9,97 4,58
GLOBUS PALUDUS 5,27 7,10 6,37 12,70 6,99 7,69 1.3 12,7 5,27
AMYGALOID NUCLEUS 3,21 6,14 5,28 13,77 4,12 6,5 1,88 13,8 3,21
LATERAL HABENULA 13,1 7,65 11,01 12,38 5,13 9,86 1,51 13,1 5,13
MEDIAL HABENULA 9,64 8,23 9,12 15,24 5,24 9,49 1,63 15,2 5,24
VENT. THALAMIC NUCLEUS 8,32 6,49 7,46 15,48 6,28 8,81 1.71 15,5 6,28
DORSOMED. THALAMIC NUCLEUS 12,3 19,05 7,79 21,28 7,20 13,5 2,87 21,3 7.2
LATERAL THALAMIC NUCLEUS 9,28 8,23 3,50 15,09 7,56 8,73 1,87 15,1 3,5
ENTOPEDUNCULAR NUCLEUS 2,94 5,20 6,09 7,21 2,62 4,81 0,89 7,21 2,62
HYPOTHALAMUS 6,71 9,14 6,47 16,28 4,17 8,55 2,09 16,3 4,17
PARIETAL CORTEX 11,8 12,24 8,55 19,58 8,02 12 2,07 19,6 8,02
AUDITORY CORTEX 13,6 7,10 10,63 34,44 10,75 15,3 4,89 34,4 7,1
HIPPOCAMPUS 9,79 6,22 7,73 25,50 7,27 11,3 3,6 25,5 6,22
SUBSTANTIA NIGRA (PR) 6,55 7,49 6,87 14,42 4,21 7,91 1,72 14,4 4,21
INFERIOR COLUCULUS 24,4 7,31 13,55 32,65 10,75 17,7 4,7 32,7 7,31
PONTINE RETICULAR FORMATION 5,74 7,13 5,28 10,61 4,39 6,63 1,09 10,6 4,39
VISUAL CORTEX 7,57 7,75 8,14 17,76 5,74 9,39 2,13 17,8 5,74
CEREBELLUM 8 6,28 14,27 5,91 8,61 1,73 14,3 5,91
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Table 4.8
UNCORRECTED Tc99m ACTIVITY (uCi/g)
Seizure animals
LEFT (FOCUS) RAT 6 RAT 7 RAT 8 RAT 9 RAT 1C MEAN SB/1 Max Min
CENTRALFOCUS 3,95 11,32 4,06 7,78 3,42 6,11 1,52 11,32 3,42
PENUMBRA 7,01 15,70 11,63 8,23 5,76 9,67 1,80 15,70 5,76
FRONTAL CORTEX 4,42 9,87 7,20 6,44 3,80 6,35 1,08 9,87 3,80
CINGULATE CORTEX 3,75 14,49 11,51 9,29 6,65 9,14 1,86 14,49 3,75
SUBCORTICAL WHITE MATTER 1.76 5,94 4,09 2,82 2,29 3,38 0,75 5,94 1.76
CAUDATE NUCLEUS 8,73 15,48 10,81 6,81 3,25 9,02 2,04 15,48 3,25
SEPTAL NUCLEUS 4,70 9,40 7,57 8,48 6,10 7,25 0,84 9,40 4,70
GLOBUS PALUDUS 8,02 14,79 10,89 6,23 4,47 8,88 1,82 14,79 4,47
AMYGALOID NUCLEUS 4,56 6,08 6,64 4,14 2,97 4,88 0,66 6,64 2,97
LATERAL HABENULA 4,36 10,83 15,03 8,45 8,55 9,44 1.74 15,03 4,36
MEDIAL HABENULA 7,62 16,26 17,24 9,33 8,85 11,86 2,02 17,24 7,62
VENT. THALAMIC NUCLEUS 11,21 15,39 13,95 8,61 4,88 10,81 1,88 15,39 4,88
DORSOMED. THALAMIC NUCLEUS 8,10 17,94 14,81 8,84 8,07 11,55 2,03 17,94 8,07
LATERAL THALAMIC NUCLEUS 8,09 13,89 9,60 5,78 4,14 8,30 1,68 13,89 4,14
ENTOPEDUNCULAR NUCLEUS 2,91 9,08 5,94 3,66 2,69 4,86 1,20 9,08 2,69
HYPOTHALAMUS 4,88 9,01 6,86 4,97 7,44 6,63 0,78 9,01 4,88
PARIETAL CORTEX 3,75 8,66 8,54 4,57 4,12 5,93 1.10 8,66 3,75
AUDITORY CORTEX 4,67 9,59 9,60 6,47 5,15 7,10 1,06 9,60 4,67
HIPPOCAMPUS 5,05 12,55 10,56 8,48 4,53 8,23 1,55 12,55 4,53
SUBSTANTIA NIGRA (PR) 8,21 13,51 11,22 6,41 4,79 8,83 1,58 13,51 4,79
INFERIOR COLUCULUS 10,75 13,89 14,99 10,18 6,56 11,27 1,49 14,99 6,56
PONTINE RETICULAR FORMATION 4,60 7.74 8,77 4,83 5,82 6,35 0,82 8,77 4,60
VISUAL CORTEX 5,63 7,52 8,69 5,48 4,75 6,41 0,73 8,69 4,75
CEREBELLUM 9,08 10,04 5,45 8,19 1,08 10,04 5,45
RIGHT
CENTRAL FOCUS 5,63 10,67 11,22 9,49 4,88 8,38 1.31 11,22 4,88
PENUMBRA 5,74 12,05 9,64 7,88 4,44 7,95 1,36 12,05 4,44
FRONTAL CORTEX 5,27 10,07 8,03 7,88 3,85 7,02 1,10 10,07 3,85
CINGULATE CORTEX 4,56 14,96 13,22 8,48 6,65 9,57 1,96 14,96 4,56
SUBCORTICAL WHITE MATTER 2,51 5,87 3,72 2,35 2,31 3,35 0,68 5,87 2,31
CAUDATE NUCLEUS 8,33 12,76 9,24 6,23 4,06 8,12 1,46 12,76 4,06
SEPTAL NUCLEUS 4,60 8,77 7,42 6,35 6,87 6,80 0,68 8,77 4,60
GLOBUS PALUDUS 7,58 12,47 10,28 6,97 3,57 8,17 1.51 12,47 3,57
AMYGALOID NUCLEUS 4,02 7,07 8,23 5,42 3,08 5,56 0,95 8,23 3,08
LATERALHABENULA 4,02 12,80 13,22 9,00 8,46 9,50 1.67 13,22 4,02
MEDIAL HABENULA 7,08 13,68 14,81 7,00 8,27 10,17 1,69 14,81 7,00
VENT. THALAMIC NUCLEUS 8,37 15,87 9,84 6,14 4,00 8,84 2,02 15,87 4,00
DORSOMED. THALAMIC NUCLEUS 6,36 14,79 10,28 6,02 3,65 8,22 1,96 14,79 3,65
LATERAL THALAMIC NUCLEUS 5,05 11,19 10,77 5,60 4,00 7,32 1.52 11,19 4,00
ENTOPEDUNCULAR NUCLEUS 2,79 8,47 6,20 3,74 2,15 4,67 1.17 8,47 2,15
HYPOTHALAMUS 4,91 7,89 7,27 4,86 6,07 6,20 0,61 7,89 4,86
PARIETAL CORTEX 6,29 12,26 15,16 9,07 4,65 9,49 1,92 15,16 4,65
AUDITORY CORTEX 7,43 15,01 16,17 10,51 6,65 11,15 1,93 16,17 6,65
HIPPOCAMPUS 5,30 11,44 10,69 7,56 4,62 7,92 1,38 11,44 4,62
SUBSTANTIA NIGRA (PR) 5,27 12,51 9,72 4.71 2,94 7,03 1.77 12,51 2,94
INFERIOR COLUCULUS 10,71 13,39 15,69 10,28 7,19 11,45 1,45 15,69 7,19
PONTINE RETICULAR FORMATION 4,32 8,24 8,42 5,06 5,39 6,29 0,85 8,42 4,32
VISUAL CORTEX 6,36 11,68 13,31 8,01 5,12 8,90 1,56 13,31 5.12
CEREBELLUM 10,31 10,12 4,89 8,44 1,38 10,31 4,89
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Table 4.9
CORRECTED Tc99m ACTIVITY (uCi/g)
Seizure animals
LEFT (FOCUS) RAT 6 RAT 7 RAT 8 RAT 9 RAT 10 MEAN SEM Max Min
CENTRALFOCUS 3,84 t6 ,3 6 3,34 10,78 3,19 8,42 2,85 16,36 3,19
PENUMBRA 10,52 41,45 17,08 12,15 7,38 19,52 6,78 41,45 7,38
FRONTAL CORTEX 4,55 12,42 7,25 7,53 3,70 7,73 1,60 12,42 3,70
QNGULATE CORTEX 3,56 31,17 16,68 16,29 9,96 18,53 4,01 31,17 9,96
SUBCORTICAL WHITE MATTER 1,36 5,52 3,37 2,31 1,88 3,27 0,73 5,52 1,88
CAUDATE NUCLEUS 18,96 39,27 14,63 8,32 2,98 16,30 7,17 39,27 2,98
SEPTAL NUCLEUS 5,00 11,34 7,84 13,02 8,26 10,12 1.11 13,02 7,84
GLOBUS PALUDUS 14,69 33,35 14,86 7,10 4,74 15,01 5,80 33,35 4,74
AMYGALOID NUCLEUS 4.77 5,71 6,43 3,81 2,63 4,65 0,78 6,43 2,63
LATERAL HABENULA 4,44 14,91 34,04 12,91 19,86 20,43 4,26 34,04 12,91
MEDIAL HABENULA 12,87 48,09 60,28 16,44 22,43 36,81 9,31 60,28 16,44
VENT. THALAMIC NUCLEUS 67,99 38,45 26,95 13,49 5,49 21,10 6,52 38,45 5,49
DORSOMED. THALAMIC NUCLEUS 4,49 82,22 32,43 14,35 16,45 36,36 14,14 82,22 14,35
LATERAL THALAMIC NUCLEUS 15,09 27,38 11,65 6,26 4,22 12,38 4,69 27,38 4,22
ENTOPEDUNCULAR NUCLEUS 2,53 10,67 5,49 3,23 2,32 5,43 1.67 10,67 2,32
HYPOTHALAMUS 5,30 10,51 6,75 4,96 13,04 8,82 1,63 13,04 4,96
PARIETAL CORTEX 3,56 9,82 9,50 4,38 4,18 6,97 1,39 9,82 4,18
AUDITORY CORTEX 4,94 11,78 11,65 7,59 6,02 9,26 1,30 11,78 6,02
HIPPOCAMPUS 5,62 20,80 13,97 13,02 4,85 13,16 2,92 20,80 4,85
SUBSTANTIA NIGRA (PR) 15,72 25,27 15,80 7,47 5,32 13,47 4,06 25,27 5,32
INFERIOR COLUCULUS 48,77 27,38 33,71 21,14 9,65 22,97 4,59 33,71 9,65
PONTINE RETICULAR FORMATION 4,83 8,17 9,94 4,75 7,53 7,60 0,96 9,94 4,75
VISUAL CORTEX 6,78 7,80 9,79 5,75 4,55 6,97 1,03 9,79 4,55
CEREBELLUM 10,67 12,66 5,70 9,68 1,60 12,66 5,70
RIGHT
CENTRAL FOCUS 6,78 14,46 15,80 17,23 5,49 13,25 2,37 17,23 5,49
PENUMBRA 7,02 18,86 11,74 11,06 4,70 11,59 2,59 18,86 4,70
FRONTAL CORTEX 6,03 12,90 8,60 11,06 3,78 9,09 1,77 12,90 3,78
QNGULATE CORTEX 4,77 34,70 23,25 13,02 9,96 20,23 5,01 34,70 9,96
SUBCORTICAL WHITE MATTER 2,09 5,43 3,01 1,85 1.91 3,05 0,75 5,43 1,85
CAUDATE NUCLEUS 16,40 21,68 10,88 7,10 4,09 10,94 3,44 21,68 4,09
SEPTAL NUCLEUS 4,83 10,05 7,60 7,34 10,72 8,93 0,76 10,72 7,34
GLOBUS PALUDUS 12,70 20,46 13,25 8,68 3,38 11,44 3,24 20,46 3,38
AMYGALOID NUCLEUS 3,93 7,10 8,93 5,65 2,77 6,11 1,16 8,93 2,77
LATERAL HABENULA 3,93 21,86 23,25 15,01 19,10 19,81 1,62 23,25 15,01
MEDIAL HABENULA 10,78 26,18 32,43 8,75 17,71 21,27 4,61 32,43 8,75
VENT. THALAMIC NUCLEUS 16,63 43,33 12,19 6,93 4,00 16,61 8,11 43,33 4,00
DORSOMED. THALAMIC NUCLEUS 8,57 33,35 13,25 6,70 3,50 14,20 5,99 33,35 3,50
LATERAL THALAMIC NUCLEUS 5,62 15,98 14,52 5,95 4,00 10,11 2,69 15,98 4,00
ENTOPEDUNCULAR NUCLEUS 2,39 9,45 5,82 3,32 1,75 5,09 1,50 9,45 1.75
HYPOTHALAMUS 5,37 8,43 7,36 4,79 8,18 7,19 0,74 8,43 4,79
PARIETAL CORTEX 8,37 19,64 35,07 15,28 5,05 18,76 5,58 35,07 5,05
AUDITORY CORTEX 12,07 35,05 44,77 23,44 9,96 28,31 6,72 44,77 9,96
HIPPOCAMPUS 6,10 16,75 14,30 10,17 5,00 11,56 2,30 16,75 5,00
SUBSTANTIA NIGRA (PR) 6,03 20,63 11,92 4,58 2,60 9,93 3,66 20,63 2,60
INFERIOR COLUCULUS 47,50 24,62 39,68 21,79 11,94 24,51 5,14 39,68 11,94
PONTINE RETICULAR FORMATION 4,39 9,03 9,28 5,09 6,53 7,48 0,90 9,28 5,09
VISUAL CORTEX 8,57 17,56 23,65 11,44 5,96 14,65 3,42 23,65 5,96
CEREBELLUM 13,50 12,85 4,83 10,39 2,16 13,50 4,83
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Chapter 4
Discussion  
Choice of model of focal epilepsy
The main aim of the present study was to study the correlation between HMPAO and 
IAP uptake at very high blood flows. For this purpose, a model of generalised seizures in 
the rat would have been ideal, for reasons of technical simplicity and the high flows seen 
in such models (Horton et al., 1980). However, the study had the secondary aim to study 
the particular flow changes seen in an animal model of focal epilepsy. The penicillin model 
of focal epilepsy was chosen for its technical simplicity, and the fact that the effects of 
penicillin induced seizures on regional metabolism had been previously studied, allowing 
correlation with blood flow changes. In the event, the model proved easy to use and 
effective in producing high flows. There was no obvious technical reason why one animal 
had less intense seizures and blood flow changes than the others.
The 14C lodoantlpyrlne method
The iodo14C iodoantipyrine method is based on on the equation derived by Kety 
describing the exchange of an inert gas between blood and tissues (Kety, 1951). The use of 
g aseous tracers posed technical problem s, leading to the developm ent of 14C 
iodoantipyrine. This tracer was limited by poor diffusibility, tending to give lower values 
than earlier methods. This problem was overcome with the developm ent of iodo14C 
antipyrine by Sakurada and colleagues (1978), which gave flow values similar to those 
given by freely diffusible gas tracers. This has becom e the accepted  method for 
determining blood flow in discrete structural components of the brain. It has, however, 
been suggested that diffusion limitation may lead to underestimations of very high flows 
(Abdul-Rahman et al., 1979). Horton et al. (1980) m easured rCBF using both the iodo 
14C antipyrine method and m icrospheres during generalised  seizures induced by 
bicuculline. They found values for regional cerebral blood flow which were in general 
higher than those found in the present study (see below) and total cerebral blood flows 
which were comparable with those found using the venous outflow and xenon clearance 
methods (from Meldrum & Nilsson, 1976) in the sam e model. In their hands, the IAP
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methods gave higher values than microspheres, and they concluded that the latter method 
had underestimated flow.
The accuracy of the IAP technique depends on operator skill at certain points. 
Three operators are required; one to regulate the arterial catheter flow rate, collect 
arterial sam ples and call out the drop rate, one to regulate the arterial injection of 
iodoantipyrine and one to operate the guillotine. Coordination between the three must be 
good. Skill is required to make sure that the timing of arterial sam ples as recorded on tape 
during the procedure is transcribed accurately. After decapitation, the brain must be 
dissected out rapidly to prevent diffusion of iodoantipyrine from high to low concentration 
areas (Williams et al, 1991) to prevent loss of definition of boundaries between high and 
low flow areas, underestimation of high flows. This must be done skillfully to avoid 
structural dam age to the brain. The laboratory in which the present study took place has 
extensive experience of the procedure, and several sham experiments were carried out to 
familiarise the operators with it.
Control animals
rCBF
The blood flows seen in the non-seizure animals were within the total ranges seen 
in control animals in previous studies using the sam e methods (McCulloch et al., 1982a,b; 
Mohammed et al., 1985). However, the range was larger than that seen in any single one 
of these studies. This may have been due to the difficulty experienced in controlling 
physiological param eters, in turn due to the constraints of the experimental protocol.
In the experimental animals, seizures began as soon as  the animal began to move on 
recovery from the anaesthetic, i.e. within 2-3 minutes of its withdrawal. The point of 
measurement of cerebral perfusion was fixed at 10 minutes after seizure onset; this was 
the maximum judged acceptable in conscious animals, and the minimum judged sufficient 
to allow development of a steady state between HMPAO and IAP injections, and to allow the 
development of the high flows necessary for adequate comparison of the HMPAO and IAP 
methods. In sham animals, therefore, cerebral perfusion was m easured 10 minutes after 
they began moving on recovery from the anaesthetic. This allowed limited time for post­
anaesthetic stabilisation of physiological param eters (see below). In retrospect, a lower 
dose of penicillin might have given sufficiently intense seizures after a longer time
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period, allowing more time for stabilisation of physiological param eters.
Effect on rCBF of anaesthetic agents
Nitrous oxide slightly increases both blood flow and metabolic rate in rat studies, 
while halothane depresses metabolic rate in a dose dependent way, but increases flow 
(Edvinsson et al., 1993c). C hanges due to halothane are not hom ogeneous, but 
preferentially involve structures such as  the locus ceruleus and substantia nigra. The 
changes seen are symmetrical. Changes induced by variable residual effects of halothane 
could at leasst partially explain the variability seen  in absolute flows. It is, however, 
unlikely that the effect impacted significantly on the main object of the study, that of 
establishing the relationship between HMPAO and IAP uptake at high flows. With respect to 
the localised changes seen  in seizure animals, any localised but symmetric effects of 
halothane would be negated in results expressed as percentage asymmetry.
Effect on rCBF of craniotomy
Some sham animals showed reduction in cerebral perfusion in the neocortex 
ipsilateral to the craniotomy. While this might be due to injection of vehicle into the 
cortex, the sam e phenomenon was seen  to a marked extent in 2 of 4 animals who had 
craniotomy only (Fig). These animals were not included in the control group for the study, 
but did show that craniotomy alone was sufficient to produce neocortical hypoperfusion. In 
these cases, the craniotomy was carried out rapidly, drilling the hole in 2-3 applications 
of the drill. In the 2 animals not showing marked hypoperfusion, the craniotomy was 
carried out very slowly, allowing the bone to cool between short applications of the drill. 
These results were in accord with the previous experience of the laboratory, and the slow 
procedure was therefore adopted for the study. Drill applications were not formally timed, 
so it is possible that even minor variations in the speed  of drilling were responsible for 
some animals showing hypoperfusion and some not.
The craniotomy may also have been responsible for neocortical hypoperfusion seen 
in experimental animals. However, side-to-side differences were greater in experimental 
animals (with no difference in craniotomy technique), suggesting a contributary effect of 
seizures.
190
Effect on rCBF of injection of vehicle
Although the track of the needle could be discerned in non-seizure animals, there 
was little or no effect on perfusion in surrounding tissues, nor was there any discernible 
effect around the point of the needle, where an effect of the injection of vehicle might have 
been seen. There is therefore no evidence that any of the changes seen  in experimental 
animals was due to injection of vehicle.
Experimental animals
Comparison with previous studies
1. Studies using the penicillin model of focal motor epilepsy
Most autoradiographic studies in rat models of focal epilepsy have centred on the 
functional anatomy of the seizure, i.e. showing the extent of metabolic activity around the 
focus, and showing which structures are distantly metabolically activated or depressed 
during the seizure. These studies have m easured the local metabolic rate for glucose, 
rather than regional perfusion. Those which have used the penicillin model of focal 
epilepsy (Collins, 1976; Collins, 1978a; b; Collins et al., 1983) have found generally 
similar patterns of activation to those found in the present study, with increases in 
metabolism around the focus, in the adjacent and contralateral cingulate gyrus, and in the 
thalamus and substantia nigra, with decreases in metabolism in cortical areas ipsilateral 
to the focus. In addition to this, these studies have found increases in metabolism in the 
contralateral homotopic motor cortex, the caudate, putam en, entopeduncular nucleus, 
subthalamic nucleus and cerebellum, not seen as increases in rCBF in this study.
The degree of increase in metabolic rate in these studies was in general greater 
than the equivalent percentage increases in rCBF seen  in the present study. For example, 
Collins et al (1976) found increases (focus side c.f. contralateral homotopic area) of 96% 
in the motor cortex and 70% in the substantia nigra, Collins (1978a) found increases of 
218% in the motor cortex, and Collins (1978b) found increases of 251% in the motor 
cortex, 300% in the substantia nigra and 291% in the thalamus, com pared to control 
animals. These figures compare with side to side differences in rCBF of 56.7% (-3.3% in 
controls) for the focus, up to 161.3% (7.8% in controls) in the thalamus, and 63.2% (- 
0.5% in controls) in the substantia nigra seen in the present study.
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Decreases in rCBF in the cortex ipsilateral to the focus in the present study were 
greater than those seen in studies of local metabolic rate. The decrease in frontal cortex 
adjacent to the focus found by Collins (1978a) was 6-13%, with a reduction of 5-15% in 
the occipital cortex and 17-26% in the som atosensory cortex, all com pared with . This 
com pares to side to side differences in the present study of -12.1% (-0.3% in controls) 
in the frontal cortex, -49.5% (-28.6% in controls) in the parietal cortex, -56.8% (- 
28.9% in controls) in the auditory cortex, and -39.7% (-6.9% in controls) in the visual 
cortex.
The figures for the present study refer to percentage increases or decreases with 
reference to the contralateral side, while the past studies quoted compare absolute values 
for seizure and non-seizure groups. If the percentage difference in control animals 
(presumably that portin of hypoperfusion due to craniotomy) in the present study is 
subtracted, then the figures for the present and past studies become comparable.
Possible reasons for differences between the present and previous studies
a. Differences in intensity of seizure activity
It is possible that differing degrees of metabolic disturbance reflect different 
intensities of seizure activity. In the studies of Collins and Collins et al. mentioned above, 
various doses of penicillin (ranging from 25-300 units) were injected intracortically. 
The greater the dose, the greater the frequency of seizure movement, the wider the 
involvement of cerebral structures and the wider and more intense the metabolic 
disturbance. For example, Collins (1978) found that injection of 25 units produced mild 
unilateral seizures with 96% increase in metabolism round the focus, whil injection of 
300 units produced seizures with bilateral spread and an increase of 134% in metabolism 
round the focus. Collins (1978a) found that larger and repeated doses of penicillin 
increased the size and intensity of the metabolic disturbance, and increased the number of 
structures distantly activated by the discharges.
Differences in seizure intensity might explain som e of the above differences 
between the present and previous studies. It is certainly the case that activation (not seen 
in the present study) of such subcortical structures as the extrapyramidal nuclei, globus 
pallidus and entopeduncular nucleus, or the cerebellar hemisphere were seen  only after 
repeated injections (Collins 1978b) or after larger doses (i.e. 300 units) of penicillin 
(Collins et al., 1976), both of which resulted in more severe or bilateral seizures.
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However, Collins e t al. (1976) injected a group of rats with 25 units of 
penicillin, producing seizures which were descriptively milder than those in the present 
study i.e. involving the paw, face and head only, while those in the present study 
(excepting animal 10) also involved the hindleg and tail. Nonetheless, the disturbance in 
metabolism appears to have been greater than in the presen t study. It should be 
remembered that the deoxyglucose method requires that a steady state be achieved. For this 
reason, the animals in all the above studies had been exhibiting seizure activity for longer 
(in some cases  for a period of days (Collins 1978b) than in the present study, and this 
may well account for smaller degree of functional disturbance seen.
b. Dissociation of metabolic rate and blood flow
A further possible explanation for differences between the present study and 
studies of metabolism would be dissociation between metabolism and perfusion. The 
present study does not address this issue, nor does any study address it using the penicillin 
model of focal motor epilepsy. One study of kainic acid induced limbic status epilepticus in 
the rat (Tanaka et al., 1990) has suggested a degree of uncoupling between flow and 
metabolism, with increases in metabolic rate 2-3 times higher than rises in rCBF in the 
CA1 and CA3 areas of the hippocampus. However, in that study the two param eters were 
m easured at significantly dfferent time points, in different groups of animals. Other data 
suggests that the two param eters are coupled (Ingvar, 1986) during seizures.
c. Underestimation of high flows by IAP
It is recognised that very high levels of perfusion may be underestimated by the 
iodoantipyrine method. The ramped infusion technique produces a rising plasm a 
concentration of iodo 14C antipyrine and thereby prevents diffusion from neurones back 
into the circulation. Local brain levels of iodo 14C antipyrine at the point of death are 
determined and maintained by local cerebral blood flow, but when the animal is killed, 
diffusion from high to low concentration areas is no longer counterbalanced by differences 
in perfusion, and will continue until the brain is frozen. This effect has been described by 
Williams et al. (1991). They studied the effects of a delay of 3 minutes on rCBF, finding 
reductions of up to 50% in some structures. Such reductions were accompanied by marked 
loss of definition on autoradiographic films. This study of Williams et al. com pared
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freezing delayed by 3 minutes with immediate immersion of the head in liquid nitrogen and 
later dissection of the brain. In the present study, the brain was dissected out before 
freezing, and frozen to -40degC within one minute. No data exists to suggest what the 
degree of underestimation of high flows resulting from this lesser delay might be.
Theoretically, some index the extent of post-mortem diffusion of IAP can be gained 
from comparison of the relative definition of IAP and HMPAO films, as  diffusion problems 
affect the two tracers in a different manner. In the period after injection when plasma 
concentration is falling, but conversion of HMPAO to hydrophilic form is incomplete, some 
diffusion of the compound from neurones back into the circulation may occur, causing 
underestimation of high flows. If, as in the present study, the process is allowed to 
complete and the animal is killed after time has been allowed for all the HMPAO to convert 
to hydrophilic form, then postmortem redistribution from areas of high to areas of low 
perfusion will not occur, and neither will loss of definition on autoradiographic films. Any 
difference in definition between the two films is therefore likely to be due to post-mortem 
diffusion of IAP. In fact, the definition on IAP films was excellent, and in many cases even 
superior to that of the corresponding HMPAO film, providing no positive evidence for 
significant post-mortem diffusion (given possible technical reasons for loss of definition 
of some of the HMPAO films - see below).
One would expect the effect of post-mortem diffusion on high flow to be greatest at 
the edge of highly perfused structures, or in small highly perfused structures. In fact, in 
the sm allest structure showing a significant increase, the substan tia  nigra pars 
reticulata, the relative increase was 63.2%, which com pares with the increase in 
metabolism in this structure seen  by Collins (1978a) after a single seizure of 56%. He 
found an increase of 80% in the ventral thalamus (a larger structure), compared to 72% 
in the present study.
It is possible that som e very small (in both degree and extent) effects seen in 
studies of metabolic rate, such a s  the increases seen  in homotopic motor cortex 
contralateral to the focus, may have been lost due to post mortem diffusion of IAP. There is 
no reason to believe that they might be lost for this reason on HMPAO films. Nevertheless, 
even on the most careful inspection, changes in the homotopic cortex could not be 
discerned.
Ideally one would perform further studies to determ ine the effect of short 
postmortem delays in freezing of the brain, but this was beyond the scope of the present 
study. The above data do, however, suggest that the effect is small, even at high flows, if 
the brain is dissected out and frozen within 1 minute. This problem is further discussed 
below with respect to the relationship between IAP and HMPAO uptake.
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2. Com parisons with studies using other animal models of epilepsy
The patterns of activation and inhibition seen  during focal seizures depend mainly 
on the structure of origin of the seizure and the anatomical connexions of that structure 
(see Chapter 1). One would not therefore necessarily expect com parable patterns of 
change in metabolism or blood flow in different models of epilepsy. However, it is worth 
making som e comparisons with the degree of rise in rCBF and local metabolic rate using 
expamples from previous studies.
Limbic seizures induced by local amygdalar injection of kainic acid have produced 
flows of 400% of control values in the hippocampus, of 180% in the sensorimotor cortex, 
and of up to 185% of control values in the thalamus (Tanaka et al., 1990). Collins et al. 
(1983) found rises in glucose metabolism of up to 180% of control values in limbic 
structures in animals with limbic seizures induced by local injections of penicillin and 
picrotoxin. Lothman & Collins (1981) found increases in glucose metabolism to 440% of 
control values in the hippocampus, and to 133% of control values in the substantia nigra 
pars reticulata, in limbic seizures in the rat induced by intravenous injection of kainic 
acid.
Kindled limbic seizures have shown increases in metabolism to 83% and 173% of 
control values in the amygdala, to 92% and 224% of controls in the hippocampus and to 
230% of controls in the substantia nigra pars reticulata in 2 studies (Lothman et al., 
1985; Blackwood et al., 1981).
Studies of rCBF and metabolic rate in bicuculline-induced generalised seizures in 
the rat have found rises to 173% of control rCBF values in the sensorimotor cortex, to 
196% of control values in the thalamus (Ingvar & Siesjo, 1983), of almost 900% of 
controls in the inferior colliculi and of 860% in the thalamus (Horton et al., 1980).
With the exception of the limbic changes induced by local injection of kainic acid, 
the above changes in focal seizures are generally comparable in degree to those seen in the 
present study, e.g., increases to (mean) 113% of control values in the area around the 
focus, to 158% of control values in the septal nucleus, and to 255% of control values in 
the thalamus.
3. Comparison with changes in rCBF seen in human focal epilepsy
In a modelof focal motor seizures one might expect to see  changes analogous to those 
found in focal motor seizures in humans, and possibly to seizures originating in the
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premotor areas of the frontal lobe. Little work exists to confirm this, but a series of 
patients with frontal lobe seizures studied ictally with HMPAO SPECT (Duncan et al., J 
Neurophysiol, 1993, in press) has shown hyperperfusion of the focus, the basal ganglia, 
the thalamus, and the cerebellum. Hypoperfusion has also been shown but, a s  in the cases 
presented in Chapter 3, involving the frontal lobe or hem isphere contralateral to the 
focus. Possible mechanisms are discussed in Chapter 3. This situation may be contrasted 
with seizures originating in the mesial temporal lobe, where activation of the basal 
ganglia is more prominent (see Chapter 3)
Causes of perfusion changes seen In the present study
Given that the perfusion changes seen  in the present study have followed the 
general pattern of metabolic changes seen  in similar seizures, then it seem s likely that 
they are simply the result of the circulatory requirem ents of the metabolic activity 
required to sustain the electrical activity associated with seizures.
It seem s likely that the hypoperfusion seen  in association with penicillin induced 
seizures represents the sam e phenomenon as hypometabolism in deoxyglucose studies 
(Collins 1978a), and is therefore simply secondary to reduced metabolic demand. Collins 
suggested two possible mechanisms. Firstly, inhibition of normal synaptic excitation. He 
hypothesised that this might occur because of stimulation (by seizure activity (Collins et 
al., 1976; Schwartzkroin et al., 1975)) of the ventral thalamus, inhibiting or disrupting 
transmission of sensory data to the cortex. Secondly, an increase in inhibitory firng might 
also explain the reduced metabolic and circulatory activity. Collins pointed out, however, 
that inhibitory processes themselves require energy. Nonetheless, in the area around the 
focus, neurones show reduced firing rates and hyperpolarisation, the phenomenon known 
as 'surround inhibition' (Prince & Wilder, 1967). The studies of Collins and Colins et al. 
do show reduced metabolism in these areas, and the present study shows reduced 
perfusion, suggesting that the net effect of such inhibition (plus or minus any possible 
effect from lack of normal input) is a reduction in metabolic rate and perfusion. Why the 
reductions in perfusion and metabolism (both in studies of metabolism and in the present 
study) are greatest in the posterior cortex rather than around the focus is not clear.
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Correlation between IAP and HMPAO distribution
Effect of 99^ T c on IAP films
Contamination of IAP films by 99myc activity is very small. Over a period of 4 
days " mTc(half-life 6 hours) activity will fall to 0.000015 of original levels. By the 
time the area with the highest " mTcactivity seen in this study was exposed on 14C film, 
its activity was 0.00027uCi/g, a figure which continued to fall by half every 6 hours 
during the 2 weeks of exposure of 14C films. This would result in a maximium of 0.12% 
contamination of the the low-flow area on an IAP film mentioned above.
Effect of 14C activity on " mTcfilms
If the concentration of 99mTC HMPAO is high in a given structure, and the 14C IAP 
concentration low, then contamination will be small: maximal contamination will occur 
when the concentration of HMPAO is low and the concentration of IAP high. The maximum 
activity seen  on the IAP films in the present study was 1130nCi/g, or 1.13pCi/g. The 
lowest activity seen on HMPAO fims was just over 2fiCi/g. If the activities had been seen 
in the sam e structure, then 14C contamination would have been responsible for 56.5% of 
the optic density of that area of the HMPAO film. In this event, the original discrepancy in 
uptake between the films would have remained obvious. In fact, the equivalent structure on 
HMPAO film to that with the highest activity on IAP films had an activity of 17.94pCi/g. 
The 14C contamination of the HMPAO film in this structure was therefore 6.3%. In an area 
of low flow (left subcortical white matter in rat 2), the 14C activity was 0.195pCi/g, and 
the 99 ^ T c activity 3.64pCi/G. Contamination in this instance was 5.4%. One one would 
expect this to be the approximate level of contamination in all the animals in the present 
study, where the distribution of IAP and HMPAO was similar, with slightly lower figures 
at low flows resulting from relative underestimation of high flows by uncorrected 99m-|-c 
activities.
Pattern of HMPAO vs IAP distribution
The distribution of HMPAO as indicated by the autoradiographs was almost identical 
to that of IAP. The relatively high uptake seen in the choroid plexus was also described by
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Bullock et al. (1991), who suggested it might be due either to the unusual absorption 
characteristics of the choroid or to an underestimation of blood flow by IAP. The fact that 
uptake of HMPAO also appeared to be relatively high where the section included 2 layers of 
pia suggests that increased uptake and/or retention in the pia was responsible. There is no 
obvious explanation for the difference seen  in the supramammillary nucleus, but the 
difference in timing of the two m easurem ents during an experiment during which little 
time was allowed for achievement of steady state might also be responsible for some 
differences between IAP and HMPAO films.
The relatively poor spatial resolution of some HMPAO films may have a technical 
explanation. From the difference in resolution of bubble artefact, it is clear that whatever 
factor was responsible operated after the preparation of the sections, i.e. post mortem. 
Since resolution of scratches was the sam e in both types of film, it is likely that the 
responsible factor operated before the stage  of photography, suggesting either that 
redistribution of HMPAO carried on during exposure of the section (which seem s 
unlikely) or a that there was a technical problem with the film itself or with the 
development process. The 3H sensitive film used for HMPAO is more grainy than the film 
used for 14C, and this may have contributed to the effect.
Correlation between blood flow as calculated by the IAP method and HMPAO concentration
The main aim of this series of experiments was to test the correspondence between 
lAP-determined cerebral perfusion and HMPAO concentration at the high flows seen during 
seizures. The penicillin model produced some very high flows indeed in individual rats. In 
all the animals, the linearity of the relationship between rCBF and HMPAO (as indicated by 
" mTc activity) was improved, in most cases  to a relationship approximating to a straight 
line. In 2 animals (4 and 8) the statistical programme produced a hyperbolic curve, 
although the degree of curve was relatively small, and the relationship did not deviate 
significantly from a straight line.
The uncorrected curve fitted to the data for rats 1,6 and 7 were parabolic, showing 
fall off above flows of 250, 400 and 450ml/100g/min, respectively. W ere this to be a 
real phenomenon, it would have serious implications on the use of HMPAO as a cerebral 
perfusion tracer. As flow increases the concentration of HMPAO trapped in brain tissue 
after bolus injection will peak, and then fall a s  flow increases further. The sam e tissue 
concentration of HMPAO will therefore appear at two points on the curve, and may be 
indicative of either of two levels of perfusion. However, examination of the data points in
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the uncorrected curves for rats 1,6 and 7 show no evidence of fall off, rather showing a 
flattening of the rate of rise, which the second order polynomial curve fitted by the 
statistical software used cannot accomodate.
The results therefore show that even without the Lassen correction, HMPAO 
concentrations increase with blood flow, even at flows of over 600ml/100g/min, albeit in 
a non linear fashion. After correction, the linearity of the relationship was preserved, 
even at the highest flows seen.
The closeness of the correlation is less than that found in a previous study. Bullock 
et al. (1991) found R2 values of 0.84-0.93 using pooled data for a total of 11 rats, 
correlating flow as measured by IAP and HMPAO uptake in acute focal ischemia. Flows of 
up to just over 300ml/100g/min were seen. This com pares with the range of R2 0.74- 
0.94 for individual animals in the present study, where the range of flows was two times 
greater. The range of flows may have some bearing on this difference, as in most of the 
rats the spread of data becam e greater at high flows. This probably had two causes; the 
Lassen correction and the calculation of flow from IAP activity both tend to magnify small 
errors in densitometry as flows increase (Horton et al., 1980). The effect of the Lassen 
correction at high flows can clearly be seen  by comparing uncorrected and corrected 
correlations with rCBF. Only in Rat 3, where relatively few high flows and Tc99m 
activities were seen, was the scatter of the data not increased (and R2 reduced) by the 
application of the Lassen correction. This effect is exacerbated by the fact that the 
correction only operates over a limited range. The main determinant of this range is the 
reference value for blood flow that is chosen (see formula for the Lassen correction, 
introduction to this chapter). In this study, however, some seizure animals showed a very 
high range of flow, and the correction calculated by the function becam e vary large or 
negative. The function defined by the correction is plotted in Figure 4.1, and illustrates 
the effect.
The difference in timing of the two techniques may also be responsible. Although 
the rats were clinically in approximate steady state during the three minutes between 
HMPAO injection (necessary to allow completion of trapping, and therefore any washout 
eftect) and the performance of the IAP procedure, it is possible that flows in some 
structures changed during this period. Perfusion changes during seizures take place over a 
time scale of seconds (Penfield, 1933; 1937; , Gibbs et al., 1946), and it is possible that 
sich changes were of sufficient magnitude to affect the correlation between IAP and HMPAO 
uptake. Moreover, both groups of animals were recovering from anaesthetic during this 
period, and it is possible that changes in flow due to changing plasm a and brain 
concentrations af anaesthetic agents may have occurred (see above).
199
Densitometry was performed on the sam e slices in IAP and HMPAO films. The point 
in each strucure at which the region of interest was placed was the sam e in each film (e.g. 
in the caudate nucleus 2/3 of the way laterally along a line bisecting the structure 
horizon tally). Each structure was measured on three consecutive sections. These measures 
were designed to minimise the chance of any discrepancy between IAP and HMPAO films due 
to differences in region of interest positioning. In relatively large and homogenous 
structures such as the caudate nucleus, small changes in position of the region of interest 
will have had minimal effect. In very small structures such as the habenular nuclei, an 
effect of ROI positioning is difficult to rule out, and may have contributed to poor 
correlation between HMPAO and IAP uptake.
The uncorrected scatter diagrams were examined, and obvious outliers identified 
as follows:
Rat 1 amygdalar nucleus (L & R) 
substantia nigra (R)
Rat 3 ventral thalamic nucleus (L)
Rat 4 hypothalamus (L & R) 
hippocampus (L & R)
Rat 6 ventral thalamic nucleus (R) 
lateral thalamic nucleus (L)
These outliers are all in relatively large structures, and mostly in non-seizure 
rats. Six of the 8 outliers in non-seizures rats were pairs of homotopic structures, 
suggesting a possible real change in perfusion of the structure between HMPAO and IAP 
injection, or som e other structure-specific factor leading to a difference in uptake, in 
these cases at least.
If practice effects were responsible for scatter in the data, one would expect later 
e)periments to show less scatter. There may be some effect of this. In chronological order, 
the R2 values for the uncorrected data were 0.64, 0.67, 0.79, 0.67, 0.72, 0.87, 0.68,
0.84, 0.87, 0.84. There is some trend toward improvement in later experiments. Such an 
effect might operate at the stage of animal preparation (earlier animals took longer to 
cannulate and prepare, and it was more difficult to control their physiological parameters,
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allowing variation between the HMPAO and IAP injections), performance of the IAP 
procedure (e.g. error in the timing of arterial samples), performance of the densitometry 
(e.g. error in positioning of regions of interest).
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Conclusions
1. The pattern of change in cerebral perfusion seen in association with penicillin induced 
seizures is similar to the pattern of change seen  in studies of local metabolic rate for 
glucose.
2. HMPAO and IAP distribute in the sam e manner in rats during penicillin seizures, with 
the exception that HMPAO is taken up into the choroid plexus and possibly in the pia mater 
to a  greater degree.
3  99m-rc ancj 14q activities correlate well, even in structures where blood flow is very 
high. Although uncorrected data showed a fall off in the rate of rise of 99myc uptake vs IAP 
uptake, there was no evidence of reduction in HMPAO uptake at high flows. The results of 
this study therefore support the use of HMPAO as a cerebral perfusion tracer during 
seizures.
4. The Lassen correction improved the linearity of the relationship between HMPAO and 
IAP uptake in this study. Where the range of flow is high, however, small changes in optic 
density produce large and som etim es negative corrections, limiting the utility of the 
correction.
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Appendix
Methods
S9mTc as a radioisotopic marker
" mTc has a physical half life of 6 hours. It is produced as  a pertechnetate 
f:om the decay of " M o  in commercially available generators. Because of its easy 
cvailability, and its predominant energy peak at 140keV in the gamma range, it is 
vridely used for radioisotope imaging. The pertechenetate form does not pass the blood- 
brain barrier, and cannot therefore be used for imaging regional cerebral blood flow.
HMPAO as a radiochemical tracer of rCBF
HMPAO (hexamethylpropyleneamine oxime) is the result of an effort to 
develop a convenient tracer of rCBF which could be used with conventional rotating 
gamma cam eras. The relatively long acquisition time of these instruments m eans that 
the ideal tracer for use with them should be lipophilic, with a high first-pass 
extraction across the blood brain barrier, and should be retained in the first pass 
pattern, in much the sam e way as microemboli. 123l labelled tracers such as IMP and 
HIPDM (Holman et al., 1984) were originally developed, but these compounds had a 
relatively long uptake phase, and were unstable in the brain, allowing a degree of 
vvashout. 123l, moreover, is costly and requires a cyclotron, limiting availability. 
Suitable 99m jc labelled compounds were therefore sought.
HMPAO was developed from PnAO, a lipophilic compound which distributed in 
brain according to rCBF with a high first-pass extraction, but which was not retained. 
HMPAO was produced by alkylating PnAO. The structure of the HMPAO molecule is 
shown in Fig 1. It is a neutral and lipophilic molecule, with m eso and d,l 
d iastereoisom eric forms, the d,l form being a recemic mixture of d  and I 
enantiomers. The d,l form is less stable, and has a higher brain uptake and lower 
washout rate (Sharp et al 1986). The mechanism of the change from lipophilic to 
hydrophilic form remains uncertain, but may be related to interaction between the 
oxime groups of the HMPAO molecule and intracellular reducing agents such as 
glutathione. Neirinckx et al. (1988) showed that incubation with glutathione rapidly 
converted lipophilic HMPAO to the hydrophilic form, and that depletion of glutathione 
in brain homogenates reduced the rate of conversion. They also showed that in vivo 
retention of HMPAO in the brain, heart and liver m atched well with retention 
predicted by glutathione concentrations, although measured and predicted values in the
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lung matched less well. El Shibirny et al. (1989), however, found no correlation 
between glutathione concentration and HMPAO uptake in the rat.
" mTc HMPAO is obtained simply by mixing up to 1000MBq of 99nr>TC 
pertechnetate diluted in 5ml of saline with 0.5g of freeze dried d,l HMPAO (stored in 
a nitrogen-filled vial), and shaking for a few seconds. The percentage of total 
radioactivity in the lipophilic form (or radiochem ical purity) is 88-92%  
immediately after reconstitution. The compound is unstable in the vial: conversion to 
hydrophilic forms takes place with a T 1/2  of 2-4 hours, so it is recommended that it 
is injected within 1 hour of mixing (in the present study, HMPAO was injected within 
30 minutes of mixing). Radiochemical purity changes rapidly in saline and in blood: 
Lear (1988) found that this occurred so rapidly that by the time blood sam ples could 
be prepared for chromatography, most of the HMPAO was in hydrophilic form. The 
time curve of the conversion in blood appears to be complex, and may differ for d  and 
I forms (Lassen et al., 1988). Because of this change in radiochemical purity, the in 
vivo curve for total reactivity and that for activity in the lipophilic fraction after IV 
injection are different. Andersen et al. (1988b) m easured arterial input of lipophilic 
tracer to the brain using rapid octanol extraction of the lipophilic fraction, and found 
that while the lipophilic fraction constituted 75% of the total counts at the peak of the 
curve, it constituted only 23% 15s later. Despite the use of the rapid octanol 
technique for separating  and m easuring the lipophilic fraction, difficulty in 
determining the quantity of lipophilic HMPAO delivered to brain has remained a major 
problem in the development of a practical method for quantitating rCBF using HMPAO 
(absolute CBF for the whole brain has been m easured (Andersen et al., 1988), but 
problems in measuring regional CBF include the variation in HMPAO extraction with 
flow, and scatter effects inherent in the SPECT method).
After intravenous injection HMPAO is distributed widely in body tissues, 
approximately 4% of the injected dose reaching the brain (Sharp et al., 1986; 
Neirinckx et al., 1988). In the head, there is uptake in the thyroid, nasal and oral 
mucosa, lacrymal glands and temporalis muscles (Andersen, 1989), all of which may 
be seen on brain SPECT images . Peak first-pass extraction of HMPAO was found to be
0.81 by Andersen et al. (1988a). Andersen et al. (1988c) m easured the time course 
of externally detected head counts (Fig 4), finding at peak at 50s after IV injection. 
There was a (decay corrected) 20% decrease  in activity over the subsequent 24 
hours.
The kinetics of HMPAO can be described using the four compartment model (Fig 
2) proposed by Neirinckx et al. (1988), and Lassen et al. (1988). A represents the 
amount of freely diffusible (lipophilic) HMPAO in blood, B represents the amount of 
freely diffusible (lipophilic) HMPAO in tissue, C represents the amount of trapped 
(hydrophilic) HMPAO in tissue, and D represents the amount of trapped (hydrophilic)
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HMPAO in blood. The first-order rate constants k3 and k5 describe the conversion 
rate from lipophilic to hydrophilic HMPAO. The conversion is com plete and 
irreversible, so effectively k4 and k6 = 0. K1 describes the clearance of HMPAO from 
blood to tissue. K1=EF, where F is blood flow (ml/g/min) and E is the first pass 
extraction from blood to brain. k2=K1/l=EF/l, where I is the tissue-blood partition 
coefficient of Kety.
Lassen et al. (1988) studied the comparison of rCBF, as m easured using the 
Xe-133 intracarotid injection method, and counts recorded after intracarotid bolus 
in je c tio n s"mTc HMPAO in human volunteers. They used a three compartment model 
(Fig 3) to analyse the diffusion of HMPAO across the blood brain barrier, its uptake 
into brain tissue, its retention and its back-diffusion into blood. Compartment 1 is the 
lipophilic tracer in blood (m easurem ents of radiochemical purity of the injected 
HMPAO were made using rapid thin layer chromatography - as  the time between 
injection and arrival in brain was short, the activity peaking at 3-5s, it was assum ed 
that it did not change significantly before arriving in brain), compartment 2 is the 
lipophilic tracer inside brain tissue, and compartment 3 is the hydrophilic HMPAO 
retained in brain. They found a steady state extraction (i.e. retention) of 0.38 ±  0.05, 
the plateau being reached after a rapid decline phase of 10-12s, followed by a slow 
decline phase of 2-4 min, to 40-50% of peak values. Decay-corrected losses after 
steady state had been reached were 0.5%/hour in 2 human subjects. They found that 
the retained fraction of HMPAO d ecreased  linearly with increasing rCBF (R=-
0.18F+0.5, where R is the retained fraction of lipophilic HMPAO and F is flow). From 
their data, they derived an equation to linearise the relationship between rCBF and 
" mTcHMPAO uptake:
f /f r= o x C /C r) /(1 + 6 -C r)
where f is the true CBF, C is the measured HMPAO uptake in the brain area of interest, 
and fr and Cr are the flow rate and m easured " ^ T c  HMPAO concentration, 
respectively, in a reference region of the brain. The constant o is the ratio of the rate 
of conversion to the rate of back-diffusion and clearance in the reference region 
Applied to images, the correction has the effect of slightly increasing the contrast 
between high and low flow regions, (Yonekura et al., 1988). The correction was not 
applied to images in this study. Since a non-linear colour scale was used for visual 
interpretation, the application of a linearising correction to im ages was considered 
spurious. It is likely that the effects of the non-linear relationship between rCBF and 
HMPAO uptake are seen to some degree in the ictal and postictal work presented in 
C hapter 3, w here the ictal high-flow abnorm alities seen  may have been  
underestimated. Given that the relationship remains almost linear at flows of up to
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200ml/100g/min (see Chapter 4), it is unlikely that the data in Chapter 2 (where 
almost exclusively low-flow abnormalities were identified) was significantly affected.
Single photon emission Tomography
The aim of em ission tomography is to determ ine the three-dim ensional 
distribution in space of a gamma-emitting radioisotope. For medical purposes, the 
space usually contains all or part of the body, and the information is usually produced 
as a visual image, generally of a slice of the structure imaged, of a given thickness in a 
given plane. This three-dimensional information is reconstructed by computer from a 
series of planar images taken from different angles by the imager. The mathematical 
principles used in this process have been known for a long time (Radon, 1917), but 
in practice, account has to be taken of the finite sampling and other physical 
characteristics of the devices used (Budinger, 1980). Kuhl et al., (1963) made the 
first attempts to produce tomographic cross sections of the body using radionuclides, 
and single rotating gamma cam era systems were in use for brain imaging by the late 
seventies (Kuhl et al., 1975).
The SPECT imager usually consists of a large flat detector, behind a parallel- 
hole collimator (the 'head'). Very fine collimators improve spatial resolution, but 
reduce sensitivity. Multi-head instrum ents acquire more information during an 
acquisition of a given duration, allowing the use of a finer collimator without loss of 
sensitivity. This therefore produces images of better spatial resolution and contrast. 
Instruments with ring detectors and rotating annular collimators are also available. 
The majority of SPECT systems are single headed gamma cam eras. The cam era rotates 
around the head (Fig 5), stopping every few degrees, taking a series of images. The 
images are planar, and are of the sum of activity coming from the full thickness of 
brain, distributed in the plane of the detector. There are two types of technique for 
reconstructing a three-dimentsional data se t from these series of planar images 
im ages; filtered back-projection and iterative reconstruction (Herman, 1980; 
Williams, 1985). The former technique is based on the projection of of pixel data onto 
the reconstruction image plane, followed by a filtering process to com pensate for the 
blurring effect of back-projection, and statistical counting errors. The latter 
technique involves an initial estim ate of the distribution of the data, followed by 
repeated back-projection and comparison with the previous estim ate. The process 
stops when the differences between estimate and real data are within defined limits. 
Iterative techniques offer advantages where data is less com plete and in image 
smoothness, although they require more computational power.
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The SPECT imaging system used in the present study is dedicated to the imaging 
of the brain. Rather than producing the three-dimensional reconstruction from a 
series of planar images, it acquires a  series of axial slices one after the other 
(Stoddart & Stoddart, 1979). The device comprises 12 large sodium iodide detectors 
spaced  30° apart in a ring round the head. Each detector has a point-focused 
collimator. The detector and collimator move rectilinearly (in 3 dimensions) during 
the acquisition of each slice (Fig 6), so  that the focal point of the collimator scans 
through half the field of view, the opposite detector scanning the other half 
simultaneously. Each detector takes 128 m easurements along 6 or 9 lines in its field 
of view, which is an 8x4xZ inch cube (Z being the axial dimentsion, which is 
adjustable)(Fig 7). The field of view of the entire system is taken to be a cylinder 8 
inches in diameter, of variable height, and is therefore scanned by the focal points of 
the 12 detectors with 6-fold redundancy.
The system uses an iterative reconstruction algorithm (Stoddart & Stoddart, 
1979; Moore & Mueller, 1986), which has to take into account the fact that photons 
coming from a direction described by any line passing through the focal point at an 
angle within the angular field of the collimator, will be included in the acquired 
information, and will contribute to image blurring (see point spread function of the 
detector, Fig 7). The algorithm can be simply summarised as follows:
1. Deblur raw data to determine the boundary ellipse (of the slice) to be used in the 
estimation and correction of attenuation (i.e. attenuation of radiation as it p asses 
through tissue) effects.
2. Deblur again using filtration and attenuation correction derived from 1.
3. Reblur in a simulated scan, using the difference between the simulated and raw data 
to determine the error in the ability of the image to reproduce the raw data.
4. Repeat 2.
Usually 1-4 iterations are required before the raw data  can be reproduced 
with acceptable accuracy from the simulated image.
The head is scanned in the axial plane for practical reasons. Slice thickness is 
12mm, and sufficient contiguous 12mm slices are acquired to include the whole brain. 
These slices are then integrated into a three-dimensional representation of rCBF 
which can be sliced in any plane, with any degree of tilt. The FWHM of the system is 
8.1mm at the centre of the field and 8.7mm 8cm from the centre.
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Spatial resolution, contrast and partial volume effects
The spatial resolution of a SPECT system is empirically determined by placing 
a small diameter line source in the fields of the detector(s). The source is ideally 
infinitely small, but in practice should be small enough (commonly <1mm) as  to 
appear as a point. A signal profile is drawn through the line source at right angles, and 
a Gaussian curve is obtained. The distance between the arms of the curve at half 
maximum signal (full width at half maximum - FWHM) is defined as  the system 
spatial resolution. This distance defines the ability of the system to distinguish two 
point sources of the sam e signal strength, and to produce images with appropriate 
contrast and sharp boundaries between neighbouring structures of different signal. A 
structure of interest can be reconstructed if its size is greater than twice FWHM, 
assuming it is of similar signal to the surrounding tissues (structures with activity 
higher than the surrounding tissue are better distinguished - even a point source will 
be distinguished if it is of sufficiently high activity, albeit that its size will be 
overestimated). If the structure in question is smaller than 2 x FWHM, then the 
reconstructed volume will be different from the true volume (larger or smaller 
depending on whether its signal strength is higher or lower than surrounding 
tissues), and the difference between the activity concentration of the structure and its 
surroundings will be underestimated. This is termed the 'partial volume effect'.
The effect of scatter of emitted photons
A proportion of the photons emitted by a radioisotope will collide with 
particles in the matter through which it is travelling, and will be scattered. Such 
photons give false directional information, causing a loss of contrast. They have lower 
energy than their non-scattered counterparts, but filtration methods, including the 
use of asymmetric energy windows, are not yet adequate to compensate. Improvements 
in image quality have been reported using information acquired using a scatter energy 
window simultaneously with that acquired using a standard peak window. A proportion 
of the scatter data is subtracted from the peak window data (Koral et al., 1990). 
Systems incorporating scatter corrections are now becoming available, although their 
effectiveness has still to be shown, and scatter remains one of the problems with 
quantification of SPECT images.
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Visual analysis of HMPAO SPECT images
Visual analysis of images is of necessity subjective. Where im ages are non- 
quantitative, estimates of normality or otherwise of the pattern of signal are based on 
the previous experience of the observers of both normal and abnormal images, and are 
made in the light of cerebral anatomy in general and of individual anatomy where it is 
known to be abnormal. In the present study, the SPECT images were all of sufficient 
spatial resolution to allow the observers to infer the anatomic location of parts of the 
image of interest from the known normal or individual anatomy, and the known normal 
pattern of rCBF. The reported localisation of abnormalities of rCBF in the present 
study is based on this type of inference. Reporting entailed the assumption that if the 
brain were divided into two areas, each with a different signal level, then it was the 
smaller area that was likely to be abnormal: e.g. when one temporal lobe had lower 
signal than the rest of the brain, it was assum ed that it was the temporal lobe that was 
abnormal, not the rest of the brain.
As regards the presence or absence of abnormality (and its degree), three 
questions were asked;
1. Is the signal in a given area of the image the sam e as  that in the homologous 
contralateral area, or is there a significant asymmetry?
2. Is the signal in a given area of the image in normal relationship to the signal levels 
in homolateral areas?
3. Can any abnormality seen be accounted for simply by the anatomy?
The question of limits of normal (in numeric terms) has been addressed in 
series of normal patients (see Chapter 2, p35). To gauge the practice of visual 
analysis adopted in the present study, the exercise described in Chapter 2 was carried 
out (see Chapter 2 Discussion, p71 & Fig 2.16). This experiment showed that, using 
the colour scale adopted in this study, the observers reported asymmetries of more 
that 8% as  abnormal. However, factors other than simple asymmetry were taken into 
account by the observers: if an area of 2cm2 of the lateral temporal cortex had a signal 
level 5% less than the homotopic structure, and less than the surrounding cortex, 
then numeric analysis would regard the difference as  being within normal limits. 
However, if the area had a sharply (taking account of the spatial resolution of the 
imager) delineated boundary, then the observer is likely to notice and report the 
feature as abnormal. In this event, the answer to Question 2 (above) is no. There is at 
present no generally available system of numeric analysis which can take this type of 
factor into account. This is probably why the experiment described in Chapter 2, in 
which the observers were asked to judge symmetry of signal only, yielded a limit of
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normal close to that derived numerically in other studies, with almost no discrepant 
observations, whereas there were in practice a number of discrepancies between 
visual and numeric analysis in the present study.
As discussed in Chapter 2, the practice of reporting images by independent 
observers, followed by consensus conference when reports disagree is an accepted 
method of producing visual reports of images for scientific studies. Knowing only the 
diagnosis of epilepsy, each observer looks at the image and notes his interpretation of 
it. Once all the images have been seen by both observers, the reports are compared. 
Where reports agree, they are recorded as the result of visual analysis of the scan. 
Where reports disagree, the two obsevers then re-analyse the images together and 
produce a consensus report. The method has been largely used in SPECT studies in 
epilepsy (Rowe et al., 1989a;b; 1991 a;b; Newton et al., 1992; Lee et al., 1986; 
1987a;b;1988; Shen et al., 1990). In the present work, 139 SPECT studies were 
reported. The blinded visual reports disagreed in 18 cases, in ail of which the two 
observers had disagreed over whether an asymmetry was or was not within normal 
limits. All but one were finally reported as normal.
Numerical analysis of HMPAO SPECT images
In the present study, regions of interest were determined and measured as 
follows:
1. The anatomic structures of interest were identified on normal MRI images.
2. Using a normal image of rCBF acquired by the device used in the present study, the 
correspondence of these anatomic structures of interest with normal cortical and 
subcortical patterns of rCBF was established (the correspondence is close, and has 
been illustrated elsewhere (George et al., 1991)).
3. Regions of interest were drawn on those SPECT slices which displayed the anatomy 
of the structures to be analysed most clearly, and allowed a reasonably large ROI to be 
used so as  to have the largest sample volume possible (in practice, transaxial 
temporal lobe slices in the case of temporal lobe ROIs, and orbitomeatal slices for 
other ROIs). ROIs were drawn such that as much of the structure as possible was 
included, but that the ROIs were sufficiently within the boundaries of that structure to 
minimise partial volume effects. To further increase sample size, double thickness 
slices were used.
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4. The ROIs were placed on corresponding double thickness slices on patient images, 
according to the pattern of rCBF. ROI placem ent was symmetric, except where 
structural imaging had shown anatomic asymmetry, in which case  the ROIs were 
placed with reference to the individual's structural image.
5. The counts for the defined volume of brain were measured, and were averaged over 
the area (and therefore the volume) of the ROI. This figure was used to calculate an 
asymmetry index as described in Chapter 2, Methods section.
This method of ROI placement with maximal sample size was designed to 
minimise variations in asymmetry index due to 'small volume' variations in rCBF and 
to variations in ROI placement. Smaller and more numerous ROIs might have detected 
changes in smaller volumes of brain, but would have produced data which was much 
more intrinsically variable. In addition, the procedure used for image analysis was 
time consuming - the inclusion of a large number of ROIs would have precluded a study 
including such a large number of patients, a fundamental requirement of the aims of 
the interictal study described in Chapter 2.
The variability of asymmetry index due to variations in ROI placement was 
studied by the author (who carried out all the numerical image analysis in this work). 
Two HMPAO SPECT studies (of patients who were not among those studied in this 
work) were selected, one of high quality and one of relatively poor quality, with a 
large low flow area (so that the effect on ROI placement of difficulty in perceiving 
cortical paterns of flow could be studied). The two scans were analysed using the sam e 
procedure as in the Chapters 2 and 3 on five separate occasions separated by one week. 
The results are shown in Table 1, with means, standard deviations, ranges and 95% 
confidence limits for each ROI.
Standard deviations and 95% confidence limits were larger for the poorer 
quality scan in all ROIs with the exception of the frontal ROI. Nonetheless, standard 
deviations were within 1% (i.e. one percentage unit of the asymmetry index) on both 
scans for all structures except the basal ganglia and thalamic ROIs. This was not 
surprising, as these were the smallest of the ROIs, and both areas were surrounded by 
areas of lower flow (particularly in the case of the basal ganglia ROI which was 
adjacent to periventricular white matter) so that one would expect small variations in 
placem ent to result in relatively larger variations in asymmetry index. With the 
exceptions of the basal ganglia and thalamic ROIs, 95% confidence limits of the 
measurements were within 5% in the first scan, and within 3% in the second. Rowe et 
al. (1991) measured five scans on 2 occasions separated by 2 weeks. They found that 
the asymmetry m easurem ents differed by 1.5% ±  1.8% in the mesial temporal 
cortex, by 3.1% ±  5.9% in the anterolateral temporal cortex, and by 0.2% ±  2.5%
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in the posterolateral temporal cortex. Repeating several analyses on only two 
occasions is probably not the most informative way to study variablity in ROI 
placement, nonetheless the figures presented here probably com pare favourably 
rather than otherwise with those of Rowe et al. This may be because of the larger ROIs 
used in the present study, and the superior spatial resolution of the imager used 
(allowing more accurate and consistent placement of ROIs with respect to the anatomy 
as inferred from blood flow patterns).
The above exercise was carried one year after the image analysis in the main 
study. The operator had not used the sam e method of ROI placement in the meantime, so 
it is unlikely that a practice effect falsely improved the results of repeat analysis of 
SPECT images.
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Figure 1
The chemical structure of 99nnjc p nAO and " mTc HMPAO (reproduced from Neirinckx 
et al., 1988)
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Figure 2
Four-compartmental model describing in vivo kinetics of " ^ T c  HMPAO, as proposed 
by Neirinckx et al., (1988) and Lassen et al. (1988)(reproduced from Neirinckx et 
al., 1988).
A = freely diffusible lipophilic complex in blood; B = freely diffusible lipophilic 
complex in tissue; C = nondiffusible, hydrophilic complex in tissue; D = nondiffusible 
hydrophilic complex in blood; Ki = transfer of " ^ T c  from blood to tissue; K2 -K6  = 
first order rate constants for the transfer of " mTc HMPAO between compartments.
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Figure 3
Three-compartment model used by Lassen et al. (1988) to describe the kinetics of 
" mTc HMPAO after intracarotid bolus injection.
A
D
cB
A1 = lipophilic " mTc HMPAO in blood; A2 = lipophilic " mTc HMPAO in brain tissue; 
A3 = hydrophilic HMPAO retained in brain
Figure 4
Time course of 99mTc HMPAO uptake into brain after intravenous injection as 
assessed  by externally detected head counts in man (reproduced from Andersen et al.f 
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Figure 5
The functioning of a single head rotating gamma camera. In practice, commonly used 
acquisition protocols involve 64 images per study, with 30s acquisition time per 
image, and therefore a total acquisition time of 32 minutes. The entire study is 
acquired as a single unit.
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Figure 6
The functioning of the SME 810 mutidetector SPECT system. The detectors can scan 3, 
6 or 9 lines during the 3 minute acquisition of each slice. The acquisition time varies 
from 30-60 minutes, depending on the protocol used. The study is acquired slice by 
slice, the patient being physically moved downward with respect to the plane of the 
detectors each time a slice is completed. The slices are combined to make up an image 
of the whole brain.
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Figure 7
Diagramme of a detector and collimator from the imager used in the present study. The 
point spread function (PSF) is the volume taken into account by the reconstruction 
process (analogous to the optical concept of 'depth of focus' of a lens). The axial 
projection of the scan pattern of the detector is shown (u,v scan pattern) (reproduced 
from Stoddart & Stoddart, 1979).
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Appendix Table 1
Results of measurement of ROIs placed on 5 occasions 1 week apart
ROI
Mean of 5
m easurem ents SD Min Max 95%CL+ 95%CL-
Scan 1 (asymmetry index)
Lat Temp -32 ,15 0,81 -33 ,10 -30 ,98 -30 ,12  -34 ,186
Mes Temp 13,16 0 ,5 7 12,49 13 ,97 14 ,59  11 ,73
Occipital -6,11 0 ,6 7 -6 ,99 -5 ,32 -4 ,45  -7 ,7804
Frontal -11 ,84 0 ,2 6 -12 ,18 -11 ,54 -11 ,18  -12 ,492
Bas Gang 0 ,94 1,22 -0 ,79 2,31 4 ,0 0  -2 ,1127
Thalamus 4 ,3 3 1,28 2 ,5 0 6 ,04 7 ,5 2  1 ,1414
Parietal -7 ,65 0 ,64 -8 ,37 -6 ,90 -6 ,04  -9 ,265
Scan 2
Lat Temp 12,69 0 ,44 12,26 13,24 13,79 11 ,583
Mes Temp -1 ,09 0 ,16 -1,31 -0 ,87 -0 ,70 -1,4851
Occipital -0 ,73 0 ,43 -1 ,25 -0 ,10 0 ,3 8 -1 ,8394
Frontal 4 ,6 0 0 ,44 4 ,0 9 5 ,1 0 5 ,7 0 3 ,5095
Bas Gang -10 ,24 1,15 -10 ,34 -7 ,33 -7 ,36 -13 ,115
Thalamus 12,89 1,33 10 ,88 14 ,13 16 ,23 9 ,5616
Parietal 10 ,69 0 ,39 10,34 11 ,29 11 ,67 9 ,7069
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